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Abstract 
Background: Ghana has developed two main community-based strategies that aim to increase 
access to quality treatment for malaria, diarrhoea and suspected pneumonia, and to improve 
household and family practices: Home-based Care (HBC) and Community-based Health Planning 
and Services (CHPS). After two and eight years of HBC implementation in the Volta and the 
Northern Regions respectively, and more than 10 years of CHPS implementation in both regions, 
there was the need to assess the performance of these strategies in delivering care and preventive 
messages for children under-five with fever, diarrhoea or cough. Objectives: To assess (i) the 
curative component in terms of utilization, appropriate treatment given and client satisfaction; (ii) 
the preventive component in terms of carers’ disease knowledge and health behaviour and (iii) to 
determine the cost per case appropriately diagnosed and treated under the HBC and CHPS. 
Methods: A household survey was conducted in the Volta and Northern Regions. The study 
population were carers of children under- five who had a fever, diarrhoea and/or cough in the last 2 
weeks previous to the survey. In addition, a cost analysis was conducted. Results: HBC utilization 
was 17.3% and 1.0% in the Volta and Northern Regions respectively, while CHPS utilization was 
11.8% and 31.3%, respectively. HBC in the Volta Region was successful in reaching the poorest, 
contributing to health equity. Less than 50% of malaria, diarrhoea and suspected pneumonia cases 
received appropriate treatment in both regions and under both strategies. Health education messages 
from community-based agents (CBAs) in the Northern Region were associated with the 
identification of at least two signs of severe malaria (adjusted Odds Ratio (OR) 1.8, 95%CI 1.0, 3.3, 
p=0.04), two practices that can cause diarrhoea (adjusted OR 4.7, 95%CI 1.4, 15.5, p=0.02) and two 
signs of severe pneumonia (adjusted OR 7.7, 95%CI2.2, 26.5, p=0.01)-the later also associated with 
prompt treatment (p<0.5). In addition, HBC was associated with prompt care seeking behaviour in 
the Volta Region and CHPS with prompt care seeking behaviour in the Northern Region. The cost 
per case appropriately diagnosed and treated was lower under the HBC than under CHPS in the 
Volta Region. HBC unit costs from the societal perspective were higher in the Northern Region 
than in the Volta Region and than CHPS due to a high number of CBAs and low preventive and 
curative activities. However, household costs under the HBC strategy were lower than under CHPS 
in both regions, reducing the burden of health care cost for families. Conclusions: Several actions 
should be undertaken to improve HBC and CHPS performance ensuring the availability of drugs 
and CBAs (particularly in the Northern Region). The contribution of HBC to health equity, reduced 
household costs, disease knowledge and healthy behaviours may justify the inclusion of HBC 
(preventive and curative services) in the National Health Insurance Scheme benefit package. 
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Integrating statement 
While working in Dodowa Health Research Centre (Ghana) being the scientific officer at the 
Institute of Infectious Disease of Poverty, I was in contact with many MSc and PhD students. This 
experience made me feel a strong need in continuing learning and improving my skills. Because of 
my excellent previous experience with the LSHTM doing my MSc in Epidemiology several years 
ago, I started to explore the research programmes at the LSHTM, where I discovered the DrPH 
programme. Based on my background, having worked in different countries in international 
cooperation and lately in a research centre, and with a desire to keep on working in a public health 
organisation, I believed that the DrPH programme fit better with my profile than the PhD 
programme.  
The DrPH programme started with two compulsory modules: Evidence based Public Health Policy 
and Planning and Understanding Leadership, Management and Organizations. With the first module 
I learnt the importance of systematic reviews and how to conduct them; the relationship between 
research and policy/practice; the importance of research to inform evidence based policies, 
understanding that there are other factors that influence policy making such as values, experiences, 
resources or pressure groups; that researchers and policy makers are different communities with 
different interests,  and the importance of bringing them together in order to researchers understand 
and focus their research on real health problems and policy makers to be willing to use research 
results. However, without a well performing organization to implement policies, even if they are 
sound and evidence based, nothing will change. Therefore, I learn different methodologies to 
analyse an organisation and I conducted a strategic analysis of the National Health Insurance 
Scheme in Ghana. I understood the importance of the management and leadership to implement a 
policy and to improve the health of a population. That both, good managers and leaders are 
important, but organizations which are over managed but under led lose any sense of spirit or 
purpose, while poorly managed organizations with strong charismatic leaders may soar temporary 
to crash shortly thereafter. I also learnt more about my personality through a residential workshop 
with my classmates. This was a great experience that helped me to develop my Personal 
Development Plan reflecting on where I am, where do I want to be and which actions do I need to 
undertake to attain my goal.  
These compulsory modules ended with the Organizational and Policy Analysis exercise. I chose to 
evaluate the impact of Dodowa Health Research Centre (Ghana) on national health policies. This 
exercise helped me to explore different methodologies to assess the impact of research; to learn 
about the process of how research is generally conceived, implemented, disseminated and perceived 
by stakeholders in Ghana as well as identifying factors that influence the use of research for policy 
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making. Finally, I suggested how these findings could be considered in the Dodowa Health 
Research Centre strategic planning to reach its goals.  
The last component of the DrPH programme was the thesis. Living in Ghana, enjoying working 
with infectious diseases and believing that evaluation is a necessary tool to understand where we 
are, to improve performance and reach goals as well as being accountable, I wanted to evaluate a 
malaria intervention in Ghana. Understanding the importance of research for policy making, and the 
barriers for translating research into policy (which I learnt during my OPA), I started a collaboration 
with policy makers since research conception to identify research needs. Home- based care in 
Ghana was gaining interests and funds, moving from malaria home- based care to integrated 
community case management. However, programme managers were not sure about the success of 
this strategy based on the routine data and were interested in deepen explore its impact. Therefore, I 
decided to assess the home- based care strategy, including in the study another community strategy 
implemented in Ghana called Community-based Health Planning and Services. After several years 
of national implementation, what was the performance of these strategies in delivering preventive 
messages and care for children under-five with fever, diarrhoea or cough? There were several 
studies that have looked at HBC in Ghana. However, most of these studies focused in a few 
districts, looked particularly at the curative component of malaria HBC and were conducted in a 
more “controlled” context or under research study conditions rather than in a real-life programme 
context. Therefore, my objectives were to assess the programme implementation of the curative 
component- in terms of utilization, appropriate treatment given and client satisfaction-, the 
preventive component- in terms of cares’ disease knowledge and health behaviour- and the cost 
analysis of HBC and CHPS for the management of malaria, diarrhoea and pneumonia in children 
under-five years of age. The National Malaria Control Programme of Ghana believed this study was 
pertinent and decided to finance the field work. This thesis presents the introduction, the review of 
the evidence, the objectives, methodology, results, discussion and conclusions of this assessment.  
After almost five years engaged in the thesis and the DrPH programme, I can say that I learnt and 
improved several personal and technical skills. Being persistent and positive was critical to finish 
the DrPH programme, particularly when difficult moments arrive. I learned that it was not enough 
to do good work- it was necessary to do perfect work, trying for our best. Being specific, sending 
clear messages was another critical aspect that I learnt and I am still learning. I felt the importance 
of understanding that every piece of research must fit in a context and must respond to a research 
need. I improved my technical skills in epidemiology, statistical analysis and economic evaluations. 
I learnt that research doesn’t end with analysis and results. How we look at results, its interpretation 
and its significance at different levels- organizational, policy, local, regional, national or global- 
closes the circle and makes the difference between a good and a perfect piece of work. Finally, the 
  
8 
DrPH programme helped me to become a leader in Public Health that understands policy context, 
how to engage with stakeholders, encourage teams, communicate results, ensure high technical 
quality and standard of work and knows its own limitations, being able to seek advice and to learn 
from any opportunity.  
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Chapter 1. Introduction 
 
 
1.1. Malaria control and elimination and home-based care 
 
The World Health Organization (WHO) recommends a combination of measures for malaria control 
and elimination. Those measures include (i) preventive vector control, mainly through universal 
coverage of long lasting insecticidal nets (LLIN) and indoor residual spraying (IRS); (ii) preventive 
chemotherapy particularly to pregnant women and infants; (iii) universal prompt diagnosis and 
appropriate treatment of malaria and (iv) strong malaria surveillance (1, 2). WHO set the target to 
eliminate malaria from at least 35 countries by 2030 (2). 
Seeking care and seeking care promptly is critical to reduce mortality due to malaria. Access to 
antimalarials within 24 hours of the onset of malaria symptoms is vital to prevent progression to 
severe malaria or death. The Roll Back Malaria (RBM) partnership recommends that 100% of those 
suffering from malaria should have prompt access to affordable and appropriate treatment within 24 
hours of onset of symptoms (3, 4).  
Data from 18 nationally representative surveys conducted between 2013 and 2015 in sub-Saharan 
Africa where the mortality burden from malaria is greatest, showed that an average of about 51% of 
febrile children sought care at any time from onset of symptoms in formal facilities (public or 
private), 13% in informal private facilities (pharmacies, kiosks and traditional healers) and 36% did 
not seek care, with variations among countries (5). Factors such as distance from home, poverty, 
financial constraints (direct and indirect cost), demands of domestic life, perceived poor quality of 
services, drug stock outs, and health workers’ behaviour have led to self-treatment of fever cases 
and the risk of inadequacy and/or bad quality of treatment.  
There are three key strategies that seek to improve physical access to quality treatment which are: 
extension and improvement in the quality of formal health care system, improvement in the 
informal private sector (mainly drug shops), and the home-based care (HBC) of fevers (6). These 3 
strategies are not mutually exclusive and should be complementary considering the different 
country specific characteristics. 
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1.1.1. Extension and improvement in the quality of formal health care systems  
The extension and improvement in the quality of formal health care systems, reducing or removing 
all out-of- pocket payments may improve the use of formal health services (6). Distance from health 
facility, quality of care and cost of services are recognised barriers for the use of health services (7-
15). The Alma -Ata Conference called for the need to increase geographical access to health 
services (16). The 2008 World Health Report also stated the importance of building health 
infrastructure to achieve universal health coverage (17). With the aim of accomplishing this need, 
health planers often set the target of 5km distance, or a 1 hour walking travel time equivalent, from 
households to a public health facility (18-20). Low quality of care not only may decrease the use of 
services but also can explain unsatisfactory health outcomes. Quality of care is gaining interest in 
the last decades as geographic access to health care is not enough to save lives (21). A patient must 
be correctly assessed, classified and treated to reduce morbidity and mortality. The integrated 
management of childhood illness (IMCI) strategy aims to improve the quality of care given at 
facility level through improving case management skills of health-care staff and improving overall 
health systems among other things (section 1.3). Out-of- pocket spending for health care prevents 
people from using health services or from continuing treatment because they cannot afford to pay. 
Each year, approximately 150 million people experience financial catastrophe, meaning they are 
obliged to spend on health care more than 40% of their income, and the global gap between those 
who can access needed health services without fear of financial hardship and those who cannot is 
widening (22, 23). Recognising the benefits of removing user fees for access to health services, a 
global coalition on Universal Health Coverage (UHC) was launched in December 2014 (22) to 
accelerate reforms that ensure everyone, everywhere, can access quality health services without 
being forced into poverty. The UHC has 3 main objectives (i) equity in access to health services - 
those who need the services should get them, not only those who can pay for them; (ii) ensure 
quality of health services to improve health and (iii) financial-risk protection - ensuring that the cost 
of using care does not put people at risk of financial hardship (24). 
 
1.1.2. Improvement in the informal private sector 
The elimination of user fees is helping but not solving the problem of inequitable access to 
treatment (6). Transport costs and opportunity costs may also prevent people from seeking care in 
the formal health system, especially during the rainy season. Instead, drug shops are visited to seek 
care, although the cost of the drug might be higher than in a public health facility (which often are 
subsidized) and the drugs prescribed, the doses and the duration of the treatment is often not correct 
(6, 25-27). Different interventions have been put in place to improve the management of fevers (and 
also diarrhoea and suspected pneumonia) in the drug shops. The Affordable Medicines Facility for 
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Malaria (AMFm) pilot project conducted between July 2010- December 2012 in Cambodia, Ghana, 
Kenya, Madagascar, Niger, Nigeria, Tanzania, and Uganda aimed to increase affordability, 
accessibility, and use of artemisinin combination therapies (ACT) and eliminate the ineffective 
medicines sold in shops and pharmacies (28). An independent evaluation showed that the AMFm 
initiative had not fully achieved the aim of ACT affordability nor the elimination of ineffective 
antimalarials from the market. However, of the 8 pilots, 5 were successful in increasing availability 
through an increase of at least 20% of outlets stocking ACTs, 5 pilots were successful in reducing 
by 3 times the median price of ACT relative to the most popular antimalarial that is not an ACT in 
private for-profit outlets, and 4 pilots increased by 10% the ACT market share (29, 30). Lessons 
learned from Phase 1 were incorporated into the Global Fund core grant management and financial 
processes and the AMFm was subsequently renamed the Private Sector Co-payment Mechanism 
(28). The introduction of rapid diagnostic test (RDT) in drug shops and the training of drug sellers 
have showed positive effects in increasing appropriate treatment (26, 31-34).      
    
1.1.3. Home-based Care of fevers 
WHO and RBM states that in settings with limited access to health facilities, diagnosis and 
treatment should be provided at community level through community case management of malaria, 
recommending the introduction of RDT and rectal artesunate for referral when possible (1, 4, 35). 
The HBC strategy recognizes the importance of, and seeks to improve the effectiveness of, self-
medication practices. This strategy involves presumptively, or with parasitological confirmation, 
treating febrile children with pre-packaged antimalarial drugs distributed by members of the 
community and thus has the potential to reduce inequities in access to quality drugs. Challenges of 
HBC are an inevitable increase in overuse of antimalarials and a possible impact of this on 
increased risk of resistance to these antimalarials when parasitological confirmation is not done or 
drugs are taken incorrectly. 
Financial sustainability needs to be addressed when HBC aims to be implemented on a large-scale 
(6). Surprisingly, there is not much evidence on different experiences and approaches to HBC 
financing. WHO identified five approaches to the financing of long-term home-based care, which 
means to ensure that an individual who is not fully capable of long-term self-care can maintain the 
best possible quality of life. The 5 financing approaches identified were: (i) general taxation, (ii) 
social or health insurance, (iii) users’ fees, (iv) private insurance and (v) use of unpaid personnel 
(36). Although these approaches were developed for the care of people of all ages who have long-
term health problems, due to programme similarities (health personal reaching patients at the 
community), I consider that the financing approaches identified are also appropriate for HBC. 
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 1.2. Diarrhoea and pneumonia control measures and home-based care 
 
Diarrhoea and pneumonia in children under-five remain the leading cause of death globally, being 
responsible for an estimated 700,000 and 1.3 million deaths respectively in 2011 (37). Several 
systematic reviews showed that treatment of diarrhoea with zinc, ORS and feeding strategies, 
antibiotics for shigella, cholera and cryptosporidiosis, antibiotics for pneumonia and oxygen 
systems are effective for reducing mortality due to diarrhoea and pneumonia (14). How to make 
these proven interventions available to those in need is another critical question. The extension and 
improvement of the quality of formal care, the improvement of informal care and home- based care 
play an important role in reducing morbidity and mortality due to diarrhoea and pneumonia. The 
integrated Community Case Management (iCCM) of childhood illness was officially endorsed by 
UNICEF and WHO in 2012 (38).  
 
1.3. Integrated Management of Childhood Illness  
 
In the 1990s and due to the intolerable number of child deaths from preventable causes, WHO and 
UNICEF developed the integrated management of childhood illness (IMCI) to reduce the morbidity 
and mortality of children under- five (39). This strategy includes preventive and curative elements. 
The IMCI strategy has 3 aims: (i) to improve the management of childhood illness through an 
integrated approach (as opposed to a disease-specific approach), (ii) to strengthen the health system 
and (iii) to improve family and community health practices. The last aim is also called community-
IMCI. 
The rationale behind the preventive component of the IMCI strategy and the aim of improving 
health and community practice is that good quality of care once sick is insufficient to reduce 
mortality (40). Families should provide adequate home care to support the healthy growth of their 
children and to prevent them from being sick. They also need to respond appropriately when their 
children are sick, seeking appropriate and timely assistance and giving recommended treatments 
(40, 41).  
There are several community and family practices that promote child survival, child growth and 
development that are supported by community- IMCI. In 2004 Hill et al (42) reviewed the potential 
impact of 12 key practices identified by UNICEF and WHO on child survival, child growth and 
development. Subsequent studies and reviews agreed with the potential benefit of these practices 
and added other preventive strategies to reduce the morbidity and mortality of children particularly 
due to malaria, diarrhoea, pneumonia and under nutrition (14, 43-45) which are the leading causes 
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of death in children under- five (46). Some of the practices identified are vaccination, exclusive 
breastfeeding during the first 6 months of life, adequate complementary feeding after six months of 
age, deworming, vitamin A supplementation, hand washing, water quality, adequate faeces 
disposal, continued feeding and increased fluids during illness, use of insecticide treated nets, 
intermittent preventive treatment for pregnant women and appropriate care seeking behaviour. 
Finally, not adhering to treatment and referral instructions may cause treatment failure, drug 
resistance and the later misuse of leftover medicines. In 2009, the Global Action Plan for prevention 
and control of pneumonia (47) stated that identification of disease signs and appropriate care 
seeking behaviour is one of the strategies to improve child survival, particularly in areas where 
child mortality is higher than 40 deaths per 1000 live births. A review conducted in 2014 aiming to 
estimate the percentage of caregivers in low and middle income countries with a child of less than 
five years who were able to recognise signs of malaria, diarrhoea and pneumonia in their child, and 
subsequently sought care (48) suggested that those carers that identify severe signs of the disease 
are more likely to seek care. 
The IMCI strategy has been evaluated in 5 countries with different study designs: Brazil, Peru, 
Tanzania, Uganda and Bangladesh (49). The study in Brazil showed a better performance in IMCI 
facilities when compared with facilities not implementing IMCI, particularly in disease assessment, 
disease classification and in communication with carers of children under- five, although this was 
not translated into better carers’ knowledge on how to administer the treatment (50). In Peru, 
children under- five visiting IMCI health facilities were better assessed. With regards to treatment, 
counselling and availability of drugs and supplies, the results were mixed (51). IMCI facilities in 
Tanzania and Uganda showed  better assessment, classification of disease, better counselling and 
better carer’s knowledge on how to take care of their sick children, with less effect on drugs and 
commodities supply in the facilities and without significant effect in reducing child mortality (52-
54). The cluster randomised control trial conducted in Bangladesh showed the IMCI facilities 
provided a better assessment, treatment and counselling, and increase in exclusive breastfeeding, a 
reduction in stunting and an increase in the use of health facilities by children under- five with more 
children with severe signs being taken to a health provider, but without an effect on reducing child 
mortality (55, 56). 
 
1.4. The epidemiology of Malaria, Diarrhoea and Pneumonia in Ghana 
 
During the past 30 years, the under-five year mortality rate has declined in Ghana from 145/1,000 
live births in 1998 to 60/1,000 live births in 2014 (57), with an infant mortality of 41/1,000 and a 
neonatal mortality of 29/1,000 live births. These mortalities are higher in the north of the country 
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and in the rural areas. The main causes of under-five mortality are neonatal related causes (38%), 
malaria (20%), pneumonia (11%) and diarrhoea (8%) (46). Despite this decline in under-five year 
mortality, the Millennium Development target of 40/1000 was not reached (58). In 2012 the Child 
Survival Call to Action set “A Promise Renewed” with the target of decreasing under-five mortality 
rates to 20 or fewer deaths per 1,000 live births by 2035 in all countries (46). 
 
1.5. The Ghana Health System 
 
The Ghana Health Sector comprises the Ministry of Health and 16 Agencies dealing with service 
delivery, regulation, production of its human resources and purchasing health services. The 
Ministry of Health (MoH) has the responsibility for policy formulation, monitoring and evaluation, 
resource mobilization and regulation of health service delivery. The Ghana Health Service (GHS) is 
one of the 16 agencies of the Ghana Health Sector and is the principle provider of health services, 
followed by the Christian Health Association of Ghana, the private sector and NGOs, especially in 
the rural areas (59).  
Health service delivery is organized at three main levels: national, regional and district, with the 
district having a sub-district level and incorporating a community health delivery system. The 
provision of services or health interventions are packaged and delivered in teaching hospitals, 
regional hospitals, district hospitals, health centres and in two community- based interventions: 
Community-based Health Planning and Services (CHPS) and HBC.  
The health system in Ghana is financed by the government (including donor funds) covering 38% 
of the health cost, out of pocket money corresponding to 37%, other private sources (9%) and by 
the National Health Insurance Scheme (NHIS) covering 16% of the health costs (59).  
The NHIS was introduced in Ghana in 2003 through Act 650, which was replaced in 2012 by Act 
852 (60). The aim of the scheme is to (i) improve financial access to health services, (ii) improve 
the quality of the services and (iii) control the prices for services and drugs. The way the NHIS is 
funded is mixed: (i) Voluntary premiums from subscribers, in an attempt to capture the informal 
sector (corresponding to 4% of the insurance fund), (ii) Mandatory sales taxes and levis (2.5% of 
sales) are earmarked for health, which covers the exempt groups (61% of the insurance fund), (iii) 
Social Security and National Insurance Trust (SSNIT) (2.5% of the social security) which covers 
contributors and pensioners (15% of insurance fund) and (iv) Other sources like interest earned on 
NHIS reserves and sector budget support, (19% of insurance fund). Groups exempted from paying 
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premiums include: pregnant women, children under 18, adults older than 70, contributors and 
pensioners of the SSNIT, persons with mental disorder and indigents.  
The NHIS was designed to cover at least 95% of the burden of all disease. Health services are 
delivered through NHIS-accredited providers, from hospitals to CHPS compounds, including the 
private sector. As of 2013, 36.8% of the total population was an active NHIS enrolee while the 
target was 75% of the total population. 
In 2009-2011 the NHIS expenditures exceeded revenues, with the differential being -14, -47, -87.6, 
-7.5 and -40.6 million US$ in 2009, 2010, 2011, 2012 and 2013 respectively, at the respective 
annual conversion rate (61-63). Both claim costs and administrative expenses have increased 
significantly in 2009 and 2011; particularly the administrative cost has tripled (61, 64).  
The main NHIS challenges are financial sustainability, identification of indigents, high cost of 
medicines, ability to pay premiums and renewal challenges.  
 
1.6. Community- based interventions in Ghana 
 
Ghana has developed two main community based interventions or delivery strategies that aim to 
reduce barriers to physical access to quality treatment: the HBC and the CHPS.  
The HBC started on a pilot basis in Ghana in 1999 to treat suspected malaria cases (65). The pilot 
programme initially used chloroquine, shifting to ACT in 2005 (66). In 2009 and in the context of 
IMCI, Ghana developed the Home Management of Malaria, ARI and Diarrhoea in Ghana: 
Implementation Guidelines(65). HBC was defined as prevention, early case detection and prompt 
and appropriate treatment of fevers, acute respiratory infections (ARI) and diarrhoea in the 
community. Therefore, integrated Community Case Management (iCCM) was introduce in Ghana 
in 2009.  
The HBC strategy corresponds to the lowest level of health care delivery in Ghana and it is 
designed to be implemented within the health system, reporting activities to CHPS (when existing) 
or to the next health facility level. Community-Based Agents (CBAs) are provided with 
Information, Education and Communication (IEC) materials to conduct IEC activities to address the 
preventive aim of the strategy. All CBAs in the 3 northern regions (Northern, Upper East and Upper 
West Regions) provide treatment for malaria, diarrhoea and suspected pneumonia cases based on 
clinical symptoms and with the support of ARI timers for measuring the respiratory rate to diagnose 
pneumonia cases, mainly with the financial support of the United Nations Children’s Fund 
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(UNICEF). Those in the rest of the country have received the same training as the three northern 
regions but provide only malaria treatment with the support of the Global Fund to fight AIDS, TB 
and malaria (GFATM), and refer diarrhoea and suspected pneumonia cases for further management. 
Other projects implemented by Non-Governmental Organizations (NGOs) support the iCCM on a 
smaller scale in different regions of the country. The HBC guidelines states that the service 
provided should be free, although some regions (such as the Northern Region) decided that users 
should give a small amount of money to CBAs to avoid risking continuity and commitment of the 
strategy as can be seen in other countries (67-69). No target was set for iCCM utilization as a 
proportion of other delivery points for treatment of sick children. 
The strategic plan for malaria control in Ghana (2008-2015) set the objective to provide community 
based treatment to all (100%) communities (70). Each targeted community of 2000 people should 
have at least 2 CBAs. The implementation was planned to be phased, from 2009 to 2013 to reach 
100% of the rural districts (123 out of the 138 existing districts in 2006) (71), contributing to the 
target of 90% of children under-five (an estimated of 4,600,000 children) having access to ACT 
within 24 hours of the onset of symptoms. Due to urbanization of the country and the increase in 
number of districts (now 216), the NMCP revised their targets related to the number of districts 
implementing iCCM prioritising the rural districts.  
 
Using national routine data, it was reported that since the introduction of the strategy, 25,338 CBAs 
were trained (72) and the strategy has reached all regions (DHIMS2). In 2014, 163,468 cases of 
fever, cough and/or diarrhoea in children under five years old were seen through the strategy 
(Figure 1). Based on the under-five population by region, the regions reporting more HBC activity 
were the Upper West Region, the Upper East Region, the Volta Region and the Eastern Region. It is 
important to note that level of overall activity of HBC varied between regions, as did HBC’s 
preventive and curative components. The Upper West Region focused on the curative component, 
while the Upper East Region reports a balance of preventive and treatment activities and the Volta 
and Eastern Regions reported a high number of preventive activities with lower numbers of 
treatment. The regions with less activity were Greater Accra and Central region, which corresponds, 
together with the Ashanti Region, to the regions with the highest urban population (73). Conversely, 
the Northern Region has the third highest rural population (69.7%) after the Upper East and Upper 
West Regions, and has one of the lowest reported HBC activity, with a preventive component that is 
almost non-existent.    
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Figure 1. Home-based Care activity by region in 2014. Source: DHIMS2. WR: Western Region; CR: Central Region; 
GA; Greater Accra Region; VR: Volta Region; ER; Eastern Region; AR; Ashanti Region; BAR: Brong Ahafo Region; 
NR; Northern Region; UER; Upper East Region; UWR: Upper West Region. 
 
 
The CHPS strategy was developed in Ghana attempting to respond to the 1978 Alma Ata 
Conference and the ‘Health for All’ principle (74). The vision of the CHPS strategy was to 
accelerate progress towards the Millennium Development Goals 4 and 5 on child health and 
maternal health respectively. Its goal was to transform the dynamics of rural health care service 
delivery from community health care providers who passively wait for patients into outreach 
workers who actively seek patients in communities and their homes, also known as doorstep 
services (75). This strategy was a result of a collaboration between researchers and health 
administrators. Ghana developed the CHPS strategy in four phases. Phase 1 (the Navrongo pilot 
study) was developed between 1994 and 1996 to assess whether the CHPS strategy was culturally 
appropriate. The phase 2 conducted between 1996 and 2003 (the Navrongo experimental trial) 
assessed the impact of CHPS on fertility and child mortality. Results showed that in the first 3 years 
of the project, the total fertility rate declined by 1 birth per women in the intervention communities 
while it remained the same in the comparison areas (75). In the communities where community 
nurses were deployed, child mortality declined by one-half in only 3 years. Within 7 years, child 
mortality declined by two-thirds. Phase 3 occurred between 1998 and 2004 to validate results and 
approaches of the Navrongo experiment. Replication of the Navrongo experiment in the Nkwanta 
District (Volta Region), showed that CHPS contributed to an increase in access and use of health 
care. In the fourth phase (from 2000 and on-going) the CHPS strategy became a national 
programme that needed to scale up countrywide (75).. In 2008 between 10-80% and 10-40% of the 
population in the Volta and the Northern Regions were reported as covered by CHPS services (75). 
To support the scale up and diagnose and address barriers on the CHPS expansion, the Ghana 
Essential Health Intervention Programme (GEHIP) was created in 2009 
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A key component of the CHPS strategy is that traditional leaders of the community must accept the 
CHPS concept and commit themselves to supporting it. The CHPS strategy is based upon a basic 
facility known as a community health compound where health care is provided by a resident 
community health nurse or community health officer. These salaried nurses provide basic 
preventive, curative and promotional health services in homes or in the community health 
compound. The services provided include immunizations, family planning, supervised delivery (if 
the nurses have training on child deliveries), antenatal/postnatal care, treatment of common diseases 
such as malaria, diarrhoea and acute respiratory infections (ARI), first aid for minor injuries and 
skin conditions, adequate referrals, supervision of CBAs and health education. With the 
introduction of IMCI in Ghana in 1998 (76), all primary health facilities including CHPS are 
implementing the IMCI strategy for the management of childhood illnesses. CHPS can also be 
accredited providers of the National Health Insurance Scheme (NHIS). The services provided at the 
CHPS are free for those having a valid national health insurance card. The target for CHPS 
coverage is that a geographical area of a 4 kilometres radius and between 4500-5000 persons should 
be covered by a CHPS compound (77, 78). The CHPS strategy started a national scale up in 2000 
and it continues its expansion (79). In 2008 between 10-80% and 10-40% of the population in the 
Volta and the Northern Regions were reported as covered by CHPS services (75). 
 
1.7. HBC, CHPS and Health Systems 
 
To achieve national and international goals, including the reduction of child mortality, a well 
performing health system is necessary. The WHO describes a health system as one that “consists of 
all organizations, people and actions whose primary intent is to promote, restore or maintain health” 
(80). The goal of a health system is to improve health and health equity, in ways that are responsive, 
financially fair, and make the best or most efficient use of available resources. A health system has 
four vital functions: service provision, resource generation, financing and stewardship.  
 
To promote common understanding of what a health system is and what constitutes health systems 
strengthening taking into account its vital functions, WHO developed a framework consisting of 6 
building blocks (81). These building blocks are: (i) service delivery, which refers to how an 
effective and safe intervention can reach those that need it, when and where needed, with minimum 
waste of resources; (ii) well performing health workforce, which refers to availability of sufficient 
staff, fairly distributed, competent, responsive and productive to deliver interventions; (iii) well-
functioning health information system, which refers to the importance of producing health 
  
27 
information on health determinants, health system performance and health status to be analysed, 
disseminated and used in a reliable and timely manner; (iv) access to medical products, vaccines 
and technologies, which need to be of good quality, safe, effective and cost-effective; (v) good 
health financing system, which have to raise adequate funds for health, in ways that ensure people 
can use needed services, being protected from financial catastrophe or impoverishment; and (vi) 
leadership and governance, which involves ensuring strategic policy, effective oversight, regulation 
and accountability. 
 
HBC and CHPS are two delivery strategies to provide effective interventions to those in need, such 
as ACT for malaria, antibiotics for pneumonia and ORS and zinc for diarrhoea among others. To 
successfully reach the expected outcomes reducing morbidity and mortality in children under- five 
through the implementation of these strategies, it is important that the health system building blocks 
are in place and successfully working. Community drugs distributors and nurses need to have the 
required skills and be in their posts to attend those in need. The information system should be able 
to collect the activity done by these interventions to be able to monitor and evaluate the strategies to 
ensure adequate performance. A good procurement system and distribution chain should be in place 
to make sure the staff can provide ACT, antibiotics and ORS-zinc to sick children. The financing 
system must raise funds to finance these strategies, pooling financial risk (spreads financial risks 
from an individual to all pool members), and allocating or using funds (strategic purchasing of 
services) in a way that promotes efficiency and equity. (81-83). Finally, policies, regulation and 
leadership should guide the implementation of these strategies to obtain the expected outcomes 
while being accountable. If one or more of these blocks are not working appropriately, the strategies 
will experience challenges to reach their goals.  
 
1.8. Justification for the study and study aim 
 
In Ghana, malaria, pneumonia and diarrhoea continue to be the main causes of under-five mortality. 
This mortality is higher in the north of the country and in the rural areas. Community-based 
interventions have the potential to reduce the morbidity and mortality of children under- five years 
of age and have been endorsed by the Roll Back Malaria, WHO and UNICEF.  
 
Ghana first introduced CHPS in 1994 and then HBC in 1999 to improve access to health services.  
After several years of national implementation, there is the need to assess the performance of these 
strategies in delivering preventive messages and care for children under-five with fever, diarrhoea 
or cough. There are several studies that have looked at HBC in Ghana. However, most of these 
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studies focused in a few districts, looked particularly at malaria HBC, focused on the curative 
component and were conducted in a more “controlled” context or under research study conditions 
rather than in a real life programme context (84-88). The routine information system was not 
providing enough information about who was using these two strategies and how were they 
performing in providing appropriate treatment for malaria, diarrhoea and pneumonia, as well as in 
delivering health promotion and disease prevention messages. In addition, there was no financial 
plan to support the HBC strategy for the long- term. If the HBC strategy shows benefits to the 
population, sustainable financing strategies that can effectively integrate HBC into the current 
health system financing model are crucial for a long-term intervention. HBC inclusion in the NHIS 
could be a long-term solution.  
Based on the points just mentioned, the aim of this study was to assess the national implementation 
of the HBC and CHPS strategy in Ghana for the prevention and management of malaria, diarrhoea 
and pneumonia, under programme conditions, in order to provide evidence by which to improve 
performance and to guide long term financing strategies.  
 
1.9. Structure of the thesis 
 
This thesis is organised in seven chapters. Chapter 1 presents the introduction, justification of the 
study and study aim. Chapter 2 includes a literature review on the impact of malaria, diarrhoea and 
pneumonia home-based care on health outcomes and its cost- effectiveness. It also presents relevant 
literature around monitoring and evaluation. The aim and objectives of the thesis are presented at 
the end of the chapter. Chapter 3 describes the methods used to address each objective. 
The thesis has three results chapters. The structure of these result chapters follows a manuscript 
structure with a short introduction, a brief summary of methods used- which are described in detail 
in Chapter 3-, a results section, discussion and conclusions. Chapter 4 assesses the curative 
component of HBC and CHPS in terms of utilization, appropriate treatment given and client 
satisfaction. HBC and CHPS utilization were assessed based on treatment- seeking behaviour when 
the child was sick. Appropriate treatment was based on adherence to national guidelines and 
satisfaction was based on the perceptions of the carers after the treatment-seeking visit. Chapter 5 
assesses the preventive component in terms of carers’ disease knowledge and health behaviour. 
Disease knowledge was assessed based on the identification of causes and signs of severe disease, 
and its association with the sources of health education messages received. Health behaviour was 
assessed based on reported prompt care seeking behaviour, reported adherence to treatment, 
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utilization of mosquito nets and having improved sanitation facilities, and its association with the 
sources of health education messages received. Chapter 6 analyses the cost per case appropriately 
diagnosed and treated under the HBC and CHPS.  
Chapter 7 includes a general discussion, conclusions and their implications in terms of programme 
implementation and policy.   
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Chapter 2. Literature Review 
 
 
2.1. Introduction 
 
Three reviews were conducted in 2014 to explore the impact of HBC on health outcomes, its cost-
effectiveness and to inform my research questions and methods. In addition, I also explored 
methods to monitor and evaluate health care interventions to better clarify my choices of objectives 
and study design.  
 
2.2. Methods 
 
Three separate reviews were conducted. For the three reviews, the Medline database and the 
Cochrane database of systematic review was searched in 2014 and again in 2016.   
To explore the impact of home-based care of malaria, the terms used were (malaria or fever) AND 
(under five or children under five or child*) AND (home-based management or home-based care or 
home management or community-based or community case management) AND (Africa). The 
Cochrane database of systematic reviews was also searched looking for home-based care.  
To explore the cost-effectiveness of home- based care, I used the words (cost-effectiveness or cost-
benefit or economic evaluation) AND (fever or malaria or pneumonia or suspected pneumonia or 
ARI or cough) AND (under five or children under five or child*) AND (home based care or home 
management or home management of fever or home care services). 
To explore the impact of home-based care of diarrhoea and suspected pneumonia, the terms used 
were (pneumonia or suspected pneumonia or ARI or cough) AND (under five or children under five 
or child*) AND (home- based care or home management or case management).  
 
2.3. Impact of home-based care of malaria 
 
Among 370 papers found in Medline database, 2 were systematic reviews conducted in 2007 (37) 
and in 2014 (38). A third systematic review was found in Cochrane database which was conducted 
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in 2013 (39). Due to the numerous and recent systematic reviews found (the last one was conducted 
in 2014), I felt that it was appropriate to focus on these 3 reviews to analyse the effect of HBC.  
The inclusion criteria for studies reviewed in 2007 were: (i) the intervention evaluated consisted of 
administration of presumptive antimalarial treatment for fever illness; (ii) the treatment was 
administered by local community members without formal training; (iii) the outcomes were malaria 
morbidity or mortality; and (iv) studies were conducted in Africa. Studies were not excluded based 
upon their design. Results showed that of the 6 studies conducted in Sub-Saharan Africa that met 
the inclusion criteria, the impact on morbidity and mortality was mixed. The quality of the evidence 
of the studies included was not evaluated. Two studies showed no health impact; one study showed 
decrease in malaria prevalence and incidence; one study showed a decreased in severe malaria cases 
and another decrease in risk of progression to severe malaria. Only one study in Ethiopia showed a 
reduction in child mortality (Table 1). This was a randomised control trial (RCT) conducted in 
Tigray between 1996 and 1998 which showed a reduction in under-five mortality by 40% (95% CI 
29·2, 50·6; p<0·003) in the intervention localities that provided chloroquine at community level 
(Annex 1). 
The 2013 systematic review included only RCT and quasi-RCT (including controlled before-and-
after studies and interrupted time series studies), that evaluated the effect of antimalarial treatment 
presumptively or after a positive RDT, given by community members without formal training. 
Therefore, not all 2007 systematic review studies were included. Results from this review addressed 
the efficacy of HBC or its potential effect in treating malaria under ideal conditions. Conclusions 
from the 10 studies that met the inclusion criteria were that HBC probably increases the proportion 
of people with fever who receive an appropriate antimalarial within 24 hours and it may also reduce 
all-cause mortality, but to date this has only been demonstrated in rural Ethiopia. The quality of the 
evidence (based on the assessment of risk of bias in included studies) was considered moderate for 
these findings (89).  
The third systematic review conducted in 2014 aimed to expand the 2007 systematic review taking 
into consideration changes in policy guidance on malaria treatment and the integration with other 
community interventions such as diarrhoea and suspected pneumonia management. Therefore, it 
included studies published from 2000 to May 2013 where the main outcome was attributable to 
malaria community case management. Forty-three studies were included using a variety of study 
designs: randomized controlled trials (RCT), cluster RCTs, pre-post studies with or without control, 
interrupted time series designs, qualitative studies, case studies, process evaluations and cost-
effectiveness studies. The quality of the studies assessed for the 12 RCTs found was considered 
high while the quality of the 3 controlled pre-post studies was considered lower than the RCTs. The 
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conclusions of the systematic review were that HBC can provide good quality malaria care 
including performing procedures such as rapid diagnostic tests. Adding diarrhoea and suspected 
pneumonia management to the management of fevers (then called integrated community case 
management-iCCM) did not reduce the quality of malaria case management if adequate training 
was provided and supervision was maintained (90). This third review includes three more studies 
conducted in Ghana (86), Ethiopia (91) and Senegal (92) not included in either of the previous 
reviews that looked at the effect of HBC on child mortality compared with the standard care. All 
three of these studies found reductions in child mortality that were statistically significant. The 
study in Ghana (a cluster- RCT conducted between January 2006 and December 2009) showed a 
30% reduction in under-five mortality in the intervention arm which consisted of the provision of 
ACT at community level (RR= 0.70, 95%CI 0.53, 0.92, p = 0.011). The second study conducted in 
Ethiopia between May 2005 to April 2007 (a before- after study with control group) tested the 
deployment of ACT with RDT at community level. Results showed a reduced risk of malaria-
specific mortality in the intervention district (RR=0.60, 95%CI 0.40, 0.90, p = 0.013). The study in 
Senegal also tested the deployment of ACT with RDT at community level. This was a before- after 
study with controls conducted between August 2009 and May 2010. The mortality data was 
obtained from routine data (in contrast to the bi-annual census done in the Ghana study and 
household surveys done in the Ethiopia study). Results showed a decrease in the incidence of in-
hospital deaths due to malaria by 62.5% (95% CI 43.8-81.2) in the intervention regions, while the 
decrease in comparison regions was smaller and not statistically significant.  
Issues related to implementation (e.g. availability of community drug distributors, availability of 
drugs or supervision), may decrease the expected impact of the strategy (93). A 2010 survey 
conducted in 44 sub- Saharan African countries showed that among the 40 countries that responded, 
83% had adopted national policies supportive of treatment by community drug distributers of 
diarrhoea,  74% for malaria and 65% for pneumonia (94).  
 
2.4. Cost-effectiveness of home-based care 
 
The cost- effectiveness of HBC is another issue to be addressed when deciding its inclusion in a 
health system. Only four studies were found on Medline that looked at the cost- effectiveness of 
home management of fevers in Kenya, Uganda, Zambia and Ghana (Annex 2). All of them 
concluded that malaria HBC was cost- effective, although it might not be appropriate for all settings 
(95-98). However, there are some differences between these studies worth to be mentioned. The 
study in Kenya was conducted between 1998 and 2000 and looked at the cost-effectiveness of 
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training drug shopkeepers to provide adequate chloroquine treatment for suspected malaria cases 
compared with no training, from the societal perspective. Data for this analysis was obtained from a 
before-after study with controls where effectiveness data was obtained from 2 households surveys. 
Results showed that the cost per additional febrile episode appropriately treated was US$4.0 in the 
early implementation phase and the cost per disability- adjusted life-years (DALYs) averted due to 
the intervention was US$18.38. The study in Uganda used an interactive Markov Model which 
calculated the cost per DALYs averted and the ICER of presumptive malaria treatment through 
community distributors versus conventional care (a mid-size hospital) from the societal and 
provider perspective. Results showed that even using the most effective antimalarial, home-based 
care remained cost-effective only in areas of high and medium malaria transmission when access to 
conventional care is low. The cost-effectiveness study conducted in 2009 in Zambia compared the 
cost per appropriate treatment of providing ACT and RDT at community level versus the standard 
care (low-size health facilities) from the provider perspective. Effectiveness data was obtained from 
community drugs distributors and health facilities registries. Results showed that home-based care 
for treating malaria was more cost- effective that the conventional care (cost per additional case 
appropriately diagnosed and treated was US$4.18). The study conducted in Ghana between 2006 
and 2009 compared presumptive malaria treatment with ACT at community level versus standard 
care from the societal perspective. This was a stepped-wedge cluster RCT that measured the effect 
with and without two different interventions and measured only the cost of the interventions. 
Therefore, from the information provided it seems that the authors did a cost-outcome analysis. 
Authors concluded that the cost per DALY averted at community level versus standard care was 
less than the standard US$150 threshold recommended by the WHO (ICER using ACT alone= 
US$90.25 and using ACT +Amoxicillin= US$114.21), and was also cost-effective for reducing 
under- five mortality in rural settings.   
 
2.5. Impact of home-based management of diarrhoea and pneumonia 
 
Five hundred ten papers were found. Among them, 5 systematic reviews looked at effect of 
diarrhoea and pneumonia HBC in reducing morbidity and mortality (99-103). Due to the numerous 
and recent systematic reviews found (the last one was conducted in 2015), I felt that it was 
appropriate to focus on these 5 reviews to analyse the effect of HBC. 
 
The first one (99), conducted in 1992, was a meta-analysis that included six studies looking at 
pneumonia HBC and child mortality. All six studies showed a reduction in pneumonia related child 
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mortality. However, it is important to note that (i) two studies did not report P values and 95%CI; 
(ii) the reduction in child mortality was not significant in another study; and (iii) CHW did not 
provide pneumonia treatment-the professional health worker did- in one study. Authors concluded 
that pneumonia HBC reduced infant mortality by 20% and under-five mortality by 25%. In 2003, 
Sawazal and Black updated their meta-analysis. Nine studies were included, five of them were 
already included in the 1992 meta-analysis (100). From the 9 studies, (i) treatment was provided by 
health workers other than CHW in 2 studies and (ii) 1 study did not provide 95% CI or p value. 
Conclusions from the meta-analyses were that pneumonia HBC reduced overall mortality of 
neonates, infant and children (by 27%, 95%CI 18-35; 20%, 95%CI 11-28; and by 24%, 95%CI 14-
33, respectively). The third systematic review (101) aimed to include a wider range of community 
interventions. With respect to pneumonia case management, nine articles were included and seven 
were already included in previous systematic reviews. From the nine studies, (i) one study reported 
treatment by a midwife instead of a CHW, (ii) the reduction in pneumonia related mortality was not 
significant in two studies and (iii) one study did not provide 95%CI or p values. Conclusions from 
the meta-analyses were that community case management can reduce by 35% (95%CI 18-48) 
pneumonia related child mortality and overall child mortality by 21% (95%CI 12-30). The fourth 
systematic review aimed to update the previous one on pneumonia, and to include diarrhoea HBC 
(103). Twenty-four studies were included, eleven studies and two studies were included in the meta-
analysis for pneumonia and diarrhoea related mortality, respectively. From the eleven studies, (i) 
two studies reported treatment provided by professional workers, (ii) the reduction in pneumonia 
related mortality was not significant in two studies; (iii) one study did not provide 95%CI or P value 
and (iv) one study did not have enough power to detect an effect on mortality. With regards to 
studies reporting on diarrhoea related mortality, only one of the two studies showed a significant 
reduction in mortality. The second study showed a reduction in diarrhoea related mortality, 
although this was not significant and treatment was provided by professional health staff instead of 
CHW. Conclusions from this review (Das et al 2013) (103) were that HBC was associated with a 
160% increase in the use of ORS for diarrhoea, an 80% increase in zinc use, 13% increase in 
seeking care for pneumonia, 9% increase in seeking care for diarrhoea, and a 32% reduction in 
pneumonia specific mortality whereas evidence for diarrhoea- related mortality was weak. 
 
Because of most of the studies included in the four previous reviews were done in Asia, the fifth 
systematic review included only studies conducted in Africa assessing the community case 
management of pneumonia. Only studies where CHW received shorter training than professional 
staff and CHW provided treatment were included (102). Conclusions from this review were that 
there was a lack of evidence on the efficacy and effectiveness of community case management of 
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pneumonia, arguing that there were only a few studies (15), with different methodologies, only two 
out of fifteen were in West Africa and only two looked at reductions in mortality. Of these two 
studies, only one showed a reduction in mortality although the p value and 95% CI was not 
reported. The main difficulty in terms of CHW experiences was in counting the respiratory rate and 
therefore classifying pneumonia cases. Authors concluded that adherence to guidelines was lower in 
integrated interventions than in community case management of pneumonia. Annex 3 presents a 
summary of the studies included in the five systematic reviews. 
 
2.6. Evaluation of health interventions 
 
Evaluation of interventions increasingly plays a role in health care (as well as in other fields). 
Stakeholders want to know the value received for the funds given and to use this information to 
guide their decisions in steering the health system towards better outcomes. 
There is a vast bibliography on types of evaluation and on methods to conduct an evaluation. For 
example, process evaluation assesses if the intervention has been implemented as planned and 
examines how the context and mechanisms of action lead to the outcomes achieved (104). Outcome 
evaluation assesses the achievement of short-term, intermediate, and long-term objectives (105). 
Impact evaluation aims to identify the causal relationship or attribution of the outcome to the 
intervention under study (105, 106). Formative evaluation informs on-going projects and 
summative evaluations are conducted at the end of the project (107). Economic evaluations 
compares different alternatives in terms of both their costs and consequences (108). With regards to 
the different study design to conduct an evaluation, there are experimental studies, quasi 
experimental studies, observational studies, qualitative studies, economic studies and mixed 
methods, particularly when the intervention is complex (106, 109, 110). Different study designs will 
be selected based on the objectives of the evaluation, resources available, the context and the degree 
of certainty on causality or attribution required. Experimental studies (impact evaluations) are the 
gold standard to address causality although they are not always appropriate or possible (for example 
when resources are constrained, when the intervention has already been tested, or when the 
interventions is already being implemented). Quasi experimental studies (using techniques such as 
differences in differences, regression discontinuity and matching and interrupted time series) can be 
useful when causality needs to be addressed and experimental studies are not feasible to conduct. 
Observational studies with a control group (cross sectional studies, case-control and cohort studies), 
may be appropriate depending on the study objective. When no external control group is possible 
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(as in my study) attribution can be addressed by introducing questions regarding source of the 
treatment/service received (109, 111).  
Frameworks can help to systematically analyse areas where health interventions could have an 
impact. Although different frameworks may have common dimensions or areas to evaluate, they 
also have specific areas of attention. For example, the WHO Primary Care Evaluation Tool  (112) 
focuses on the four vital functions of the health system mentioned in section 1.4 (service provision, 
resource generation, financing and stewardship) and divides service provision into four key 
characteristics to be evaluated: access to services (understood as use of health services), continuity 
of care- (or follow up from one visit to the other), comprehensiveness (which refers to a full range 
of services such as curative and disease prevention) and coordination of care (such as from primary 
to secondary health care). The Centre for Disease Control and Prevention guide (109) describes 5 
areas of evaluation: implementation (or process evaluation), effectiveness (or outcome evaluation), 
efficiency, cost-effectiveness and attribution. Smith et al, described four dimensions to be 
considered when evaluating a health care intervention (113): equity, effectiveness, efficiency or 
cost- effectiveness and the humanity of the health care or health care intervention. Smith et al 
defines equity as the fair distribution of a health service (or health state) in a population among 
groups or individuals. Often, one cause of inequity may be that some groups are less able to access 
to health services than the others. Effectiveness is defined as the benefits of a health service 
measured by improvement in health in a real population, under normal circumstances. Efficacy is 
defined as the benefits of a health intervention under ideal conditions. Cost- effectiveness is defined 
as the relation of the cost of an intervention to the benefits obtained. Humanity is the quality of 
being humane. It refers to the social, psychological and ethical acceptability of the services that 
people received from a health care intervention.  
It is important to note that there is a high variation on the meaning and use of different terms 
depending on the approach. For example, in the evaluation of programmes, outcomes refer to the 
results of programmes, and outcome evaluations can be called effectiveness evaluation as 
mentioned above (109, 114). In epidemiology, outcome can also be called response variable and it 
is a broad term referring to any defined disease, state of health, health related event or death. Also 
in epidemiology, effect refers to the association between a risk factor, predictor or intervention and 
the outcome. Efficacy will be called if the relationship between both (intervention and outcome) has 
been addressed in a controlled context, under ideal conditions. Effectiveness will be assessed under 
real life conditions (115). In economic evaluations, effectiveness measures can be final health-
related measures of outcome, such as life-years gained, intermediate outcomes or outputs- such as 
percentage of cholesterol reduction- if the link between, the intermediate outcome or output and 
final outcome can be established. In general though, one should choose an effectiveness measure 
  
37 
related to a final health outcome to allow comparison with other studies and to have a trade-off that 
guides on the decision if an intervention is more cost-effective than other (108, 116). Efficiency is 
another term that has different meanings. In the evaluation of programmes, efficiency often refers to 
the optimal use of resources to achieve intended outcomes (109, 117). In economic evaluations, 
Drummond et al use the term of efficiency evaluation as economic evaluation (108), while Smith et 
al particularly refers efficiency to one type of economic evaluation (cost-effectiveness) (113) 
Another aspect is how to measure results of a programme or health intervention. Indicators are used 
to demonstrate change in a situation, or the progress in, or results of, an activity, project, or 
programme. Indicators are necessary to help determine what data needs to be collected. They can be 
classified in different ways. A direct indicator is called when it clearly measures the intended result. 
Indirect or proxy indicators are linked to the result by one or more assumptions and they are used 
when the most direct indicator is not practical or not feasible (118). Indicators can measure inputs, 
process, outputs, and outcomes. Input indicators measure the number of resources involved in an 
activity, for example, number of people to be trained or training material developed in a year. 
Process indicators measure the progress of activities in a programme/project and the way these are 
carried out, such as percentage of people that received a training. Output indicators measure short- 
term results, the quantity, quality, and timeliness of the products, goods or services resulting from 
an activity, project or programme (for example, percentage of people that improve in  disease 
knowledge). Outcome indicators measure medium and long-term results generated by programme 
outputs, such us the use of adequate treatment or change in prevalence of a disease (119). Indicators 
measuring long-term outcome are sometimes called impact indicators, and the evaluation assessing 
this long-term goals impact evaluations, making some confusion with the definition of impact 
evaluation described above which particularly addressed the causal relationship or attribution of the 
outcome to the intervention (114, 120). Indicators needs to be “SMART”: they need to be specific, 
measurable, achievable, relevant and time-boud (121, 122).  
The way the indicators selected are collected will depend on the information needed. There are a 
variety of methods to collect information such as observation, revision of existing records, data or 
documentation, testing of abilities, biological measurements, in-depth interviews or surveys. 
Observations can be used to observe behaviour or practices, rather than asking people what they 
think or how they behave. Revision of records/documentation produced is an important source of 
information to monitor and evaluate programmes/interventions, but they might not have all the 
information needed, or it might be necessary to verify some information. Biological measurements 
are objective, in that they are independent both of the subjects’ perceptions and, where instrumental 
or laboratory methods are used, of the researcher. In-depth interviews are good to explore new ideas 
or concepts from specific people and they use semi-structured questionnaires or open-ended 
  
38 
questions. Surveys are particularly useful to find small amounts of information from a wider 
selection of people in the hopes of making a general claim. Surveys use closed-ended questions or 
structured questionnaires (123-125). 
 
2.7. Discussion 
 
Although with promising results, particularly with respect to malaria HBC, there is still little 
evidence that malaria, diarrhoea and pneumonia home-cased care can reduce mortality in Africa. 
With regards to malaria HBC, only seven studies were found reporting on overall and malaria 
specific mortality. Among these seven studies, six used similar study design and data collection 
tools (quasi experimental or RCT, with health demographic surveillance and parasitemia surveys). 
Among these six studies, three studies did not show a reduction in mortality, and authors argued 
that previous high self-treatment in the community, limited availability of CHW and small sample 
size could have been the reasons (68, 89, 90). The seventh study, which evaluated the scale up of 
malaria HBC covering a larger area in Senegal (92), did show an effect on mortality, although this 
was at facility level using routine data. No study was found assessing the effect of diarrhoea HBC 
on child mortality in Africa. With regards to pneumonia HBC, only one out of 2 studies showed a 
reduction on child mortality in Africa, although the P value was not given (Figure 2).  
 
Figure 2. Summary of studies on malaria, diarrhoea and pneumonia HBC conducted in Africa by topic addressed 
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Among all the studies found conducted in Africa, the majority explored the effect of the curative 
component of HBC, particularly related to malaria. In those studies, indicators such us HBC 
utilization, treatment and prompt treatment and referrals were often used. Surprisingly, the 
preventive component was much less explored (only 12 out of 46 studies). Taking into 
consideration that HBC normally includes a preventive component and the importance of health and 
community practices to improve child survival, child growth and development (section 1.3), it 
seems that the preventive components is often neglected when conducting HBC studies. When 
included, the outcomes used were related to disease knowledge and health behaviour such as the 
recognition of severe signs of disease, seeking care practices, use of ITN or compliance with 
treatment. Studies on cost- effectiveness of HBC were almost non-existent. Excluding the study that 
addressed the training of shopkeepers, only 3 addressed the management of fevers through 
community volunteers. And among them, only 2 used a final health outcome (DALYs) as the 
effectiveness measure. The third one used an intermediate outcome (appropriate diagnosis and 
treatment) which, although some economists will accept it as an effectiveness measure due to its 
linkage with the final health outcome (reduction on mortality due to malaria (35)), others do not.   
Most of these studies were conducted between 2004 and 2014 (36 out of 46) using a variety of 
study designs (RCT-13, before-after with controls-10, before -after without controls-5, post study 
with controls-2 and post study without controls-16). Interestingly, most of them were conducted in 
few districts with strong supervision. To mention the exceptions, only 3 studies were conducted in 
large areas with regular/standard supervision (92, 126, 127). With regards to the study duration, 20 
out of 47 studies lasted 2 or more years, and only 2 studies lasted 4 or more years.  
With regards to the evaluation of health interventions, there is a vast documentation on types of 
evaluation, methods to conduct evaluation and frameworks to systematically analyse areas that 
should be addressed when evaluating a health intervention. In addition, the meaning of the 
terminology used may differ depending on the approach or perspective. Rather than discussing the 
appropriateness of different terms, it is more appropriate to clearly define what we mean when 
using a particular term to avoid confusion and misunderstanding. 
 
2.8. Conclusion 
 
There is a quite extensive literature assessing the effect of HBC in Africa, mainly addressing 
malaria HBC, under controlled circumstances and reaching few districts. There is limited but 
promising results on the effect of malaria HBC in reducing child mortality, but no evidence 
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regarding diarrhoea and pneumonia HBC and child mortality in Africa. Studies assessing HBC 
clearly focus on the curative component, showing positive results particularly in improving access 
to prompt treatment even when diarrhoea and suspected pneumonia cases are integrated in the 
strategy. The preventive component has been less explored although with positive results regarding 
improvements in disease knowledge and on how to administer drugs. HBC cost-effectiveness has 
been barely addressed although the few studies found (3) showed that HBC was more cost-effective 
than the standard care.  
Exploring the effectiveness of HBC under programme conditions, in large areas and after several 
years of implementation is necessary to understand implementation issues and how they may 
decrease the expected outcomes of the strategy. Efforts should be made to conduct comprehensive 
evaluations, without focusing on only one aspect of the intervention and considering its continuity 
and coordination with other interventions. An appropriate approach could be to follow the Smith et 
al dimensions, considering its simplicity and clarity. When selecting the study design, this should 
ensure the attribution of results to the intervention.  
Therefore, I decided that the aim of my study was to assess the implementation of the HBC and 
CHPS strategy in Ghana under programme conditions, in a large area and after several years of 
implementation in order to provide evidence by which to improve performance. Three objectives 
were defined: 
Objective 1: To assess the curative component of the HBC and CHPS strategies in terms of 
utilization, appropriate treatment given and client satisfaction. 
Objective 2: To assess the preventive component of the HBC and CHPS strategies in terms of 
carers’ disease knowledge and health behaviour. 
Objective 3: To determine the cost per case appropriately diagnosed and treated under HBC and 
CHPS. 
These 3 objectives cover the four dimensions of Smith et al approach described in section 2.5. 
Equity will be addressed when analyzing the utilization of the curative component of the HBC and 
CHPS strategies. Effectiveness will be assessed by analyzing the appropriate treatment given as 
well as through disease knowledge and health behaviour. These indicators are considered to be 
proxy indicators of child morbidity and mortality as the data to populate more direct indicators were 
not possible to obtain (more details in chapter 3). With regards to the third dimension (cost-
effectiveness) and considering that (i) my effectiveness measure is an intermediate outcome (not 
considered the best effectiveness measure to conduct a cost-effectiveness analysis), and (ii) the 
importance of knowing the cost of interventions, their affordability and the appropriate financing 
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strategies to support them, I decided to conduct a cost-analysis which will be useful to guide 
discussions on the long-term financing of HBC. Finally, humanity will be assessed through users’ 
satisfaction with the curative component.  
With regards to methods to address these objectives, a post-intervention study without controls 
through a household survey, taking into consideration that both HBC and CHPS are implemented 
throughout the study area, was considered an appropriate approach. This design has been used 
previously in studies assessing HBC (Annex 1 and 3) and it can inform about the current situation, 
as a complement to information from routine data through the District Health Management 
Information Systems. In addition, a qualitative study using in-depth interviews might also provide 
information about the how and why of the results obtain though the household survey, providing 
more insight of the bottlenecks and enablers of the strategies. However, the qualitative study was 
not possible to conduct due to availability of funds.  
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Chapter 3. Methods 
 
 
3.1. Study site 
 
The Volta and Northern Regions were purposively selected (Figure 3). I wanted to include a region 
implementing iCCM and one malaria only HBC, to have a better picture of HBC in Ghana. Based 
on this first requirement, the NMCP suggested the Volta and Northern Regions. The Volta Region 
targeted only rural districts for the HBC implementation and implements mostly malaria HBC (with 
the exception of some communities supported by NGOs which implement integrated HBC), despite 
all districts having received drugs for the management of diarrhoea and suspected pneumonia in 
2013. The Northern Region implements iCCM due to availability of funds from UNICEF. Based on 
the monthly activities reported through the routine monitoring information system (District Health 
Information System-DHIMS II), the NMCP had some concerns on the low performance of iCCM in 
Northern Region compared to the other two northern regions (Upper East and Upper West 
Regions), although the iCCM coordinator in the Northern Region believed this low performance 
was due to under reporting of activities. In contrast, the NMCP was satisfied with the malaria HBC 
implementation in the Volta Region. Selecting one “good” and “bad” performing was believed to be 
a good strategy to contrast results with those of DIMS II and to see possible differences that could 
help identify enablers and barriers of the HBC implementation in Ghana. The CHPS strategy is 
uniform across regions of the country.  
The Volta Region has a malaria prevalence of 17%, diarrhoea prevalence of 7.6% and suspected 
pneumonia prevalence of 2.1% in children under five (MICS 2011). The rural population 
corresponds to a 66% of the total population. Two rainfall seasons occur in the middle and coastal 
belts, one major season is in April/July with a peak in June and one minor season is in 
September/November with a peak in October. The north of Volta Region has one rainy season - 
May to October with a peak in August. 
The Northern Region has a malaria prevalence of 48%, diarrhoea prevalence of 21.4% and 
suspected pneumonia prevalence of 6.3% in children under five (128). The rural population 
corresponds to 70% of the total population. In the north the rainy season begins in May and ends in 
October (129). Climatically, religiously, linguistically, and culturally, the Northern Region differs 
greatly from the politically and economically dominating regions of central and southern Ghana, 
and it is similar to the two other northern regions (Upper East and Upper West).  
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Figure 3. Map of Ghana 
 
3.2. Defining utilization of services 
 
Utilization of services does not have a single definition. There is a vast bibliography defining the 
utilization of health care, access, and its different dimensions and determinants. Cabieses and Bird 
(2014) (130), reviewed the different access definitions used and how they evolved over time. One 
of the first definitions of access had a focus on “demand side” and was referred as the ability to 
reach health services. Then, more focus has been made on the “supply side” or availability of health 
services. Other authors like Penchasky and Tomas (1981) defined access as the “fit or interaction” 
between the user and the system, defining 5 dimensions of access: availability, accessibility, 
accommodation, affordability and acceptability (131). Since then, several frameworks of access to 
health care in relation to poverty and identifying barriers to health care have been developed. 
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Cabieses and Bird in their Glossary of Access defined 3 components and 4 barriers to access to 
health care (130). The components of access were geographical access (or availability of health 
care), financial access (or affordability) and socio-cultural access (or acceptability of health care). 
The barriers were personal barriers (lack of awareness, stigma and lack of information), financial 
barriers (costs that deter people from accessing care), organizational barriers (structure and process 
of the health care system) and physical/geographical barriers. Utilization of health care is defined as 
the realized access or the actual use of the services which is the definition I used in this study. The 
components and barriers to health care were also addressed and described in this study when 
looking at factors associated with the use of community services. Analysing the association between 
socioeconomic status and utilization of HBC and CHPS I also addressed equity in HBC and CHPS 
utilization (first dimension described in section 2.5).  
 
3.3. Defining appropriate treatment given 
 
I chose appropriate treatment given for children under-five presenting with fever, diarrhoea and 
cough, as a measure of the effectiveness of the curative component of HBC and CHPS. This 
indicator was defined in the HBC and CHPS guidelines, can be compared with other studies (Annex 
1), it is feasible to obtain from my study and allows me to attribute the results obtained to the 
different strategies based on the source of treatment. In addition, appropriate treatment given is a 
proxy indicator of child mortality. Malaria cases can progress rapidly to severe disease and death if 
malaria treatment is not administered in the first 24-48h from onset of symptoms (35). Prompt 
treatment with a full course of effective antibiotics is key to reduce pneumonia deaths (132). ORS 
and zinc are effective therapeutic interventions to reduce diarrhoea mortality (14). 
Appropriate treatment refers to those with specific symptoms receiving the treatment and 
procedures defined in the national guidelines. Therefore, this study will compare the treatment 
received against national guidelines and not against control groups.  
Other studies have used different health outcomes to assess the effectiveness of the curative 
component of HBC, such as anaemia prevalence, malaria prevalence or mortality due to malaria, 
diarrhoea or pneumonia. However, measuring anaemia or malaria prevalence requires laboratory 
resources while malaria, diarrhoea and suspected pneumonia related mortality would require a 
much bigger sample size. In addition, as the interventions are implemented in all districts under 
study (there are no intervention and control groups), it would have been difficult to attribute these 
outcomes to these particular interventions.  
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There are two other outcome measures or effectiveness measures, particularly used when doing 
economic evaluation, which allow comparison with other diseases. These are the Disability 
Adjusted Life Years (DALYs) averted and the Quality Adjusted Live Years (QALYs) gained 
(chapter 6). Calculating DALYs using a simple tree model could have been a good option to 
consider instead of appropriate treatment given. However, during the DrPH review it was 
considered that using DALYs would be too much work for a DrPH thesis while using cost per 
appropriate treatment was a good and realistic alternative, also comparable with other studies (98). 
Calculating QALYs was not considered because (i) the studies found on HBC cost effectiveness 
used DALYs (Table 2) and (ii) it requires an extra cost to calculate the quality-adjustment weight 
for malaria which rely on preference-based measures directly elicited from general population 
samples or from groups of patients (133). 
 
3.4. Defining users’ satisfaction 
 
Users’ satisfaction with the way health care is provided is used to assess the humanity of the health 
care, one of the four dimensions of a health care evaluation which involves respecting the principles 
of autonomy, dignity, beneficence and non-maleficence of every patient (113, 134). Fitzpatrick 
(1997) described 5 areas that address the principles mentioned above: interpersonal skills, 
information given, technical competence, the organization of health care and time spent with the 
patient (113). Several authors have indicated the importance of exploring all these areas (as opposed 
to a single general question) to assess satisfaction, as it may vary based on the domain explored 
(135-137). A minimum of 5 alternative responses are recommended to allow a more precise 
expression of users views and to increase reliability of the instrument (138, 139). Satisfaction rates 
will be influenced by characteristics of the patient (such as age of respondent, expectations and 
health status) and those related to the health system (139, 140) although in general, expressed levels 
of satisfaction are typically high (134, 135, 141). Therefore, some authors recommend to focus on 
the dissatisfaction data, to compare with other groups or trends (134) and to look at experiences 
with the health services rather that asking for satisfaction (141, 142).  
 
3.5. Defining disease knowledge and health behaviour  
 
Disease knowledge and health behaviour were chosen to assess the effectiveness of iCCM and 
CHPS on family and community health practices regarding malaria, diarrhoea and pneumonia. 
Health behaviour is understood as the combination of knowledge, practices, and attitudes that 
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together contribute to motivate the actions we take regarding health. Indicators chosen to measure 
disease knowledge were: (i) carers of febrile children under-five being able to identify the cause and 
practices that can cause malaria, diarrhoea and pneumonia and (ii) carers of febrile children under-
five years of age being able to identify signs of severe disease. Indicators chosen to measure health 
behaviour were: (iii) children under- five sleeping under ITNs, (iv) improved sanitation facilities in 
the household, (v) promptness in seeking care and (vi) adherence to treatment.   
I believe these indicators are appropriate to measure the effectiveness of the preventive component 
of the HBC and CHPS strategies because (i) they can measure the objectives of the HBC and 
CHPS; (ii) they can be comparable with other studies (Annex 1, (49)), (iii) they are feasible to 
obtain from my study and (iv) allow me to attribute the results obtained to the different strategies 
based on the source of health messages. In addition, these indicators are proxy indicators of child 
survival, child growth and development as described in section 1.3. 
As mentioned in section 2.5, there are other study designs that can address the causal relationship 
between the interventions and the outcomes. However, as the objective of this study was not to test 
a new hypothesis but to assess the implementation of two national strategies already in place, I 
consider that a cross sectional study, being able to identify the source of the health messages, and 
attribute these to the strategies under evaluation, is appropriate for my study objective.   
 
3.6. Defining case appropriately diagnosed and treated 
 
The definition of ‘case appropriately diagnosed and treated’ was used to address objective 3. It 
refers to a malaria, diarrhoea or suspected pneumonia case that received treatment according to 
guidelines (section 3.3) or a child without malaria, diarrhoea or suspected pneumonia that was not 
prescribed the recommended drugs to treat malaria, diarrhoea or pneumonia.  
 
The use of two different but similar measures (appropriate treatment given to measure the 
effectiveness of the curative component and case appropriately diagnosed and treated for the cost 
analysis) have an explanation. Appropriate treatment given was an indicator used in many studies as 
described in Chapter 2 and in Annex 1. Using the same indicator will allow me to compare my 
findings with the other studies as mentioned above. Case appropriately diagnosed and treated also 
takes into consideration those cases that were un-necessarily treated which is important when 
analysing costs. 
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3.7. Other study definitions 
 
The following study definitions were used for the data analysis: 
(i) Appropriate provider refers to public or private medical facility, CHPS, CBAs or 
licensed chemical shop (128). HBC is delivered by CBAs. 
(ii) Utilisation of HBC or CHPS is defined as carers taking their child under five, to a CBA 
or a CHPS, respectively, when the child has symptoms of fever, cough or diarrhoea.   
(iii) Flexibility of time of a CBA or of a health facility for a child to attend, refers to carers’ 
opinion on “open hours”, or “open service” meaning the times during the day that a 
child can be seen by a provider.  
(iv) User satisfaction refers to carers experience with the service received after the treatment 
seeking visit.  
(v) Definitions specific to case management of malaria, pneumonia and diarrhoea, and their 
differentials by HBC and CHPS used in the study are presented in Table 1.  
(vi) Definitions specific to disease knowledge and health behaviour under HBC and CHPS 
strategies are presented in Table 2. 
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Table 1. Definitions specific to case management of malaria, pneumonia and diarrhoea under HBC and CHPS 
strategies 
Definitions HBC (65) CHPS (143) 
Malaria All fever cases when no laboratory tests are 
available. 
 
All fever cases when no laboratory tests are 
available or when malaria test was 
positive.  
 
General danger signs Vomiting, convulsions, unconscious or not 
breastfeeding. 
 
The same definition as in HBC 
Severe malaria signs Little or no urine, dark coloured urine, 
marked jaundice or abnormal bleeding. 
 
The same definition as in HBC 
Appropriate treatment 
of malaria 
Children aged 6 months to 5 years diagnosed 
with malaria receiving 3 days of ACT. 
If more than 7 days with fever, general 
danger signs or severe malaria signs, child 
must be referred with rectal artesunate. 
Children aged 2 months to 5 years 
diagnosed with malaria receiving 3 days of 
ACT. 
If more than 7 days with fever, general 
danger signs or severe malaria signs, child 
must be referred with IM quinine, IM or 
EV or rectal artesunate plus an IM dose of 
chloramphenicol. 
Prompt treatment of 
malaria 
Malaria cases that received an antimalarial 
drug in within the first 24 hours of the onset 
of symptoms. 
 
The same definition as in HBC. 
 
Diarrhoea  3 or more loose or watery stools in a 24-hour 
period. 
 
The same definition as in HBC. 
Appropriate treatment 
of diarrhoea 
Children older than 6 months with diarrhoea 
of less than 7 days that receive ORS and zinc 
for 14 days. 
If the child is less than 6 months, had 
diarrhoea for 7 days or more, blood in stools 
or is dehydrated, he/she should be referred 
with ORS. 
 
Children with diarrhoea of less than 14 
days receiving ORS and zinc for 14 days. 
 
If diarrhoea for 14 days or more, blood in 
stools or is severely dehydrated, he/she 
should be referred to hospital with ORS. 
ARI or suspected 
pneumonia 
Cough with fast or difficult breathing* The same definition as in HBC 
Severe pneumonia Noisy breathing or chest in-drawing 
 
The same definition as in HBC  
Appropriate treatment 
for suspected 
pneumonia 
Children older than 6 months with cough 
and fast or difficult breathing of less than 7 
days receiving amoxicillin for 5 days.  
If the child is less than 6 months or had 
symptoms for 7 days or more, he/she should 
be referred.  
If there are signs of severe pneumonia, he/she 
should be referred with amoxicillin. 
Children older than 2 months with cough 
and fast or difficult breathing of less than 
14 days receiving amoxicillin or 
cotrimoxazol for 5 days. 
If the child is less than 2 months or had 
symptoms for 14 days or more, he/she 
should be referred.  
If there are signs of severe pneumonia, 
he/she should be referred with IM 
chloramphenicol 
*ARI timers are available in the Northern Region under the iCCM strategy to help diagnose suspected pneumonia. If 
severe pneumonia is suspected, the child must be referred to a CHPS compound or a Health Centre. **Nurses at CHPS 
compounds do not have ARI timers. The diagnosis is made based on clinical signs. If a severe pneumonia case is 
suspected, the children must be referred to a higher level of health facility. Some district hospitals, all regional hospitals 
and teaching hospitals have X-Rays to help diagnose pneumonia. Health centres, district hospitals, regional hospitals and 
teaching hospitals have laboratory facilities to help diagnose malaria, diarrhoea and pneumonia.  
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Table 2. Definitions specific to disease knowledge and health behaviour under HBC and CHPS strategies 
Definitions HBC and CHPS strategies 
Knowledge of the cause of malaria Identification of mosquitoes as vectors of malaria transmission. 
 
Knowledge of the causal behaviours/practices 
of diarrhoea 
Identification of at least 2 practices that cause diarrhoea among  
(i) not washing hands before eating,  
(ii) not washing hands after defecation,  
(iii) not drinking clean/boiled water and (iv) having flies on food.  
No other responses were considered as correct knowledge. 
 
Knowledge of the cause of pneumonia Identification of microorganisms as responsible for the disease. 
 
knowledge of causal behaviours/practices of 
pneumonia 
Identification of children not having been vaccinated. 
No other responses were considered as correct knowledge. 
 
Knowledge of signs of severe malaria Identification of at least 2 signs among  
(i) unconsciousness,  
(ii) convulsions,  
(iii) very pale,  
(iv) yellow coloured, 
(v) not breastfeeding and  
(vi) vomiting everything. 
 
Knowledge of signs of severe diarrhoea Identification of at least 2 signs among  
(i) more than 7 days duration,  
(ii) blood in faeces,  
(iii) dehydrated and  
(iv) not breastfeeding/feeding. 
 
Knowledge of signs of severe pneumonia Identification of both:  
(i) chest in drawing and  
(ii) noisy breathing. 
 
Having a mosquito net hanging At least 1 net over any bed / mat 
  
Improved sanitation facility Flush toilet, pit latrine or ventilated improved latrine 
  
Prompt treatment Care seeking in the first 24 hours of onset of symptoms 
  
Adherence to treatment Following the instructions received from providers on how to take the 
medicine prescribed. 
 
 
3.8. Study design and sampling procedures 
 
To address objectives 1 and 2, a cross sectional household survey was conducted. To address 
objective 3, a cost analysis was conducted (Figure 4). 
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Figure 4. Conceptual Framework of the study   
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3.8.1. Cross Sectional Household Survey 
The cross sectional household survey was an observational study, post implementation and without 
controls. The effectiveness of the delivery of the curative and preventive components was assessed 
against national guidelines and standard definitions. The study population were carers of children 
under- five who had a fever, cough and or diarrhoea in the last two weeks.  
The sample size was estimated using the standard formula for estimation of a proportion and 
adjusting for clustering: 3.84p(1-p)/e²) *DE (144). A prevalence of 50% of the population who are 
satisfied with the strategies was used to obtain a conservative sample size and ensure sufficiency for 
the estimation of utilization of the community services and several outcomes. A design effect of 1.5 
(145) and a precision of 5% were used. Adding 10% for non-response, the sample size required in 
each region was 633, giving a total sample size of 1267 households across the two regions.  
A stratified three stage cluster survey was conducted in each region. In order to have the sample 
representative of the whole region, whilst being logistically feasible, regions were divided into 3 
areas. From each area, 2 districts and from each district four clusters were selected using probability 
proportional to size (PPS). Then, from each cluster 27 households were selected, making a total of 
648 in each region. To select the districts (first stage) the list of districts implementing HBC (all 
districts implement the CHPS strategy) with its population was used. To select the clusters (second 
stage) the list of communities implementing HBC with its population was used. From the 24 
districts in the Volta Region, only 8 were targeted for the implementation of HBC because of their 
rural population and were included in the sampling (Annex 1). In the Northern Region, all districts 
and communities were included in the sampling, as HBC was implemented everywhere. 
Households with children under- five that had fever, diarrhoea or cough in the last two weeks prior 
to the interview were randomly selected in each cluster using a modified EPI sampling technique 
(third stage) (146). To select households, a location near the centre of the community was first 
identified and a random direction was defined by spinning a pen. A random household (the first 
household) along the chosen direction pointing outwards from the centre of the community to its 
boundary was chosen and checked for compliance with the inclusion and exclusion criteria. 
Whether the criteria were met or not, the next closest household was visited until the required 
number of households with a child with a fever, diarrhoea or cough in the 2 weeks preceding the 
survey were surveyed. Interviews were conducted with the carer of the sick child. In cases where 
there was more than 1 eligible child in a household, only one of them was selected randomly by 
ballot paper.  
The cross sectional study design selected was appropriate to evaluate the implementation of the 
preventive and curative components of HBC and CHPS strategies for children-under five in the two 
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regions, based on the outcomes of interest. This study was not a proof of concept, but an evaluation 
of an on-going programme that is already implemented at the national level. It was not possible 
therefore, to adopt study designs including interventions and controls, or indeed randomly selected 
intervention and control areas. To attribute the outcomes to the delivery strategies under study, the 
questionnaire included different question such us “where did you seek care”, “from where did you 
receive the drug”, “from where did you receive malaria preventive messages”, as used previously in 
a similar study in Ghana (147).  
Cross sectional studies have been used in many HBC studies (Annex 1), making it possible to 
compare my results to those of other studies. However, this cross sectional study would ideally have 
been complemented with a qualitative study that could help to explore barriers and enablers of 
delivery of appropriate curative and preventive care for malaria, diarrhoea and pneumonia through 
HBC and CHPS. Validating carers’ responses obtained from the household survey with CBAs 
records or with CBAs observation would have strengthened my results. Carers’ responses may be 
subject to recall bias, and may be influenced by understanding of instructions and by difficulties in 
the identification of symptoms, particularly those related to suspected pneumonia which are more 
difficult to identify. CBA records may suffer from inaccurate or incomplete reporting. Observation 
is considered the gold standard (90) but also has the limitation of potentially influencing 
performance (CBAs might perform better when under observation than when alone in the 
community, also called the Hawthorne effect (148)) and conducting observations is more time 
consuming and required more resources. A data validation exercise using reviews of CBA registers 
was originally planned together with a qualitative study. However, these sub-studies were not 
possible to conduct as the organization that had promised to finance the studies withdrew one 
month before planned implementation.  
The sampling scheme chosen is also appropriate for the study aim. Stratified 3 stage sampling with 
PPS ensures that all participants have an equal probability of being selected (avoiding selection 
bias) and it is cheaper and more feasible to conduct than simple random sampling. As the aim of the 
study was to evaluate the HBC and CHPS strategies, only communities designated by policy as 
implementing both strategies were included in the sampling. In the case of the Northern Region, all 
communities were designated as implementing both strategies, so all districts and communities 
were included in the sampling and the results represent the population of children under five that 
had fever, diarrhoea or cough in the 2 weeks previous to the survey in the Northern Region as a 
whole. In the Volta Region, HBC was targeted to some rural districts leaving out the urban ones. 
The results from the Volta Region therefore do not represent the whole region: only the population 
of children under- five that had fever, diarrhoea or cough in the 2 weeks previous to the survey in 
the communities designated as implementing HBC and CHPS (Annex 4 describes the districts 
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included in the sampling). Finally, it is important to note that I am not comparing the Volta Region 
with the Northern Region, nor malaria HBC with iCCM as both regions are different culturally and 
epidemiologically. I am only describing results found in each region and in each strategy.  
 
3.8.2. Cost analysis 
A cost analysis was conducted to determine the cost per case appropriately diagnosed and treated 
under the HBC and CHPS, addressing objective 3. The definition of case appropriately diagnosed 
and treated has been defined in Chapter 3, section 6.  
Economic costing was done from the societal perspective, which considers costs to households and 
the health system. The unit cost was defined as total cost incurred in treating one case of malaria, 
diarrhoea and pneumonia. Details on how the cost was calculated are described in chapter 6.  
Once the unit cost for diagnosing and treating a malaria, diarrhoea and pneumonia case under the 
HBC and CHPS strategy was obtained, the cost per case appropriately diagnosed and treated was 
calculated using a sample of 100 eligible children from the survey. Finally, a sensitivity analysis 
was conducted.  
Results from economic evaluations may suffer from bias or uncertainty. There are four types of 
uncertainty that might affect results of economic evaluations: methodological uncertainty, 
parameter uncertainty, structural uncertainty and generalizability. Methodological uncertainty refers 
to the analytic methods used in the analysis, for example the methods used to estimate productivity 
loses. If a methodological uncertainty is suspected, repeated analyses should be run using different 
methods. Parameter uncertainty arises from the imperfect knowledge of true values of the 
parameters that are used in the analysis, for example due to sampling variability. Parameter 
uncertainty can be dealt with by using both deterministic (one-way and multi-way sensitivity 
analysis) and probabilistic sensitivity analysis (PSA). Structural uncertainty refers to the appropriate 
methodology for combining the input parameters. If a structural uncertainty is suspected, repeated 
analyses should be run using different models where uncertainties regarding model structure exist. 
Finally, generalisability refers to the extent to which study results can be applied to another context 
or setting (149). Using data from systematic reviews instead of from one study and modelling are 
two approaches to deal with generalisability of findings. 
Sensitivity analysis allows exploration of how these uncertainties could affect the cost and cost-
effectiveness results. There are several types of sensitivity analysis as mentioned above. One- way 
sensitivity analysis is the simplest type of sensitivity analysis where values of different parameter 
are modified one at a time across a plausible range, while the other parameters remain at their 
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baseline values. Threshold analysis (a type of one-way sensitivity analysis) aims to identify the 
value of a parameter above or below which the intervention is cost-effective. One-way sensitivity 
analyses are easy to use, provide flexibility in parameter choice, they are logical, and they could be 
a good starting point to understand the structure of a particular cost or cost-effectiveness analysis. 
However, they have also been criticised particularly due to the fact that the incremental cost or cost-
effectiveness ratio might be influenced by more than one parameter at a time. Multivariate 
sensitivity analysis allows a variation of the value of several parameters at the same time. Scenario 
analysis is a type of multi-way sensitivity analysis were the worst and best- case values are used for 
the cost-effectiveness analysis. Multi-way sensitivity analysis also has some weaknesses: the 
interaction among different parameters might imply that the simple addition of different parameters 
might not be appropriate. In addition, the presentation and interpretation of a multi-way sensitivity 
analysis can also be difficult as the number of parameters modified increases. Finally, probabilistic 
sensitivity analysis (PSA) uses distributions which randomly generates a large number of mean cost 
and effectiveness estimates. This sensitivity analysis is believed to be the most comprehensive way 
of dealing with some forms of uncertainty in economic evaluation. However, practicality issues like 
the choice of the distribution, the assumption of independence between parameters, or the fact that 
PSA do not address generalizability, are their weaknesses (149, 150). 
To deal with uncertainty in this study, I decided to conduct a one-way sensitivity analysis. I 
believed that parameter uncertainty was the uncertainty that could most affect my results. Even 
though PSA can be considered as the best approach to deal with it, one-way sensitivity analysis is a 
good starting point to see how different values may affect the cost analysis, while being a more 
reasonable methodology to choose when compared to PSA, particularly due to the amount of time 
available to conduct the DrPH thesis. The parameters chosen for the sensitivity analysis were 
different discounting rates, different facility cost, different HBC and CHPS utilization and different 
HBC effectiveness. Different discounting rates to annualise capital values affect the cost of treating 
a malaria, diarrhoea or suspected pneumonia case particularly in the CHPS facilities. Therefore, I 
decided to explore whether using a discounting rate of 5% and 7% (instead of 3%) would affect the 
cost-effectiveness analysis. With regards to different facility costs, and as mentioned in section 
5.3.1, I conducted a cost analysis in two CHPS facilities in each region. Average CHPS costs in 
each region were used to conduct the cost- effectiveness analysis. However, I believed that it is also 
important to take into consideration not only average costs but also the less and more costly CHPS 
as this variation could influence results. Different HBC and CHPS utilization might influence the 
cost per case appropriately diagnosed and treated under both strategies. For example, if HBC 
invests in training CBAs but few people visit them, the cost per treatment under HBC would be 
high and therefore, it may influence the cost-effectiveness results. Data from the household survey 
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gave a point estimate and a 95%CI of the HBC and CHPS utilization. I considered that using the 
limits of the 95%CI as the values for the sensitivity analysis was the most appropriate approach. 
The 95%CI limits for the HBC utilization in the Volta Region were 5.8% and 45.7%; for CHPS 
utilization in the Volta Region were 6.7% and 22.9%; for HBC utilization in Northern Region were 
0.2% and 3.9% and for CHPS utilization in Northern Region were 10.6%, 68.6%. Similarly, the 
effectiveness of the HBC strategy (understood as the number of cases appropriately diagnosed and 
treated) may also influence the cost analysis. However, it was not possible to calculate the 95%CI 
of HBC the effectiveness for the three diseases in both regions. Considering the low effectiveness 
found (see Chapter 3), I consider that a 50% increase or decrease in HBC effectiveness was a good 
criteria to see how a change in HBC effectiveness might affect the cost analysis (as a lower % of 
increase or decrease was too low to see a difference in number of cases appropriately diagnose and 
treated) (Table 3).   
 
Table 3. Parameters used for the sensitivity analysis 
Parameters Values tested Rational  
Discounting rates 3%, 5% and 7%  Different discount rates to analyse capital values may influence the 
cost of diagnosing and treating a case, particularly in a CHPS 
facility. 3 % was chosen following a standard practice. 5% and 7% 
was believed to be a good range for comparison found in other 
studies. 
 
Facility costs Average, higher 
and lower costs 
Average cost of the CHPS facilities was used to do the cost 
analysis. However, different facility costs may influence the 
comparison with HBC.   
 
HBC and CHPS 
utilization 
95% CI The use of HBC and CHPS affects the cost per diagnosis and 
treatment. Using the 95%CI obtained from the survey was believed 
to be the best approach to explore higher and lower utilization.  
 
HBC effectiveness  50% higher and 
lower 
effectiveness 
Being HBC the “new” intervention, it seemed important to explore 
how better or worse performance will influence cost. Due to the 
low numbers, it was not possible to obtain the 95%CI of the HBC 
effectiveness in both regions. Therefore, a 50% increase and 
decrease in effectiveness (understood and the number of cases 
appropriately diagnosed and treated) was a good range to see 
changes in number of cases appropriately diagnosed and treated.    
 
3.9. Data collection 
 
Survey data collection was done during the 5th to 16th April 2014 in the Volta Region and during 
the 23rd June to 3rd July 2014 in the Northern Region. Three teams of 4 field workers with one 
field supervisor were recruited in Dodowa Health Research Centre (DHRC) for the Volta Region 
data collection and in the regional directorate in Tamale for the Northern Region data collection. 
The recruitment process and selection criteria included an interview, previous experience as a field 
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worker and in DHRC, and secondary education level. The training was done in DHRC for the Volta 
Region team and in Tamale for the Northern Region team. The training was of one week duration 
and included one day piloting the questionnaire. The same field supervisors and the trainers were 
used in both regions.  
Data collection was done using a structured questionnaire which included socio-demographic 
information of the carer, care seeking behaviour, experience with CBAs and other health providers, 
costs involved when seeking care, exposure to health education messages, knowledge of the 3 
diseases, health behaviour and household characteristics. To ensure that the data collected was of 
good quality, supervisors conducted checks for errors on the questionnaires, daily. This exercise 
was followed by a meeting with field workers to give feedback on issues found and discuss how to 
solve the problems identified.  
Data on costing was collected from the household survey, from the Health Administration and 
Support services, from the National Malaria Control Programme, from CHPS and from the NGO 
Plan International which supports the HBC in the Volta Region. Data costing started during data 
collection but last much longer, until the end of the thesis.  
 
3.10. Data management and analysis 
 
Survey data were double entered and validated using EpiData 3.1. Survey data processing and 
analysis was done using STATA 12. Initial data examination and prevalence estimates were 
obtained using tabulations adjusted for survey design. Pearson’s design based chi-square was used 
to test for associations. Survey logistic regression was used to obtain adjusted estimates.  
Principal components analysis (PCA) was used to create socio-economic quintiles and compare 
outcomes across these quintiles. The variables used to generate the socioeconomic quintiles were 
ownership of the house, number of rooms, type of flooring, availability of electricity, radio, 
television, refrigerator, telephone, bicycle, motorcycle, car, canoe, tractor, source of water, type of 
sanitation, main source for cooking and number of people living in the household. The advantage of 
using a PCA over the more traditional methods based on income and consumption expenditure is 
that it avoids many measurement problems such as recall bias, seasonality and data collection time. 
PCA is easy to calculate and it can use the type of data that can be easily collected in household 
surveys. Socio-economic categorization is obtained by ranking then classifying households within 
the distribution into various groupings. Therefore, while it is useful for considering inequality 
between households, it cannot provide information on absolute levels of poverty within a 
community. It can be used for comparison across countries, settings or over time, provided the 
separate indices are calculated with the same variables. Critics of PCA argue that the technique is 
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arbitrary, that the method of choosing the number of components and the variables to include is not 
well defined. Whether the first principal component can predict SES status will depend on the 
nature of data and the relationships between variables that are being considered, the validity of the 
variables included and their reliability (151).  
To ensure good quality data at this stage I used three strategies. When creating the data entry 
interface in EpiData and before entering the data, I set up data checks to avoid data entry errors.  
For example, restricting data entry to certain values or accepting values only on a certain conditions 
(jumps). Once all checks were done and tested, a double entered and validation was done to identify 
errors during the data entry. Entering the data a second time allows to check both files for 
inconsistencies. Finally, and before the data analysis, I cleaned the data looking for possible errors, 
inconsistences and missing values, revising filled in questionnaires if needed.  
 
3.11. Ethics 
 
Ethical approval was obtained from the Ghana Health Service-Ethical review committee (ID NO; 
GHS-ERC: 04/09/13) and from the Ethics Committee of LSHTM (ethics ref: 6442). Administrative 
approval was obtained from the respective regions and districts. Carers of children gave written 
consent to be interviewed (Annex 9). 
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Chapter 4. Assessment of the HBC and CHPS curative component  
 
 
4.1. Introduction 
 
As mentioned in Chapter 1, section6, Ghana has developed two main community- based 
interventions or delivery strategies that aim to reduce barriers to physical access to quality 
treatment, contributing to reducing the morbidity and mortality of children under- five years of age. 
These community-based interventions are HBC and CHPS. HBC started in Ghana in 1999 to treat 
suspected malaria cases (65). In 2009 and in the context of Integrated Management of Childhood 
Illness (IMCI), Ghana introduced the iCCM to address fevers, ARI and diarrhoea in the community. 
The CHPS strategy started in a pilot phase in 1994 (74) with the aim of improving access to health 
care. Among other services, CHPS provided treatment of common diseases such as malaria, 
diarrhoea and acute respiratory infections (ARI).  
This chapter reports on the assessment of the curative component of the HBC and CHPS strategies 
(objective 1 of the thesis) in terms of utilization of services, appropriate treatment given and users’ 
satisfaction in the current context, without additional supervision, in a large geographic area and 
considering the management of fever, diarrhoea and cough for children under- five years of age. 
 
4.2. Household survey 
 
A household survey was conducted 2 years and 8 years after implementation of HBC in the Volta 
and Northern Regions of Ghana respectively. Details of the study design were described in Chapter 
3, section7. This was a stratified three stage cluster survey where carers of children under-five years 
of age presenting with fever, diarrhoea or cough in the previous two weeks were interviewed on 
their care seeking behaviour, the treatment received and their experiences with the providers.  
I also mentioned that validating carers’ responses obtained from the household survey with CBAs 
records or with CBAs observation would have strengthened my results. It was not possible to 
conduct this sub-study. However, two studies on antimalarial use and dosage used where carer’s 
reports were compared to HBC records showed similar results (87, 88), and therefore support my 
study design. 
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4.3. Data analysis 
 
Assessing which factors or predictors that are associated with the utilization of these interventions 
might help to understand who is using the service and under which circumstances. This information 
can be useful to address equity (when the predictor is the socioeconomic status), to identify enablers 
or barriers as well as for planning purposes.  
 
To explore the potential association between HBC and CHPS utilization and potential predictors, 
the crude OR was obtained using univariate logistic regression, and the adjusted OR using 
multivariate analysis based on a framework that I developed (Figure 5 and Table 4). To do this, 
firstly, the association of each factor (adjusted only for district) with the HBC and CHPS utilization 
was estimated. All individual factors whose association reached significance at p<0.1 were included 
in a multivariate analysis. All factors that remained significantly associated with the outcome 
(p<0.1) in this model were retained. The variables included in this model were the core group of 
individual variables. Secondly, all community factors whose association reached significance at 
p<0.1 (adjusted only for district) were added into the core group of individual variables. All factors 
that remained significantly associated with the outcome (p<0.1) in this model were retained. 
Thirdly, all health system factors whose association reached significance at p<0.1 (adjusted only for 
district) were added into the core group of individual and community variables in a multivariate 
analysis. All variables that remained significantly associated with the outcome (p<0.05) in this 
model were retained in the final model. Two- way interactions were tested with all the variables 
retained in the final model. 
 
 
 
 
 
 
Figure 5. Simplified conceptual hierarchical framework for HBC and CHPS utilization 
  
Individual factors 
Community factors 
Health system factors 
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Table 4. Potential predictors of the framework for HBC and CHPS utilization 
Category Variable 
Individual factors Age of child 
Sex of child 
Age of care taker 
Education of care taker 
Household socio economic status 
Community factors Preventive messages sent by CBAs and CHPS  
Preventive messages sent by other sources 
Open hours (flexibility of time) of a CBA and CHPS to attend a child 
Health system factors Active NHIS card 
Distance to a health facility 
Type of closest facility 
Open hours (flexibility of time) of the closest facility  
 
4.4. Results  
 
A total of 1,356 interviews were conducted in the Volta and Northern Regions (685 and 671 
respectively) (Table 5).  
 
Table 5. Number of interviews conducted by district and region 
Volta Region Northern Region 
District Name Freq. District Name Freq. 
Hohoe municipality 115 Central Gonja 114 
Jasikan 113 East Gonja 118 
Ketu North 98 East Mamprusi 120 
Krachi East 114 Saboba 110 
Krachi West 121 Sawla-Tuna-Kalba 106 
North Tongu 110 Tolon Kumbugu 117 
Total interviews 671 Total interviews 685 
 
Among the children included in the study, fever was the most prevalent reported symptom during 
the last two weeks prior to the survey [621/671 (90.9%) in the Volta Region and 635/685 (94.4%) 
in the Northern Region], followed by cough [408/671 (65.9%) in the Volta Region and 334/685 
(53.1%) in the Northern Region] and diarrhoea [287/671 (49%) in the Volta and 291/685 (42.7%) in 
the Northern Region] (Table 6). 
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Table 6. Prevalence of symptoms and care seeking behaviour by region 
Indicator Volta Region Northern Region 
 N %** N %** 
Had Fever during past two weeks* 621/671 90.9 635/685 94.4 
Had Diarrhoea during past two weeks 287/671 49.0 291/685 42.7 
Had Cough during past two weeks 408/671 65.9 334/685 53.1 
Had suspected pneumonia during past two weeks 153/671 21.4 80/685 10.2 
Sought care (for any of the 3 symptoms)  639/671 93.1 626/685 92.8 
- From CBA 90/671 17.3 8/685 1.0 
- From CHPS 61/671 11.8 228/685 31.3 
- From Health Centre 130/671 12.2 155/685 21.1 
- From Hospital  153/671 24.2 83/685 13.0 
- From Private clinic 19/671 4.0 25/685 7.3 
- From Licensed chemical seller 153/671 19.5 88/685 14.9 
- From Drug peddler 29/671 3.3 33/685 5.5 
- From Traditional healer 0/671 0 6/685 0.6 
- From Other providers 4/671 0.4 0/685 0 
- Care not sought 32/671 6.8 59/685 7.3 
Not aware/ Don’t have CBA 213/671 29.8 314/685 40.6 
Sought care in the first 24h (for any of the 3 symptoms) 299/671 40.0 413/685 62.5 
- From CBA 58/90 56.0 6/8 79.9 
- From CHPS 22/61 36.3 163/228 76.9 
- From Health Centre 62/130 33.8 104/155 72.4 
- From Hospital  60/153 45.7 54/83 59.0 
- From Private clinic 4/19 20.6 12/25 47.8 
- From Licensed chemical seller 74/153 40.8 58/88 59.1 
- From Drug peddler 16/29 49.7 14/33 55.6 
- From Traditional healer 0 0 2/6 43.2 
- From Other providers 3/4 54.7 0 0 
Sought care in the first 24h in case of fever 278/621 40.2 385/635 62.5 
Sought care in the first 24h in case of diarrhoea 140/287 40.6 159/291 58.3 
Sought care in the first 24h in case of cough 178/408 39.4 188/334 54.9 
Sought care in the first 24h in case of suspected pneumonia 71/153 33.4 47/80 56.4 
Sought care from appropriate provider (for any of the 3 symptoms)  609/671 89.6 587/685 86.4 
Sought care from appropriate provider in first 24h (for any of the 3 symptoms) 282/671 38.1 397/685 59.1 
* Fever refers to hot body or chills. ** Weighted estimates. 
 
4.4.1. Utilization of HBC and CHPS strategies 
Almost all respondents in both regions (93%) indicated that they sought some form of care when 
the child’s symptoms started in the past two weeks preceding the survey, and more than 86% did it 
from an appropriate provider (Table 6). Seeking care from an appropriate provider was not 
associated with the SES (p=0.6 and p=0.2 in the Volta and Northern Regions) but it was associated 
with having an active NHIS card in the Northern Region (p=0.01) (data not shown in table). 
About 30% of carers visited a community-based health provider (HBC or CHPS) when their child 
had fever, cough or diarrhoea (29.1% and 32.3% in the Volta and Northern Region). Although 
CHPS coverage was found to be similar in both regions (41% and 43% of households have a CHPS 
as the closest health facility in the Volta and Northern Region) and the distance to the closest health 
facility is larger in the Northern Region (61% versus 45% have a health facility at less than 1 hour 
walking in the Volta and the Northern Region), HBC was more utilised than CHPS in the Volta 
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Region (17.3% of carers visited a CBA) and CHPS were much more used than HBC in the Northern 
Region (31.3% of carers visited a CHPS) (Table 6). 
Within regions the utilization of HBC and CHPS varied by districts (Table 7). HBC utilization in 
the Volta Region ranged from 35.3% (95% Confidence Interval (CI) 20.8 to 53) in Krachi East to 
0.3% (95% CI 0.01, 0.9) in Jasikan (p=0.001). In the Northern Region HBC utilization was 
generally very low and the percentage of carers reporting that they were not aware of CBAs or that 
they don’t have CBAs in the community was higher than in the Volta Region [314/685 (40.6%) 
versus 213/671 (29.8%) respectively]. The utilization of CHPS in the Volta Region varied from 
27.1% (95% CI 2.5, 84.3) in Krachi West to 2.5% (95% CI 0.3, 15.2) in Hohoe municipal (p=0.2). 
In the Northern Region, the utilization of CHPS ranged from 56.5% (95%CI 27.9, 81.2) in Saboba 
to 4.7% (95%CI 2.4, 9.2) in Central Gonja (p=0.004). 
Only 282/671 (38.1%) of carers in the Volta Region and 397/685 (59.1%) in the Northern Region 
sought care from an appropriate provider the same day or the day after the onset of fever, diarrhoea 
or cough (Table 6). While children seeking care from a CBA within 24h of onset of symptoms was 
significantly higher when compared with other appropriate providers collated in the Volta Region 
[58/90, 56.0% (95%CI 48.7, 63.08) versus 224/519, 39.4% (95%CI 29.2, 50.5), p=0.03], children 
seeking care from CHPS in the Northern Region also tended to do it more promptly when compared 
with other appropriate providers collated [163/227, 77.0% (95%CI 70.2, 82.7) versus 234/357, 
63.6% (95%CI 50.2, 75.2), p=0.02]. In the Northern Region, a higher percentage of fever cases 
sought care in the first 24hours of the onset of symptoms than diarrhoea or cough cases [385/635 
(62.5%) of fever cases, 159/291 (58.3%) of diarrhoea cases and 188/334 (54.9%) of diarrhoea cases 
sought prompt care). If comparing fever versus diarrhoea and versus cough (excluding those that 
have both symptoms) in seeking prompt treatment, the differences were not significant: 72.8% of 
fever cases (95%CI 62.1, 81.5) versus 60.8% of diarrhoea cases (95%CI 13.5, 93.9), p=0.5] sought 
prompt care; 79.2% of fever cases (95%CI 69.5, 86.5%) versus 57.3% of cough cases (95%CI 10.5, 
93.8, p=0.3] sought prompt care (data not shown in table).  
 
Factors associated with HBC and CHPS utilization in the Volta Region 
The final model showed that, compared to carers of sick children younger than 6 months, carers of 
sick children were more likely to visit a CBA if  children were older than 6 months (adjusted OR 6-
23 months 4.1, 95% CI 3, 5.5; adjusted OR ≥24months 4.1, 95% CI 1.4, 11 ; p=0.01), or if, 
compared to those living at less than 15 min walking, they lived further than 15min walking 
distance to a health facility (adjusted OR health facility 15-30min walking 36.9, 95% CI 1.6, 805), 
p=0.03;  30min-1 hour adjusted OR 61.8, 95% CI 4.8, 788, p=0.01;  1-2 hours adjusted OR 85, 95% 
CI 6.8, 1056, p=0.01;  ≥2hours adjusted OR 36.4 (1.5, 851), p=0.03).  Flexibility of time of the 
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CBA to attend to a child had a borderline association with utilization of HBC: compared to carers 
reporting that CBAs were not flexible, adjusted OR CBAs flexible 14 (95% CI 0.4, 417), p=0.08. 
Carers from households in higher socio-economic quintiles were less likely to take their children to 
a CBA than those in the lowest socio-economic quintile (adjusted OR lower middle quintile 0.2, 
95% CI 0.08, 0.7, p=0.03; adjusted OR upper middle quintile 0.3, 95% CI 0.06, 1.4, p=0.09; 
adjusted OR upper quintile 0.3, 95% CI 0.01, 1.5, p=0.08). No association with the middle SES 
quintile compared with the lower level was found (Table 8).  
No interaction was found between HBC utilization and any other variable. No factor was found to 
be associated with the utilization of CHPS compounds.  
 
Factors associated with HBC and CHPS utilization in the Northern Region 
Due to low HBC utilization in the Northern Region (n=8) it was not possible or useful to look for 
predictors of HBC utilization.  
With regards to CHPS utilization, carers having as the closest facility a health centre or a private 
clinic were less likely to go to a CHPS compound (adjusted OR health centre 0.01, 95% CI 0.002, 
0.08; adjusted OR private clinic 0.008, 95% CI 0.001, 0.5, p=0.02 (Table 9). No interaction was 
found.  
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Table 7. Utilization of HBC and CHPS by district and region 
 Volta Region Northern Region 
 HBC CHPS  HBC CHPS  
Districts n/N % (95% CI)* P n/N % (95% CI)* P Districts n/N % (95% CI)* P n/N % (95% CI)* P 
Jasikan 2/107  0.3 (0.01, 0.9) 0.001 13/107 11.3 (7.2, 15.5) 0.2 Sawla-Tuna –Kalba 1/97 1.1 (0.08, 13)  0.3 61/97 52.4 (22.3, 80.8) 0.004 
Krachi East 22/111  35.3 (20.8, 53)  10/111 17.9 (11.5,26.9)  Central Gonja 1/100 0.1 (0.009, 3.3)  8/100 4.7 (2.4, 9.2)  
Krachi West 23/119 12.7 (0.5, 78)  17/119 27.1 (2.5, 84.3)  Tolon Kumbugu 2/103 3.7 (1.6, 8.4)   24/103 20.0 (6.1, 48.7)  
Hohoe Mun.  10/111  10.9 (4.5, 23.9)  4/111 2.5 (0.3, 15.2)  East Gonja 0/112 0  46/112 22.6 (5.8, 57.7)  
Ketu North 12/91  12.2 (3.6, 33.7)  6/91 7.9 (5.1, 11.9)  Saboba 1/102 1.1 (0.3, 3.8)  55/102 56.5 (27.9, 81.2  
North Tongu 21/100  19.9 (8.1, 41.2)  11/100 10.6 (1.4, 49.0)  East Mamprusi 3/112 2.4 (0.7, 7.5)  34/112 22.5 (14.6, 57.5)  
TOTAL  90/639 18.5 (5.8, 45.7)  61/639 12.7 (6.7, 22.9)  TOTAL 8/626 1.0 (0.2,3.9)  228/626 33.7 (10.6,68.6)  
* Weighted estimates.  
Table 8.  Unadjusted and adjusted predictors of HBC and CHPS utilization in the Volta Region 
 HBC CHPS 
Potential predictors Unadjusted Adjusted  Unadjusted Adjusted  
 n/N %* OR (95% CI) P ** OR (95% CI) P n/N %* OR (95% CI) P ** OR (95% 
CI) 
P 
Sex child             
Female 38/273  12.5 1.0 0.3   20/273 8.2 1.0 0.1   
Male 43/335 18.1 1.5 (0.4, 5.1)     37/335 15.3 2.0 (0.6, 6.4)    
Age group             
<6 months 4/48  13.1 1.0 0.07 1.0 0.01 6/48 24.6 1.0 0.2   
6-23 months 37/244  24 2.3 (1.4, 3.7)  4.1 (3, 5.5)  25/244 13.2 0.4 (0.1, 1.4)    
>=24 months 49/347 16.4 1.7 (0.3, 7.8)  4.1 (1.4, 11)  30/347 10.3 0.3 (0.1, 1.0)    
Marital status             
Single 5/44 5.1 1.0 0.6   5/44 13.4 1.0 0.3   
Married/co-habited 82/548 19.6 5.8 (0.6, 56)    54/548 14.1 0.9 (0.1, 8.1)    
Separated/divorced 2/34 1.8 0.5 (0.0, 6.5)    1/34 0.1 0.008 (0.0001, 0.3)    
Widowed 1/13 53.8 24 (0.3, 1567)    1/13 0.4 0.02 (0.0004, 1.08)    
Age respondent             
<20 years 3/33 8.4 1.0 0.9   1/33 1.7 1.0 0.6   
20-29 years 36/281 20.7 1.2 (0.04, 33)    27/281 13.5 6.9 (0.2, 198)    
30-39 34/215 13.9 0.7 (0.01, 33)    25/215 14.3 7.2 (0.2, 176)    
>=40 years 15/106 23.6 1.5 (0.03, 66)    7/106 8.5 4.3 (0.06, 292)    
Education of care taker             
None formal 51/243 30.3 1.0 0.5   27/213 16.5 1.0 0.1   
Primary 14/142 6.6 0.2 (0.09, 0.9)    22/142 15.3 1.3 (0.1, 9.4)    
Middle/secondary 24/246 10.2 0.4 (0.08, 2.1)    12/246 5.8 0.4 (0.06, 2.5)    
Technical/Tertiary 1/8 4.9 0.3 (0.003, 41)    0/8 0 -    
Socioeconomic status             
Lower 20/129  41.7 1.0  1.0  24/129 16.5 1.0    
Lower middle  21/122 14.7 0.2 (0.07, 0.7) 0.03 0.2 (0.08, 0.7) 0.03 14/122 18.8 1.3 (0.8, 2.1) 0.14   
Middle 23/126  13 0.2 (0.03, 23) 0.15 0.3 (0.04, 3.3) 0.2 10/126 10.0 0.8 (0.1, 4.4) 0.7   
Upper Middle 16/125 10.6 0.2 (0.004, 1.4) 0.08 0.3 (0.06, 1.4) 0.09 5/125 5.9 0.4 (0.01, 17.4) 0.5   
Upper 9/128 6.3 0.1 (0.01, 1.5) 0.08 0.1 (0.01, 1.5) 0.08 7/128 9.1 0.7 (0.09, 6.7) 0.7   
CBA accessibility             
Not flexible 4/82  4.3 1.0 0.09 1.0 0.08 3/82 1.9 1.0 0.2   
Flexible 86/299 36.6 14 (0.3, 537)  14 (0.4, 417)  29/299 17.6 10.8 (0.6, 182)    
Not aware/don’t have CBA 0/202  0 -    29/202 12.9 7.4 (0.3, 159)    
Don’t know 0/56  0 -          
Receiving preventive messages from             
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CBA/CHPS compounds 
No 30/479 6.9 1.0 0.003 1.0 0.9 13/427 3.9 1.0 0.4   
Yes 40/87 58.7 12.2 (4.9, 30.2)  0.9 (0.9. 1)  42/139 29.3 1.2 (0.5, 3.0)    
Active NHIS             
Yes 65/452 16.4 1.0 0.3   42/452 11.9 1.0 0.5   
No  25/187  23.8 1.4 (0.4, 4.4)    19/187 14.6 1.2 (0.3, 4.1)    
Distance to facility (including CHPS)             
Less than 15 min walking 4/50  0.4 1.0  1.0  14/143 11.2 1.0    
Between 15 min- 30 walking 6/92  8.9 36 (0.7, 1793) 0.04 36.9 (1.6, 805) 0.03 16/180 9.5 0.7 (0.2, 2.6) 0.5   
Between 30 min- 1 hour walking 38/180  20.8 58.8 (5.3, 645) 0.01 61.8 (4.8, 788) 0.01 23/191 16.2 1.1 (0.3, 3.4) 0.7   
Between 1 and 2 hours walking 31/191 26.6 69.1 (5, 950) 0.01 85 (6.8, 1056) 0.01 6/69 16.5 1.2 (0.1, 12.2) 0.7   
Health facility accessibility/ CHPS 
accessibility 
            
Not flexible 6/81 19.9 1.0 0.5   15/46 29.5 1.0 0.9   
Flexible 81/535  17.9 1.1 (0.6, 2.1)    40/110 27.4 1.0 (0.4, 2.1)    
Closest facility             
CHPS 22/165 27.2 1.0 0.6   55/165 26.0 1.0 0.1   
Health Centre 27/275  14.8 0.4 (0.09, 1.7)    2/275 0.7 0.02 (0.0009, 0.5)    
District Hospital 36/167  10.7 0.7 (0.06, 7.4)    4/167 5.9 0.2 (0.01, 2.6)    
Regional hospital 0/3  0 -    0/3 0 -    
Private clinic 5/24  11.1 0.5 (0.02,11.4)    0/24 0 -    
Other 0/5  0 -    0/5 0 -    
*Weighted estimates. ** Overall P-value not available for all variables due to sparse data within stratified categories' 
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Table 9.  Unadjusted and adjusted predictors of CHPS utilization in the Northern Region 
*Weighted estimates. ** Overall P-value not available for all variables 
 
 
 
 
 CHIPS  
Potential predictors Unadjusted Adjusted  
 n/N %* OR (95% CI) P ** OR (95% CI) P 
Sex child       
Female 103/267 35.0 1.0 0.1   
Male 101/278 36.1 1.2 (0.8, 1.8)    
Age group       
<6 months 20/51 34.6 1.0 0.5   
6-23 months 84/228 29.6 0.5 (0.1, 1.9)    
>=24 months 124/347 36.5 0.7 (0.09, 5.2)    
Marital status       
Single 4/9 27.4 1.0 0.8   
Married/co-habited 219/597 33.8 0.6 (0.08, 5.5)    
Separated/divorced 2/4 57.6 0.8 (0.03, 18.6)    
Widowed 3/15 36.1 0.4 (0.04, 4.3)    
Age respondent       
<20 years 8/24 25.6 1.0 0.6   
20-29 years 108/259 36.4 2.1 (0.6, 6.6)    
30-39 76/230 30.7 1.5 (0.5, 4.9)    
>=40 years 36/111 35.5 1.8 (0.7, 4.7)    
Education of care taker       
None formal 183/510 35.4 1.0 0.4   
Primary 21/56 13.8 0.4 (0.1, 1.0)    
Middle/secondary 22/51 44 1 (0.3, 3.2)    
Technical/Tertiary 2/8 2 0.01 (0.0002, 1.1)    
Socioeconomic status       
Lower 38/119 39.8 1.0    
Lower middle  43/125 36.6 1.0 (0.4, 2.1) 1   
Middle 49/120 37.4 1.0 (0.1, 7.4) 0.9   
Upper Middle 50/122 29.8 0.6 (0.1, 3.8) 0.4   
Upper 42/128 12.1 0.1 (0.003, 10.1) 0.2   
CBA accessibility       
Flexible  93/212 48.3 1.0 0.2   
Not flexible 38/100 35.1 0.5 (0.001, 17.9)    
Not aware/don’t have CBA 87/292 19.5 0.2 (0.06, 1.1)    
Receiving preventive messages from 
CHPS compounds 
      
No 61/354 16.1 1.0 0.2   
Yes 150/194 77.2 2.2 (0.3, 14.6)    
Active NHIS    0.9   
No 55/204 25.3 1.0    
Yes  173/422 38.9 1 (0.5, 1.9)    
Distance to facility       
Less than 15 min walking 166/283 54.2 1.0    
Between 15 min- 30 walking 23/113 25.1 0.3 (0.09, 1.2) 0.07 0.2 (0.01, 3.0) 0.1 
Between 30 min-1 hour walking 23/103 27.1 0.4 (0.1, 1.4) 0.1 1.1 (0.04, 26.2) 0.9 
Between 1 and 2 hours walking 7/50 12.8 0.1 (0.01, 1.20 0.06 0.3 (0.001, 71) 0.5 
More than 2 hours walking 9/71 8.1 0.1 (0.03, 0.7) 0.03 0.6 (0.02, 16.0) 0.7 
CHPS accessibility       
Not flexible 18/34 46.5 1.0 0.3   
Flexible 205/293 76 2.6 (0.1, 51.2)    
Closest facility       
CHPS 223/327 73.9 1.0 0.02 1.0 0.02 
Health Centre 4/216 4.3 0.01 (0.003, 0.09)  0.01 (0.002, 0.08)  
District Hospital 0/42 0 -    
Regional hospital 0/0 0 -    
Private clinic 1/26 4.4 0.008 (0.0001, 0.6)  0.008 (0.0001, 0.5)  
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4.4.2. Appropriate treatment given for malaria, diarrhoea and suspected pneumonia 
Appropriate treatment of malaria under the HBC and CHPS strategies 
Regarding appropriate treatment of malaria, 19/77 (45.3%) and 1/7 (14.9%) of the children with 
fever that were taken to a CBA received ACT or were referred with artesunate to a health facility in 
the Volta and Northern Regions respectively (Table 10); 18/77 (45.0%) and 1/7 (14.9%) in the 
Volta and Northern Regions received ACT and 12/77 (14.9%) and 1/7 (14.9%) in the Volta and 
Northern Regions received ACT within 24 hours of the onset of symptoms. In Volta Region, some 
carers reported that they were prescribed amodiaquine monotherapy (6/78) and quinine (2/77) from 
CBAs. CBAs are not licensed to prescribe amodiaquine or quinine and amodiaquine should not be 
given as a monotherapy. However, it is difficult to determine if carers were actually given 
amodiaquine in monotherapy or if carers reported “amodiaquine” as a short name of “artesunate-
amodiaquine”. How CBAs have access to these two drugs is not clear: they may have been 
provided from the health facilities or CBAs may have purchased them at a local pharmacy for 
selling on to patients.  However, carers did not report to have paid for these drugs.  
In the case of the CHPS, 34/55 (65.3%) and 86/209 (41.7%) of the children with fever were tested 
for malaria in the Volta and Northern Regions. A high proportion of carers did not know the results 
of the test [9/37 (19.0%) and 21/92 (24.9%) in the Volta and Northern Regions respectively. Of 
those tested positive, 6/23 (20.8%) and 14/67 (8.6%) in the Volta and Northern Regions were given 
an ACT; 0/23 (0%) and 13/62 (35.1%) were given quinine (reserved for severe malaria cases that 
should be treated in hospital (152)) and 3/23 (22.3%) and 2/62 (3.8%) were given amodiaquine. 
When tested negative, only one case in the Volta Region was given ACT and none in the Northern 
Region. If considering together all uncomplicated malaria cases (those tested positive and fever 
cases without laboratory confirmation that were not referred), 7/40 (14.7%) and 26/183 (7.4%) in 
the Volta and Northern Regions received ACT (Figure 6). If malaria cases treated with quinine are 
included, then the proportion of children appropriately treated increases especially in the Northern 
Region although still not satisfactory: 8/40 (15.5%) and 57/183 (35.9%) in the Volta and Northern 
Regions. Prompt treatment with ACT or quinine was also low: 1/40 (2.3%) and 43/183 (27.3%) in 
the Volta and Northern Regions respectively. 
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Table 10. Proportion of symptomatic children receiving appropriate treatment under the HBC and CHPS by region 
Indicator Volta Region Northern Region 
 N %* N %* 
HBC 
Fever received ACT or referred with artesunate 19/77 45.3 1/7  14.9 
Fever received ACT 18/77 45.0 1/7 14.9 
Fever received prompt ACT 12/77 14.9 1/7 14.9 
Fever prescribed 3 days of ACT 16/77** 44.9 0/7*** 0 
Fever received 3 days ACT 14/77 40.7 0/7 0 
Fever received Amodiaquine 6/78 9.2 0/7 0 
Fever received quinine 2/77 0.3 0/7 0 
Diarrhoea received ORS  2/38 2.2 1/4 35.6 
Diarrhoea received ORS or was referred**** 4/38 7.6 NA  
Diarrhoea received zinc  3/38 16.3 1/4 8.9 
Diarrhoea received zinc or was referred**** 6/38 22.1 NA  
Diarrhoea received zinc for 15 days 0/38 0 0/4 0 
Diarrhoea received zinc and ORS or was referred**** 3/38 5.7 NA  
Suspected pneumonia received amoxicillin 6/25 14.1 0/1 0 
Suspected pneumonia received amoxicillin or was referred**** 7/25 31.8 NA  
Follow up visit 38/88 68.8 4/8 32.3 
Referred with a referral form 5/9 62.9 0/2 0 
Referred with artesunate suppository in case of fever 2/6 6.9 0/2 0 
Referred with amoxicillin in case of cough  2/8 59.9 0/2 0 
Referred with amoxicillin in case of suspected pneumonia 0/3 0 0/1 0 
Referred with amoxicillin in case of severe pneumonia signs 0/2 0 0/2 0 
CHPS  
Fever cases tested for malaria 34/55 65.3 86/209 41.7 
Test positive for malaria (some cases with no fever were tested) 23/37 62.1 67/92 71.2 
- Received ACT 6/23 20.8 14/67 8.6 
- Received prompt ACT 1/23 3.3 12/67 17.9 
- Prescribed 3 days of ACT 4/23 16.8 3/67 0.7 
- Received 3 days ACT 4/23 16.8 3/67 0.7 
- Received quinine  0/23 0 13/62 35.1 
- Received Amodiaquine (not recommended) 3/23 22.3 2/62 3.8 
- Referred with IM quinine or IM, EV or rectal Artesunate  0/5 0 2/4 4.5 
Test negative for malaria 5/37 13.5 4/92 4.3 
- Received ACT 1/5 4.0 0/4 0 
- Received quinine 0/5 0 0/4 0 
- Received Amodiaquine  0/5 0 0/4 0 
- Referred with IM quinine or IM, EV or rectal Artesunate  0/1 0 0/0 0 
Unknown results for malaria test 9/37 19.0 21/92 24.9 
Malaria clinical diagnosis 21/55 23.8 123/133 93.4 
- Received ACT 1/21 0.2 13/123 7.6 
- Received prompt ACT 0/21 0 10/123 6.4 
- Prescribed 3 days of ACT 1/21 0.2 4/123 1.5 
- Received 3 days ACT 1/21 0.2 2/123 0.1 
- Received quinine 1/20 2.4 19/123 26.3 
- Received amodiaquine  1/20 5.0 7/113 2.2 
- Referred with IM quinine or IM or rectal Artesunate 0/1 0 0/1 0 
Diarrhoea received zinc 7/31***** 31.3 4/86 5.5 
Diarrhoea received zinc for 14 days 0/31 0 0/86 0 
Diarrhoea received ORS 6/31 22.1 8/86 5.6 
Diarrhoea received ORS and zinc 1/30 0.3 0/86 0 
Suspected pneumonia received amoxicillin or cotrimoxazole 1/9 18.7 4/15 33.0 
Suspected pneumonia received 5 days of amoxicillin or co-trimoxazole 1/9 18.7 4/15 33.0 
Suspected pneumonia received any antibiotic****** 2/9 20.0 5/15 50.3 
Cough received amoxicillin or co-trimoxazole 7/34 30.1 30/104 27.3 
*Weighted estimates. **A high number of carers were not told about the number of days to give the medicines. ***Was 
prescribed and took ACT for 7 days. **** Only in the Volta Region as CBAs are only provided with malaria treatment. ***** 
Zinc was taken for 10 days; ******amoxicillin, PNC V, ampicillin, co-trimoxazole, cefuroxime, Azitromicin, cloxacilline, 
eritromicin flucloxacilline, or chloramphenicol. 
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Figure 6. Case management of uncomplicated malaria under the HBC and CHPS by region. (Uncomplicated malaria = 
cases tested positive or fevers when no test was conducted that were not referred). VR= Volta Region; NR= Northern 
Region; quin=quinine. T= Treatment. Differences between HBC and CHPS in the Volta Region were statistically 
significant. No test was conducted in the NR due to low numbers 
 
Appropriate treatment of diarrhoea under the HBC and CHPS strategies 
Of the children with diarrhoea that were taken to a CBA in the Volta Region, 4/38 (7.6%) and 3/38 
(5.7%) received ORS or were referred and received ORS plus ZINC or were referred respectively.  
In the case of the CHPS, only 6/31 (22.1%) and 8/86 (5.6%) of children with diarrhoea received 
ORS, 7/31 (31.3%) and 4/86 (5.5%) received zinc and 1/30 (0.3%) and 0/86 (0%) received ORS 
plus zinc in the Volta and Northern Regions respectively.  
 
Appropriate treatment of suspected pneumonia under the HBC and CHPS strategies 
Of the children with cough with fast or difficult breathing that were taken to a CBA 7/25 (31.8%) 
received amoxicillin or were referred in the Volta Region and 0/1 (0%) received amoxicillin in the 
Northern Region. In the case of the CHPS, 1/9 (18.7%) and 4/15 (33.0%) in the Volta and in the 
Northern Region received amoxicillin or co-trimoxazole according to the protocol. 
 
Follow up visits, referrals and second providers’ visits 
National guidelines state the CBA must conduct a follow-up visit one day after the first visit (65). 
This follow-up visit was conducted for 38/88 (68.8%) and 4/8 (32.3%) of the cases in the Volta and 
Northern Regions (Table 10). Artesunate suppositories were given along with a written referral in 2 
of the 6 fever cases referred in the Volta Region and in none of the 2 cases in the Northern Region. 
No amoxicillin was given in case of referral because of suspected pneumonia in either region and 
2/8 (59.9%) of the cough cases referred received amoxicillin in the Volta Region.  
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After visiting a CBA, 28/90 (42.4%) and 4/8 (63.3%) of the carers in the Volta and in the Northern 
Region went to a second provider. The main reason for this second visit in the Volta Region was 
children not getting better [24/28 (98.7%)] while in the Northern Region the reported reasons were 
not getting better [2/4 (25.5%)] and to get drugs [2/4 74.5%)] (Table 11, Figure 7). After visiting a 
CHPS, 14/61 (28.0%) and 21/228 (7.9%) of carers in the Volta and in the Northern Region went to 
a second provider. The facilities more often visited were the licensed chemical sellers in the Volta 
Region to buy drugs [8/14 (50.4%)] and health centres in the Northern Region because the child 
was not getting better [9/21 (23.8%)].   
Table 11. Places and reasons for seeking care elsewhere after visiting CBA or a CHPS by region 
 Volta Region Northern Region 
 n/N %* n/N %* 
Seeking care elsewhere after CBA 28/90 42.4 4/8 63.3 
Seeking care elsewhere in case of fever 25/28 82.6 4/4 100 
Seeking care elsewhere in case of diarrhoea 12/28 66.4 3/4 36.8 
Seeking care elsewhere in case of suspected pneumonia 6/28 10.2 1/4 20.3 
Second provider sought    
- CHPS 4/28 54.5 2/4  68.3 
- Health Centre 7/28 21.8 1/4  11.3 
- Hospital 10/28 16.3 1/4  20.3 
- Licensed Chemical seller 3/27 2.2 0 0 
- Private health facility 4/28 4.9 0 0 
Reasons for seeking care elsewhere    
- Not getting better 24/28 98.7 2/4 25.5 
- To buy medicines 3/28 1.1 2/4 74.5 
- CBA not available 1/28 0.1 0 0 
Seeking care elsewhere after CHPS 14/61 28.0 21/228 7.9 
Second provider sought     
- CHPS 2/14 11.6 1/21 9.2 
- Health Centre 0/14 0 9/21 23.8 
- Hospital 3/14 1.1 4/21 49.5 
- Licensed Chemical seller 8/14 50.4 6/21 16.8 
- Drug peddler 1/14 36.7 0/21 0 
- Traditional healer 0/14 0 1/21 0.5 
Reasons for seeking care elsewhere     
- Not getting better 5/14 51.7 20/21 99.4 
- To buy medicines 8/14 42.4 1/21 0.5 
- Nurse/doctor not available 1/14 5.8 0/21 0 
*Weighted estimates 
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Figure 7. Pathway for care seeking 
 
4.4.3. Users’ reported satisfaction 
In general, users of HBC and CHPS in both regions reported that they were satisfied, although 
consistently more in the Volta Region (Table 12). Lack of affordability and availability of drugs 
were the factors more often reported as reasons for dissatisfaction with the services received.  
 
The main reason for not being satisfied when using HBC in the Volta Region was unavailability of 
drugs [5/8 (80.24%)], while drugs not available, drugs not affordable and drugs not free [1/1, 
(100%)] were the concerns in the Northern Region. It is important to note that 3 of the 7 drugs 
(42%) and 3/138 (2.1%) given by the CBA in the Northern and the Volta Regions were sold to the 
carers.  
 
Likewise, the main reason for not being satisfied when visiting a CHPS in the Northern Region was 
drugs not available (5/23, 39.1%). CHPS users in the Volta Region reported a higher variety of 
reasons for not being satisfied (drugs not available, travel long distances, not time for seeking care 
and staff not giving information).  
 
Table 12. Users’ satisfaction after visiting CBA or a CHPS by region 
  Very satisfied Satisfied Not sure Not satisfied Absolutely 
not satisfied 
 n/N % n/N % n/N % n/N % n/N % 
Volta 
Region 
CBA 29/89   32.6 52/89 58.4 0/89 0 6/89 6.7 2/89 2.2 
CHPS 15/61      24.6 42/61 68.8 0/61 0 2/61 3.3 2/61 3.3 
Northern 
Region 
CBA 2/8 16.1 4/8 30.1 1/8 13.6 0/8 0 1/8 39.9 
CHPS 29/228 8.4 175/228 85.2 1/228 0.1 21/228 5.3 2/228 0.8 
  
Seeking care. 
First visit  
Not improving 
Need to buy 
drugs 
Seeking care. 
Second visit 
Child with 
symptoms 
Not seeking 
care  
CBA/nurse not 
available 
Cured 
Cured 
Not improving 
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4.5. Discussion 
 
This study assessed the performance of HBC and CHPS in terms of utilization, appropriate 
treatment given and satisfaction of carers of children under-five years of age with a fever, diarrhoea 
or suspected pneumonia in the last two weeks prior to the interview. 
 
4.5.1. Utilization of HBC and CHPS strategies 
 My study showed that seeking care from an appropriate provider in case of fever, diarrhoea or 
cough was high in both regions. In the case of fever, 89.9% and 86.7% of children with fever sought 
care from an appropriate provider and 38.1% and 59.3% did it in the first 24hours of onset of 
symptoms in the Volta and Northern Regions respectively. Those percentages are higher than 
previous surveys but they are coherent with the increased trend on care- seeking behaviour because 
of fever: the 2011MICS survey showed that approximately 44% and 43% of fever cases in under-
fives in the Volta and Northern Regions sought care from an appropriate provider at any time (128); 
the 2013 LQAS survey showed that 60% of fever cases in under-fives in the Northern Region 
sought care at any time and 30% in the first 24hours of onset of symptoms (153) and in the 2014 
DHS 73.6% and 83.6% of fever cases in the Volta and Northern Region sought care at any time 
(57). It should be noted that the Lot Quality Assurance Sampling (LQAS) is a method for assessing 
a programme by analysing the data produced by a small sample. While DHS and MICS serves for 
international comparison, the LQAS serves for intra-national comparison and for health system 
management (154). Depending on the objectives of the study, the sample size and the rigour of the 
sampling methods chosen, results can be representative or not of the whole population (155).The 
results from the LQAS survey are not representative of the Northern Region as they purposively 
selected 10 districts out of 20 based on their iCCM lower performance compared with the other 10 
districts. The MICS and the DHS surveys, use a similar sampling methodology than my study (156) 
but their sample size of children under five presenting with fever was between 3 and 11 times 
smaller than this study (the study population in the MICS and DHS survey includes children under-
five with and without symptoms, while my study only included children under- five with 
symptoms). 
Having an active NHIS card was associated with seeking care from an appropriate provider in the 
Northern Region as it can also be found in other studies in Ghana (157-160). Therefore, it seems 
important to continue promoting the NHIS to eliminate one of the barriers to access to care. 
However, having an active NHIS card was not associated with HBC or CHPS utilization. This is not 
surprising as the HBC is free and it is not covered by the NHIS. Although CHPS services can be 
covered by the NHIS if they are accredited, the number of services offered are fewer and less costly 
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than those offered in other health facilities. It could also be possible that if these CHPS were not 
accredited, and therefore, its services were not covered by the NHIS, those with an active NHIS 
card might prefer to seek care in another health provider covered by the insurance. However, I do 
not have information regarding if the CHPS included in the study area were accredited or not. 
The total utilization of community-based interventions was similar and slightly higher in the 
Northern Region when compared with the Volta Region (32.3% 95%CI 10.8, 65.1 versus 29.1% 
95%CI 10.9, 58.0). However, utilisation of HBC versus CHPS was different: HBC was used more 
in the Volta Region while CHPS was used more in the Northern Region.  
My results showed a similar HBC utilization to the 2013 LQAS survey in the Northern Region 
(95% CI 0.7, 6.5. However, another study conducted in one district of the Ashanti and Volta 
Regions in 2008 (87) showed higher HBC utilization (more than 68% and 75% respectively used 
HBC a year after the HBC implementation). When compared with other evaluations conducted in 
Uganda in 2007 (127)- a quasi-experimental study before and after 18months implementation of 
malaria HBC, in Uganda in 2015 (161)- a quasi-experimental study after 14 month implementing 
iCCM,  and Burkina Faso in 2003 (126)- a cross sectional study conducted before and after one year 
implementation of HBC, a higher utilization of HBC (25%, 39% and 56% respectively) was found. 
On the contrary, a recent study conducted in Burkina Faso in 2015 (cross- sectional study after 3 
years of the introduction of HBC and under programme conditions (162) showed a similar HBC 
utilization as my study (1%-9% in rural areas). Another study conducted in Ethiopia in 2015 (a 
RCT where the intervention arm implemented iCCM- with support from UNICEF for monitoring 
and for drug supply-, and the control arm implemented malaria and diarrhoea HBC with routine 
monitoring and drug supply after more than 2 years of implementation) showed 10.8% and 7,7% 
HBC utilization respectively (163). Two reasons could explain these different results in terms of 
HBC utilization. Firstly, due to differences between districts: the study in the Ashanti and Volta 
Region only focussed on 1 district per region and this current study has shown the variation of HBC 
utilization among districts specially in the Volta Region). Secondly, due to differences between 
research projects and programme implementation: the length of the projects is generally shorter and 
the quality and intensity of supervision is usually better in research projects than in routine 
programme implementation. For example, the HBC strategy in the Northern Region was being 
implemented for about 8 years before my survey and for 2 years in the Volta Region. Longer time 
implementing the strategy might bring expertise but also tiredness of the CBAs and the supervisors, 
stock-out of drugs and the need for CBA replenishment and training. The lower effectiveness of an 
intervention in the “real world” as compared to that found in research projects is already being 
discussed and addressed within the field of implementation research (164-166) which aims to 
bridge the implementation gap between knowledge and action.  
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Large differences in HBC utilization were observed between the Volta and Northern Regions. 
However, the HBC strategy in the two regions started at different times and includes different 
interventions. In the Northern Region, HBC started in 2007 first addressing malaria cases, and in 
2010 the management of diarrhoea and suspected pneumonia cases were included with the technical 
and financial support of UNICEF. The HBC in the Volta Region started in 2012 and includes only 
drugs for the management of malaria cases with the financial support of the GFATM, while 
diarrhoea and suspected pneumonia cases should be referred for further treatment. Therefore, one 
could argue that a higher HBC utilization in the Northern Region would be expected as a wider 
range of conditions are treated by the CBAs compared with Volta Region (which was not the case). 
Considering that this study was conducted in communities where according to policy HBC is being 
implemented, it is surprising that 30% of carers in the Volta Region and 41% in the Northern region 
indicated that they were not aware of the presence of CBAs or they did not have CBAs in the 
community. The two recent studies conducted in Burkina Faso and Ethiopia also reported that 33%  
and 43% of carers did not know a CBA after three and two years of HBC implementation 
respectively (162, 163). During informal communications with CBAs and community chiefs while 
conducting the survey, the field team was informed that some CBAs travelled and no one had 
replaced them yet, others stopped working as they did not have drugs to work with and some CBAs 
were known in one area of the community while not in another area, suggesting that social and 
personal issues might also affect the knowledge and the utilization of the CBA services. Therefore, 
sociocultural issues, stock out of CBA drugs or high turnover of CBAs could explain the lower 
utilization of HBC in the Northern Region as they have  also been reported in other studies in 
Ghana and elsewhere as a barrier to implementation (88, 127). A further qualitative study might 
help to understand causes of the low HBC utilization in the Northern Region.  
With respect to the Volta Region, HBC utilization was not associated with living far from a CHPS 
or with low flexibility of CHPS for attending patients. The HBC strategy in the Volta Region was 
found to be coherent with the guidelines in terms of not treating children under 6 months, it is 
reaching the poorest in coherence with its intention of being a “pro-poor” intervention and it is more 
used when there is no health facility close to the house. It is worth noting that the 2007 Uganda 
study (127) concluded that HBC was less likely to reach the poorest than the least poor and the 
authors couldn’t explain why. Three other studies in Uganda, Zambia and Burkina Faso found that 
proximity to a health facility was a barrier to HBC utilization (162, 167, 168) and another study 
found that HBC is not cost-effective in the context of proximity to a health facility (96). For future 
planning and considering only the therapeutic component of the HBC (which is the one evaluated in 
this Chapter), HBC should consider to target areas without a health facility (as was the strategy of 
the NMCP in the Volta Region).  
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With regards to CHPS utilization, proximity to a CHPS was found to be associated to CHPS 
utilization in the Northern Region (and not in the Volta Region, were carers seem to choose a 
provider based on different criteria not identified). Our results on CHPS utilization were higher than 
the results of the LQAS survey (between 6-10%). No other comparable studies on CHPS utilization 
were found in the literature to contrast these results. 
Carers visiting a CBA in the Volta Region and visiting a CHPS in the Northern Region did it more 
promptly when compared with other providers. When diagnosed with malaria, children visiting a 
CBA also received ACT more promptly than when visiting any other provider in the Volta Region 
(22.4% versus 3.8%, p=0.05). Prompt treatment received from a CBA was reported in other studies 
conducted in Rwanda (169), Uganda (127, 170), Ghana (87, 88), Nigeria (87), Burkina Faso (88, 
126), Tanzania (171), Ethiopia (88) and Malawi (88). Most of these studies looked at the 
performance of HBC at a point in time or in before-after cross-sectional studies. Only the two 
studies in Uganda (an RCT and a quasi-experimental study) were designed to test for a difference in 
prompt treatment seeking between HBC and standard treatment and their results were similar: 62% 
versus 37%, p=0.0001(170) and a significant difference at post intervention (12.3%, p=0.05) (127).  
 
4.5.2. Appropriate treatment given for malaria, diarrhoea and suspected pneumonia 
The target of treating 100% of eligible children with ACT, amoxicillin and/or ORS+ZINC was not 
met after visiting a CBA or a CHPS. This worrying fact should question the local health authorities 
particularly on the adequacy of the drug chain, as it will be described below. Acknowledging the 
difficulty of interpreting the HBC figures due to the low numbers of carers visiting a CBA in the 
Northern Region, it seems that HBC was more used and performed better in the Volta Region when 
compared with the Northern Region while CHPS in the Northern Region were more used and 
performed better than in the Volta Region. 
More malaria cases were treated with quinine (reserved for complicated cases) than with ACT in 
the CHPS of Northern Region. As only between 0-11% of cases seen in health facilities in Ghana 
are complicated cases (172, 173) a possible explanation for the frequent use of quinine could be 
stock-outs of drugs.  
The percentage of uncomplicated malaria cases treated with ACT in this study is lower than that 
found in other studies. A cross-sectional study in Ghana (84) showed that 100% of febrile children 
visiting a CBA received ACT according to CBA records. The source of information (CBA records 
versus carers’ information) could contribute to the different results. As mentioned in section 2.3.5, it 
is important to note that neither CBA records nor carers’ information are the gold standard for 
collecting this type of information, which is considered to be the direct observation of CBA work 
(90): CBA registers may suffer from inaccurate or incomplete reporting and household surveys may 
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suffer from recall bias and misunderstanding. However, two multi-country studies conducted in 
Africa used both sources of information (CBA records and carers’ information) and found (i) better 
HBC performance than my study, and (ii) similarity of results obtained from the two sources: a 
multi-country study in Ghana-Nigeria and Uganda (87) showed 59% of febrile children receiving 
ACT from a CBA and in a multi-country cross-sectional study in Ghana, Burkina, Ethiopia and 
Malawi (88) 82% of febrile children received ACT from a CBA. As mentioned before, other factors 
that could explain those differences in performance are better supervision, better supply of drugs 
with the involvement of the research teams, as well as a shorter duration of the research projects 
when compared to programme implementation. Another study conducted in Burkina Faso (126) 
with less external supervision or antimalarial supply had similar results as this study (54% of the 
febrile children received ACT from a CBA).   
With regards to diarrhoea management, a common finding among regions and strategies was the 
low percentage of cases correctly treated and children receiving either ORS or zinc, but not both at 
the same time. The LQAS survey in the Northern Region also found a low proportion of diarrhoea 
cases treated with ORS and zinc when visiting a CBA or a CHPS and authors suggested that it 
might be due to stock-outs of drugs. CBAs are provided with drugs during the monthly community 
welfare clinics conducted by CHPS’ or health centres’ nurses. However, the stock-outs of drugs 
suggests that this integration is not covering all drug needs. Results of the 2011 MICS and the 2014 
DHS also showed a low proportion of diarrhoea cases correctly treated (2011MICS: 32% and 
30.1% of diarrhoea cases received ORS and 0% and 0.2% received zinc from an appropriate 
provider excluding pharmacies in the Volta and Northern Regions respectively; 2014 DHS: 41.3% 
and 48.7% of diarrhoea cases received ORS and 0% and 5% received zinc from an appropriate 
provider excluding pharmacies in the Volta and Northern Regions). The low coverage of ORS and 
almost negligible use of zinc to treat diarrhoea cases was also reported by Gill et al 2013 (174). In 
their paper about bottlenecks, barriers and solutions to the low implementation of effective 
measures to reduce childhood pneumonia and diarrhoea deaths in low and middle-income countries, 
they stated that the main bottlenecks for diarrhoea appropriate treatment were concentrated in 
downstream areas related to provision of ORS and zinc in the community.  
With regards to suspected pneumonia case management, the 2011 MICS and the 2014 DHS also 
showed low treatment coverage: 55.7% and 41% of suspected pneumonia cases received antibiotic 
in in the 2011 and 2014 surveys nationally, respectively. However, it is not possible to make a 
direct comparison with my results as all appropriate providers were considered together. Another 3 
studies conducted in Uganda and Zambia on HBC (168, 175, 176) showed a better performance 
(between 63% to 98% of suspected cases received amoxicillin). However, 2 of them (168, 175) 
used a different methodology to diagnose suspected pneumonia cases (registries and direct 
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observation of CBA as opposed to carers’ reports) and another one used carers reported symptoms 
but in the context of a cluster randomized trial.  
Finally, there is the need to reflect on the fact that some cases received amoxicillin, ORS or zinc 
when visiting a CBA in the Volta Region (as the GFATM is only supporting ACT drugs). It seems 
feasible to believe that CBAs still had some of these drugs distributed in 2013 in stock, or CBAs 
bought these drugs to be distributed among sick children. 
 
4.5.3. CBA follow up visits, CBA’referrals and second visit to health providers 
Reported CBA follow up visits on the day after the first visit and adequate referrals were higher in 
the Volta than in the Northern Region (although interpretation must be done with caution due to the 
low numbers of HBC visits in the Northern Region). The best performance was on the follow up 
visits, 68.8% of under-fives that visited a CBA received a follow up visit in the Volta Region. 
Written referrals in the Volta Region (62.9%) were higher than in another study in Ghana where 
written referrals in case of fever decreased from 21.8% at the beginning of the project to 15.1% two 
years later (85). Giving artesunate suppository in case of CBA referrals of fever cases and one dose 
of amoxicillin in case of referrals of cough cases was not a common practice.  
My study showed a higher proportion of carers that sought care elsewhere after visiting a CBA than 
the study in Dangme West district (84) (where only 3.9% of the carers sought care elsewhere). 
Since for the HBC strategy in the Volta Region CBAs were expected to refer diarrhoea and 
suspected pneumonia cases, one would expect a higher proportion of carers seeking care elsewhere 
in the Volta Region than in the Northern region. However, 42% and 63% of carers in the Volta and 
Northern Region sought care elsewhere after visiting a CBA because of unavailability of drugs and 
children not getting better. This is coherent with the LQAS survey where only 16% of the CBAs 
had ACT, ORS, Zinc and amoxicillin on the day of the survey in the Northern Region. With regards 
to HBC in the Volta Region, it is important that HBC coordinators emphasise the importance of 
referral with a form, as seeking care elsewhere can be seen as a failure of the programme while 
referral can be interpreted as appropriate management of cases. 
The low coverage of appropriate treatment found should make policy makers and health partners in 
Ghana reflect upon the new “Integrated community case management guidelines” which will 
include pregnancy and neonatal care, nutrition in under 5 and the inclusion of RDT for the 
diagnosis of malaria. Before adding more components to the HBC strategy, adherence to protocol 
through ensuring availability of drugs, adequate supervision and continuous replacement of CBAs 
must be ensured.    
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4.5.4. Users’ satisfaction 
The present study included only 3 questions on satisfaction: “Were you satisfied with the service 
received when you seek care”, “If not or absolutely not, why” and “If yes or absolutely yes, why”. 
As mentioned in section 3.4, a study addressing satisfaction should consider different areas or 
dimensions of satisfaction to ensure the validity of the instrument (in that case, our survey). 
However, the 2 questions asking why yes or why not, including an open response, gave a possibility 
to see which of the areas described by Fitzpatrick (177) were more relevant to the carers which can 
be further analysed through a qualitative study. Most of the ‘not satisfied’ responses were due to 
availability and affordability of drugs, child not recovered and staff not professional, which relates 
to the organization of health care and technical competence. 
Lack of availability and affordability of drugs were the main factors for carer dissatisfaction of 
services in both regions. Therefore, emphasis must be given to avoiding drug stock outs. Also, a 
reflexion must be undertaken about carers paying CBAs for drugs. Although paying CBAs’ for their 
drugs could be a strategy to retain CBAs, carers valued free drugs as a positive element of the HBC 
strategy. Secondly, it is a contradiction with the NHIS which established free treatment for children 
under five. Thirdly, because this practice is not considered in the HBC guidelines, which only states 
“to ensure that cost of iCCM would not be a barrier to accessing treatment, drugs should be given to 
clients at no cost or the National Health Insurance Scheme (NHIS) may cover all drugs”. 
 
Limitations of the study 
The response rate was very high for the survey with no refusals to participate. The variables 
described in the study represent only the population of sick children during the last two weeks prior 
the interview and not the whole population. 
The study looked at programme implementation against guidelines and targets of the national 
programme. Comparison between north and south was done based on the understanding that regions 
are different from the cultural and epidemiological point of view and without directly comparing 
malaria HBC with integrated HBC. Different epidemiological burden would not be expected to 
influence results, as the target population was children with symptoms. As guidelines are the same, 
carers’ seeking behaviour and the management of cases by providers are expected to be the same in 
both regions. However, finding these children when doing the data collection was easier in the 
Northern Region as the prevalence of the three diseases was higher. As this was a cross sectional 
study, no reference to causality can be made, only association among variables (for example when 
analysing predictors of HBC and CHPS utilization). In addition, cross sectional studies can deal 
with possible known confounders while they cannot deal with unknown confounders. 
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In section 3.7.1, I described the adequacy of using a cross sectional study, basing my results on 
responses of carers of children under-five. Although this study design has been used in many other 
studies, carer’s responses may suffer from recall bias and may be influenced by their understanding 
of instructions and the identification of symptoms. To reduce recall bias particularly on the 
treatment received, study participants were limited to those with symptoms in the two weeks prior 
to the survey. In addition, each field worker carried to the households pictures of the antimalarial 
drugs, antibiotics, ORS and zinc available in the districts to help the identification of drugs during 
the interview, in case carers did not remember or had not kept the drug package.   
Morbidity data collected is subjective as it is based on a mother’s perception of illness and their 
understanding about their children’s disease and the treatment given, with no validation of their 
responses (using CBAs/CHPS registers or observation). Therefore, interpreting results particularly 
related to suspected pneumonia must be done with caution as fast breathing, chest in drawing or 
noisy breathing can be perceived differently by the carers and the provider and therefore, treated 
differently. The same is the case with diagnostic procedures and treatment given and understood. A 
patient could have been given “artesunate-amodiaquine” but referred to have received 
“amodiaquine”. Or the patient might not remember the name of the drug, even with the help of the 
drugs pictures that were taken to the field to conduct the survey. However, the use of carers’ reports 
to classify malaria, diarrhoea and suspected pneumonia has been used in the MICS, DHS and other 
studies (176). In addition, two studies on antimalarial use and dosage using both sources of data 
(HBC records and carers’s reports) showed similar results (87, 88). Finally, if some children were 
misclassified (for example being attributed with one symptom while they do not have it), this is not 
likely to have introduced a differential bias between HBC and CHPS. 
Some of the results had large confidence intervals even though the formula used to calculate the 
sample size was adequate. The clustering of indicators by district was larger than expected and 
therefore a bigger design effect could have been more appropriate (DE=2 instead of 1.5). As a 
result, the sample size was small for some indicators. 
 
4.6. Conclusions 
Utilisation of HBC was higher in the Volta Region while CHPS utilisation was higher in the 
Northern Region. HBC utilization was almost non-existent in the Northern Region. Poorer children, 
children older than 6 months and those living far from a health facility were more likely to use HBC 
in the Volta Region. HBC contributed to prompt treatment of fevers in the Volta Region.  
Appropriate treatment for the three diseases was low in the HBC and CHPS areas, in the Volta and 
Northern Regions. Carers were satisfied with the services received. Lack of availability and 
affordability of drugs were the factors most reported as a cause of dissatisfaction.  
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More efforts should be made in the provision of drugs, replacement of CBAs and in monitoring the 
CBA and CHPS performance, especially if more components are to be included in the HBC 
strategy. A well-functioning integration of services might help to improve provision of drugs and 
supervision. Sustainability of HBC needs to be addressed.  
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Chapter 5. Assessment of the HBC and CHPS preventive component  
 
 
5.1. Introduction 
 
In 1978, the Alma- Ata declaration called for urgent action from governments to improve health and 
reduce inequities by promoting primary health care and providing promotive and preventive 
services in addition to curative and rehabilitative services (178). In 2008 the director general of the 
World Health Organization (WHO) advocated for a return to the Alma- Ata values, principles and 
approaches for addressing priority health needs and the fundamental determinants of health (179). 
In 1990s, the IMCI strategy was introduced with the aim of reducing the number of deaths among 
children under- five years of age (39). This strategy includes a preventive component with the aim 
of improving family and community health practices recognising that success in reducing childhood 
mortality requires more than the availability of adequate health services (40) (Section 1.3). IMCI 
emphasises inter-personal communication to improve family and community practices.   
Both HBC and CHPS have an important preventive component, which is often not monitored or 
evaluated. However, the HBC guidelines stated that operational research regarding the effect of 
HBC on community health practices was needed (65). 
CBAs of the HBC strategy in Ghana contribute to disease prevention by conducting IEC activities 
including the promotion of insecticide treated nets (ITN), malaria intermittent preventive treatment 
for pregnant women (IPTp), indoor residual spraying (IRS) and hygiene measures. When the HBC 
strategy was introduced in 2007 in the Northern Region with the support of UNICEF, it was called 
community- IMCI. CBAs delivered health messages to contribute to the IMCI aim of improving 
family and community health practices. In 2010 the name of the strategy changed to iCCM. 
According to policy, CBAs have a stock of IEC materials and conduct health education activities in 
the community on a monthly basis. Health education activities are supervised by health facility staff 
and CBAs include these activities in their monthly reports to health facilities. Health education 
sessions may include groups such as in churches, mosques or prayer camps or may target 
individuals. It was reported that 163,468 children under-five were checked for illness and 503,550 
IEC activities were conducted in 2014 through the HBC strategy nationally (source: DHIMS2-
District Health Information Management System 2. Chapter 1, Section 6, Figure 1). 
CHPS implement the IMCI strategy (now called IMNCI which is Integrated Management of 
Neonatal and Childhood Illnesses (180)). Health promotion and disease prevention messages are 
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delivered by nurses to carers in the waiting area of health facilities (group education sessions), 
during consultation (individual sessions) and during outreach visits (individual or group sessions). 
Nurses from CHPS also include IEC activities in their monthly reports to the district.  
Table 13 summarises the preventive component of HBC and IMCI strategies. The type of messages 
delivered by these two strategies are very similar, with the IMCI messages being more 
comprehensive, including child growth, vaccine promotion, appropriate care for children living with 
HIV and full antenatal care promotion.   
After several years of national implementation, government and donors wish to assess the 
implementation of HBC and CHPS. In this chapter I assessed the preventive component of the HBC 
and CHPS strategies in terms of carers’ disease knowledge and health behaviour (objective 2 of the 
thesis). As HBC can contribute to IMCI with respect to the family and community practices (as 
above), it is important to note that I am comparing the preventive component implemented through 
HBC and CHPS, and not HBC and IMCI per se. The utilization, appropriate treatment, and the 
users’ satisfaction with the curative component (objective 1) and the cost analysis (objective 3) are 
reported in chapters 4 and 6, respectively. 
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Table 13. Preventive component of HBC and IMCI 
HBC family and 
community objectives 
(65) 
HBC family and community activities IMCI family and community 
objectives (76, 181) 
IMCI family and community component activities 
  Promotion of growth and 
development 
Promotion of best practices such as exclusive breastfeeding 
during first 6 months, adequate complementary feeding and 
providing a stimulating environment for the mental and 
social development. 
 
Disease prevention Promotion of hygiene measures including 
washing hands; 
Promotion of ITNs and retreatment of nets; 
Promotion of IPT for pregnant women;  
Promotion of IRS. 
Disease prevention  The same as HBC. Less emphasis on promotion of IRS 
Appropriate care at 
home 
Continue to feed and increase fluids, 
including breast milk to children when they 
are sick;  
Counselling on how to take CBA drugs; 
Tepid sponging to reduce temperature; 
Promotion of appropriate clothing when the 
weather changes. 
 
Appropriate care at home The same as HBC. Less emphasis in promotion of 
appropriate clothing when the weather changes. Counselling 
on how to take health facility drugs;  
Protect children from injury and accident and provide 
treatment when necessary. 
 
Care-seeking outside 
the home 
Correct recognition of signs of malaria, 
diarrhoea and pneumonia; 
Recognition of sings of severe disease;  
Early care seeking; 
Full compliance with treatment, follow up 
and referral; 
Identification and referral of pregnant 
women for IPT 
Take children to complete a full course of 
immunization before their first birthday. 
Care-seeking outside the home The same as HBC.  
In addition, adequate care for pregnant women and 
promotion of spacing; 
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5.2. HBC, CHPS and Health Communication   
 
Health Communication is defined by WHO as a key strategy to inform the public about health 
concerns and to maintain important health issues on the public agenda (182). The Community 
Guide (a website that houses the US official collection of all Community Preventive Services Task 
Force findings) defines Health Communication as the study and use of communication strategies to 
inform and influence individual and community decisions that enhance health. The scope of health 
communication includes disease prevention, health promotion, health care policy, and the business 
of health care as well as enhancement of the quality of life and health of individuals within the 
community (183). 
 
Disease prevention refers to the prevention of the occurrence of disease, such as risk factor 
reduction, but also aims to stop its progress and reduce its consequences once established (182).  
Health promotion is the process of enabling people to increase control over the determinants of 
health (which are the range of personal, social, economic and environmental factors which 
determine the health status of individuals or populations) and thereby improve their health (182).  
 
Health communication strategies have evolved and improved since 1960 in recognising that 
transmitting information and improving knowledge (although an intermediary outcome) is not 
necessarily enough to change behaviour. Social and economic factors of a specific behaviour should 
also be considered in behaviour change (184-186). Therefore, health communication strategies have 
evolved to increase effectiveness and use a systematic process, are based on behavioural theories 
and use social marketing techniques to develop and carry out communication activities that promote 
and sustain healthy behaviour (187, 188). This strategic use of communication to promote positive 
health outcomes which are based on proven theories and models of behaviour change is also called 
Behaviour Change Communications (BCC). Health communication considers a variety of channels 
to deliver its targeted or tailored messages to the audience (189, 190). Those channels are: (i) Mass 
media (radio, tv, etc); (ii) Small media (brochures, posters, etc.); (iii) Social media (twitter, web 
logs, etc.); (iv) Interpersonal communication (one on one or group education) and (v) Events. The 
different activities conducted to implement the communication plan are called Information, 
Education and Communication (IEC) activities. The material developed (posters, flyers, leaflets, 
brochures, booklets, etc.) is referred as IEC materials (65, 76). 
 
To address the family and community objectives described in Table 13, the HBC guidelines and the 
Community- IMCI guidelines (which are implemented by CHPS among other facilities) state that a 
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comprehensive health communication strategy is required for behaviour change (76), in coherence 
with what I just described above. These strategies consider the existing health practices and look for 
innovative approaches for behaviour change. They both include the development of IEC materials, 
training on communication strategies, partnerships with different channels to deliver messages and 
consider grouping and individual education sessions. When evaluating the effect of the IEC 
activities conducted by CBA and CHPS nurses, and understanding that transmitting information 
does not mean improving behaviour as already mentioned, efforts must be done exploring disease 
knowledge AND health behaviour. As defined in section 3.5, disease knowledge and health 
behaviour will be used as proxy indicators of the effectiveness of the preventive component.  
 
5.3. Household survey 
 
Data from the household survey as described in Chapter 3 was used to assess the effectiveness of 
HBC and CHPS preventive component. In brief, a stratified three stage cluster survey was 
conducted in the Volta and Northern Regions. In the Volta Region, only communities implementing 
HBC were included in the sampling. From the 24 districts in the Volta Region, only 8 were targeted 
for the implementation of HBC. From them, 6 districts with its communities were included in the 
sampling (Annex 1). In the Northern Region all districts and communities were included in the 
sampling, as HBC was implemented everywhere.  
Carers of children under-five years of age presenting with fever, diarrhoea or cough in the previous 
two weeks were asked about their exposure to disease prevention and health promotion messages, 
the source of the messages, their knowledge about the causes of malaria, diarrhoea and acute 
respiratory infections, the identification of signs of severe disease, treatment seeking behaviour 
when the child was sick and adherence to the treatment prescribed. Those were considered to be 
standard questions and valid for both strategies.   
Several closed-ended questions exploring carer’s disease knowledge and health behaviour allowed 
multiple answers. Compared with open-ended questions, closed-ended questions are precise, allow 
uniformity in responses, are easy to recall and are easily quantifiable. However, they require 
researchers with good knowledge of the area/topic to ensure that the appropriate answers are 
included as responses. The option “other” in a closed-ended question however allows respondents 
to give their personal answer in case the different options offered were not adequate or did not 
translate respondent believes. On the contrary, open- ended questions are useful in qualitative 
studies particularly when the researcher wants to explore a new topic which he/she is not familiar 
with. Because the richness of the information, efforts involved in analysing this type of information 
are substantial, and therefore, they are used to study small groups or populations (191).   
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Similarly with my analysis of the appropriate treatment given (Chapter 3), in this chapter I 
compared knowledge and practices against national guidelines and standard definitions and not 
against control groups.  
 
5.4. Study definitions 
 
Table 2 describes the definitions used for the analysis. As described above, carers were asked about 
different knowledge and health practices, and multiple responses were allowed. If for example two 
responses were given by one carer, where one answer was correct and the other incorrect, the carer 
was included in the group of correct knowledge.  
 
5.5. Data analysis 
 
Assessing which factors or predictors were associated with disease knowledge and health behaviour 
may help to explore if IEC activities conducted by CBAs and CHPS nurses were associated with 
disease knowledge and health behaviour, and to identify enablers and barriers of disease knowledge 
and behaviour that can be useful for future planning of health communication strategies. 
To explore the association between disease knowledge and health behaviour, and potential 
predictors, the crude OR was obtained using univariate logistic regression, and the adjusted OR 
using multivariate analysis. To do that, initial data examination and prevalence estimates were 
obtained using tabulations adjusted for survey design. 
Potential predictors of disease knowledge were explored. Disease knowledge outcomes included 
were identification by carers of (i) mosquitos as vectors of malaria transmission, (ii) at least 2 signs 
of severe malaria, (iii) at least 2 practices that can cause diarrhoea, (iv) at least 2 signs of severe 
diarrhoea, (v) microorganisms as the cause of suspected pneumonia, (vi) not vaccinating children as 
a practice that can cause pneumonia and (vii) 2 signs of severe pneumonia. Potential predictors 
explored are described in Table 3. Pearson’s design based chi-square was used to test for 
associations. Survey logistic regression was used to obtain adjusted estimates. To explore the 
potential association between disease knowledge and the factors described above, firstly, the 
association of each potential predictor (adjusted only for district) with the outcome was estimated. 
All factors whose association reached significance at p<0.1 were included in a multivariate analysis. 
All factors that remained significantly associated with the outcome (p<0. 05) in this model were 
retained in the final model. 
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The same methodology was used to explore potential predictors of children sleeping under 
mosquito nets. Potential predictors (Table 14) were explored in the univariate analysis (adjusted 
only for districts). All factors whose association reached significance at p<0.1 were included in a 
multivariate analysis. All factors that remained significantly associated with the outcome (p<0. 05) 
in this model were retained in the final model. 
To analyse potential predictors of having an improved sanitation facility, potential predictors (Table 
14) were explored in the univariate and multivariate analysis using the same methodology. 
 
Table 14. Potential predictors explored by outcome 
Potential predictors of disease knowledge 
 (i) Age of carers,  
(ii) education of carers,  
(iii) SES,  
(iv) receiving information and education messages (on malaria if questions were related malaria knowledge; on 
diarrhoea if questions related to diarrhoea disease knowledge; on respiratory infections if questions related to 
respiratory infection knowledge), and  
(v) source of the information and education messages. 
 
Potential predictors of children sleeping under mosquito nets 
(i) Age of child, 
(ii) age of respondent,  
(iii) sex of child,  
(iv) education of respondent,  
(v) SES,  
(vi) HBC and CHPS utilization,  
(vii) identifying mosquitos as malaria vectors, and  
(viii) receiving malaria education messages from different sources. 
 
Potential predictors of improved sanitation facility 
(i) Age of respondent,  
(ii) education of respondent,  
(iii) SES,  
(iv) identification of causes of diarrhoea and  
(v) receiving diarrhoea preventive messages from any source. 
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5.6. Results 
 
The number of interviews conducted in the Volta and Northern Regions, the prevalence of fever, 
diarrhoea and cough among the children that were sick two weeks prior to the survey and the 
carers’ health seeking behaviour can be found in Chapter 4, Tables 5 and 6. 
When asked about the year preceding the survey, a higher proportion of carers in the Northern 
Region reported receiving health messages than those from the Volta Region (Table 15). A greater 
proportion of carers reported receiving messages relating to malaria than those relating to diarrhoea 
or respiratory infections across the two regions. The proportion of carers who reported receiving 
malaria education messages (including information on any of: how it is transmitted, how to avoid it, 
what are the symptoms and what to do when sick) was 83.8% (95%CI 57.3, 95.2) and 89.0% 
(95%CI 80.9, 93.6) in the Volta and Northern Region respectively. In the case of diarrhoea, 73.6% 
(95%CI 43.9, 90.8) and 79.7% (95%CI 69.3, 87.2) of carers in the Volta and Northern Region 
received health education and health promotion messages respectively and 57.1% (95%CI 32.8, 
78.4) and 66.1% (95%CI 56.2,74.8) of carers in the Volta and the Northern Region received 
messages regarding respiratory infections. 
The proportion of carers in the Volta Region receiving malaria information messages from CBAs 
and CHPS were 18.5% (95%CI 4.9, 50.0) and 31.2% (95%CI 11.5, 61.3) respectively, while in the 
Northern Region was 8.5% (95%CI 3.2, 20.4) and 26.8% (95%CI 14.9, 43.3) respectively (Table 
14). Radio was a frequent source of information for malaria in both regions. Neighbours, family 
members and friends were much more important as a source of malaria information in the Northern 
Region while messages from health facilities were proportionately similar to or slightly less 
frequently a source of messages than in the Volta Region. 
The main sources of malaria information in the Volta Region were (i) radio (201/576, 34.3%), (ii) 
CHPS (118/576, 31.2%) and (iii) hospital (142/576, 25.5%). In the Northern Region, the main 
sources of malaria information were (i) neighbours (242/575, 45.8%), (ii) radio (254/575, 44.5%) 
and (iii) family members (160/575, 33.2%). In the case of diarrhoea and respiratory infections 
messages, the sources of information followed the same ranking as for malaria with the exception of 
diarrhoea in the Volta Region were CHPS were the first rather than the second source of messages 
(Table 15). 
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Table 15. Sources of malaria, diarrhoea and respiratory information and education messages in the Volta and 
Northern Regions 
Health education  Volta Region  Northern Region  
 N % (95% CI)* N % (95% CI)* 
Receiving messages on malaria 576/671  83.8 575/685  88.8 
Sources of malaria messages     
- From CBAs 74  18.5 (4.9, 50.0) 43 8.5 (3.2, 20.4) 
- From CHPs nurses 118 31.2 (11.5, 61.3) 182 26.8 (14.9, 43.3) 
- From HC nurses 195 21.7 (15.7, 29.0) 131 22.3 (11.5, 38.7) 
- From hospital nurses 142 25.5 (10.2, 50.7) 75 13.7 (7.2, 24.7) 
- Outreach clinic 23 4.0 (0.6, 22.1) 0 0 
- From radio 201 34.3 (23.6, 46.9) 254 44.5 (21.1, 70.6) 
- From neighbours 47 12.8 (6.4, 23.8) 242 45.8 (40.5, 51.2) 
- Family member 41 4.2 (1.3, 12.9) 160 33.2 (22.6, 45.9) 
- Friends 23 3.8 (2.0, 7.1) 109 18.5 (13.0, 25.7) 
- From TV 66 8.6 (2.0, 29.7) 24 2.0 (0.7, 5.4) 
- From posters 11 1.0 (0.1, 8.7) 2 0.1 (0.007, 1.7) 
Receiving messages on diarrhoea 496/671 73.65 491/685 79.6 
Sources of diarrhoea messages     
- From CBAs 55 15.0 (4.7, 38.9) 33 7.4 (2.7, 18.8) 
- From CHPs nurses 107 33.3 (12.5, 63.6) 153 28.8 (16.3, 45.6) 
- From HC nurses 161 18.1 (9.1, 32.9) 105 20.7 (10.2, 37.3) 
- From hospital nurses 106 19.0 (5.1, 50.6) 62 11.5 (5.4, 22.7) 
- Outreach clinic 23 5.1 (0.7, 27.7) 0 0 
- From neighbours 39 8.2 (2.3, 25.2) 208 46.4 (38.6, 54.3) 
- Family member 39 4.4 (1.4, 13.2) 150 31.5 (20.8, 44.6) 
- Friends 27 9.2 (3.0, 24.7) 116 20.8 (15.7, 27.0) 
- From radio 180 32.3 (23.3, 42.7) 191 37.9 (18.0, 63.0) 
- From TV 61 9.0 (1.7, 35.0) 19 4.1 (1.1, 13.3) 
- From posters 9 0.9 (0.1, 7.7) 9 0.8 (0.05, 11.9) 
Receiving messages on respiratory infections 345/669 57.1 400/683 66.1 
Sources of respiratory infections messages     
- From CBAs 34 18.2 (3.3, 59.2) 21 4.6 (1.9, 10.5) 
- From CHPs nurses 73 31.2 (12.3, 59.6) 99 21.7 (13.8. 32.5) 
- From HC nurses 99 19.0 (12.6, 27.8) 91 21.4 (9.1, 42.3) 
- From hospital nurses 78 19.6 (5.0, 53.1) 49 12.1 (3.7, 33.2) 
- Outreach clinic 13 6.0 (0.7, 34.6) 0 0 
- From neighbours 34 8.4 (2.0, 29.2) 162 41.1 (33.9, 49.2) 
- Family member 40 8.0 (1.7, 30.1) 119 28.6 (20.7, 38..1) 
- Friends 16 6.8 (2.6, 16.5) 98 21.8 (13.4, 33.4) 
- From radio 127 30.5 (20.1, 43.4) 138 34.1 (19.8, 52.0) 
- From TV 35 5.3 (1.2, 20.3) 10 0.8 (0.2, 3.5) 
- From posters 2 0.0 (0.004, 0.4) 8 1.1 (0.0, 17.4) 
*Weighted estimates 
 
5.6.1. Carers’ knowledge of malaria, diarrhoea and respiratory infections 
Most of the carers identified mosquitoes as malaria vectors (more than 90% in both regions). 
However, those that identified severe signs of malaria were much fewer (approximately 22% and 
29% in the Volta and Northern Region respectively) and with greater variation among clusters in 
the Northern Region (Table 16).  
Only 35.8% and 52.6% of carers in the Volta and the Northern Regions identified at least 2 
practices that can cause diarrhoea. Causes and practices that can cause respiratory infections were 
less known to carers than those of malaria and diarrhoea. Although the DHS 2014 reports that about 
79% and 69% of children in the Volta and Northern Regions received all basic vaccinations (57), 
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only 0.2% and 12.0% of carers in the Volta and Northern Regions knew that vaccination prevents 
their children from having respiratory infections (and from other diseases).  
 
Table 16. Carer’s disease knowledge in the Volta and Northern Regions 
 Volta Region Northern Region 
Indicator N % (95%CI)* N % (95% CI)* 
Identifying mosquito as malaria vector 645 96.8 (90.4, 98.9) 626 91.0 (84.5, 94.9) 
Identifying at least 2 signs of severe malaria 135 21.9 (13.0, 34.3) 217 28.5 (13.6, 50.2) 
Identifying at least 2 practices that can cause diarrhoea 229 35.8 (29.6, 42.5) 394 52.6 (41.2, 63.8) 
Identifying at least 2 signs of severe diarrhoea 185 30.3 (21.4, 41.0) 336 47.4 (38.6, 56.3) 
Identifying microorganism as cause of respiratory infection 92 21.1 (12.4, 33.6) 246 36.8 (23.4, 52.5) 
Identifying vaccination as practice to prevent respiratory infections 5 0.2 (0.01, 3.8) 73 12.0 (9.1, 15.5) 
Identifying 2 signs of severe pneumonia 52 8.7 (4.4, 16.5) 184 25.5 (19.7, 32.4) 
*Weighted estimates 
 
5.6.2. Predictors of carer’s knowledge of malaria, diarrhoea and respiratory infections 
In the univariate analysis, age, education and SES of carers were not found to be predictors of 
disease knowledge across the indicators assessed in any of the two regions. However, the univariate 
and multivariate analyses showed that receiving information and education messages and the source 
of information influenced the disease knowledge in both regions, and not always in a positive way 
as further described below for each of the regions separately.  
Volta Region 
The univariate analysis showed several associations between health messages and disease 
knowledge. Receiving malaria messages from any source was associated with the identification of 
mosquitoes as malaria vectors. Receiving respiratory illness and diarrhoea messages from hospitals 
and from leaflets were found to be associated with the identifications of microorganisms as cause of 
respiratory infections and at least two practices that cause diarrhoea. Receiving diarrhoea messages 
from neighbours, CHPS and posters were found to be associated with the identification of severe 
signs of diarrhoea. Receiving respiratory illness messages from TV was found to be associated with 
the identification of severe signs of pneumonia and malaria messages from friends and from health 
centres were found to be associated with the identification of severe signs of malaria. 
The multivariate analysis showed that receiving malaria education messages (from any source) 
remained associated with the identification of mosquitos as malaria vectors. Compared with those 
that did not receive messages about malaria, those that did were more likely to identify mosquitos: 
adjusted OR 15.6 (3.2, 75.9), p=0.01 (Table 17). Receiving health education and health promotion 
messages from CBAs was not a predictor of disease knowledge across any of the indicators 
explored. However, carers receiving diarrhoea messages from CHPS compared with those that did 
not were more likely to identify at least two signs of severe diarrhoea: adjusted OR 3.6 (95% CI 1.4, 
9.0); p=0.02. Diarrhoea messages from neighbours and from posters did not remain significantly 
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associated with severe signs of diarrhoea. Receiving health education messages from hospitals 
showed conflicting results. Compared with those that did not receive messages on respiratory illness 
from a hospital, those that received them were less likely to identify microorganism as cause of 
ARI: adjusted OR 0.2 (95% CI 0.1, 0.6), p=0.01. A possible explanation for these conflicting results 
could be that staff in hospitals do not focus their health messages on prevention but on how to take 
care of the child when sick. Malaria messages from friends also had negative association with 
disease knowledge. Compared with those that did not receive messages from friends, those that 
received them were less likely to correctly identify at least two signs of severe malaria: adjusted OR 
0.01 (95%CI 0.001, 0.1); p=0.01. Malaria messages from health centres did not remain significantly 
associated with the identification of malaria severe signs. 
Radio was one of the most prevalent sources of health information and promotion messages, but 
radio messages were not associated with a better disease knowledge in the Volta Region. On the 
contrary, TV and leaflets were a less common source of information but they were found to be a 
predictor of the identification of severe pneumonia signs: adjusted OR TV 9.4 (95%CI 1.9, 45.6), 
p=0.02; adjusted OR leaflets 19.4 (7.4, 50.7), p=0.002. 
Northern Region 
The univariate analysis showed that receiving diarrhoea messages (from any source) was associated 
with the identification of signs of severe diarrhoea while respiratory illness messages (from any 
source) was associated with the identification of signs of severe pneumonia. Messages from CBAs 
were found to be associated with the identification of practices that can cause diarrhoea and with the 
identification of signs of severe malaria and severe pneumonia. Receiving messages from CHPS 
was associated with the identification of mosquitos as malaria vectors and microorganisms as the 
cause of respiratory infections. Receiving messages from neighbours was found to be associated 
with the identification of mosquitoes as malaria vector, the identification of microorganisms as 
cause of respiratory infections, and the identification of signs of severe diarrhoea and severe 
pneumonia. Receiving messages from friends were associated with the identification of 
microorganisms as cause of respiratory infections, the identification of practices that cause 
diarrhoea, and the identification of signs of severe diarrhoea, severe pneumonia and severe malaria. 
Messages from family were associated with the identification of mosquitos as malaria vectors, 
microorganisms as cause of respiratory infections, practices that can cause diarrhoea and the 
identification of signs of severe diarrhoea and severe malaria. Receiving messages from posters was 
found to be associated with the identification of signs of severe malaria and with the identification 
of microorganisms as cause of respiratory infections. Finally, receiving messages from the radio 
was found to be associated with the identification of signs of severe malaria and with the 
identification of practices that can cause diarrhoea.  
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The multivariate analysis showed that carers receiving health messages from CBAs remained 
significantly associated with three indicators: compared with those that did not receive messages on 
malaria, diarrhoea and respiratory illness from CBAs, those that did were more likely (i) to identify 
at least two signs of severe malaria [adjusted OR 1.8 (95%CI 1.0, 3.3); p=0.04], (ii) to identify 
practices that can cause diarrhoea [adjusted OR 4.7 (1.4, 15.5); p=0.02] and (iii) to identify at least 
2 signs of severe pneumonia [adjusted OR 7.7 (95%CI 2.2, 26.5); p=0.01] (Table 17). Receiving 
messages from CHPS, health centres or hospitals did not remain associated with disease knowledge 
in the multivariate analysis. Malaria and diarrhoea messages from neighbours remained associated 
with the identification of mosquitos as malaria vectors and with the identification of signs of severe 
diarrhoea: adjusted OR for identifying mosquitos as malaria vector 16.2 (95%CI 0.9, 268); p=0.05; 
adjusted OR for identifying at least two signs of severe diarrhoea 3.3 (0.9, 11.4); p=0.05. Malaria 
messages received from family members were negatively associated with the identification of signs 
of severe malaria: adjusted OR 0.4 (95%CI 0.2, 0.9); p=0.04 while diarrhoea and respiratory illness 
messages from friends were associated with (i) the identification of at least two practices that cause 
diarrhoea: adjusted OR 6.9 (95%CI 2.6, 18.3); p=0.008; (ii) the identification of microorganism as 
cause of ARI: adjusted OR 9.1 (95%CI 4.4, 18.6); p=0.05 and (iii) the identification of two signs of 
severe pneumonia: adjusted OR 5.3 (95%CI 2.4, 11.6); p=0.006. Finally, exposure to malaria and 
diarrhoea radio messages remained significantly associated with the identification of signs of severe 
malaria [adjusted OR 4.3 (05%CI 1.0, 17.6); p=0.04] and with the identification of practices that 
can cause diarrhoea [adjusted OR 4.5 (95%CI 2.0, 10.2); p=0.009]. In the case of identifying the 
vaccination of children as a practice to prevent acute respiratory infections, because of the low 
numbers (only 5 carers believed that not vaccinating their children can cause respiratory infections), 
the analysis was not conducted in the Volta Region. In the Northern Region no predictors were 
found.  
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Table 17. Predictors for disease knowledge in the Volta and Northern Regions 
 VOLTA REGION  NORTHERN REGION 
Predictors n/N (%) Adjusted OR 
(95%  CI) 
P 
value 
Predictors n/N (%) Adjusted OR 
(95%  CI) 
P 
value 
IDENTIFYING MOSQUITOS AS MALARIA VECTORS IDENTIFYING MOSQUITOS AS MALARIA VECTORS 
Receiving malaria messages (any source)    Receiving malaria messages from 
neighbours 
   
No 79/95 (86.3) 1 0.01 No  292/333 (85.5) 1 0.05 
Yes  566/576(98.8) 15.6 (3.2, 75.9)  Yes 238/242 (99.0) 16.2 (0.9, 268)  
IDENTIFYING AT LEAST 2 SIGNS OF SEVERE MALARIA IDENTIFYING AT LEAST 2 SIGNS OF SEVERE MALARIA 
Receiving malaria messages from friends    Receiving malaria messages from CBA     
No 121/553 
(21.2) 
1 0.01 No 154/532 (25.5) 1.0 0.04 
Yes 2/23 (0.5) 0.01 (0.001, 0.1)  Yes 22/43 (50.6) 1.8 (1.0, 3.3)  
    Receiving malaria messages from 
family 
   
    No 140/415 (32.9) 1.0 0.04 
    Yes 36/160 (17.3) 0.4 (0.2, 0.9)  
    Receiving malaria messages from radio    
    No 52/321 (13.4) 1.0 0.04 
    Yes 124/254 (45.5) 4.3 (1.0, 17.6)  
IDENTIFYING AT LEAST 2 CAUSES OF DIARRHOEA TRANSMISSION IDENTIFYING AT LEAST 2 CAUSES OF DIARRHOEA TRANSMISSION 
    Receiving diarrhoea messages from 
CBA  
   
    No 262/458 (52.6) 1.0 0.02 
    Yes 26/33 (76.5) 4.7 (1.4, 15.5)  
    Receiving diarrhoea messages from 
friends 
   
    No 189/375 (47.3) 1.0 0.008 
    Yes 99/116 (81.6) 6.9 (2.6, 18.3)  
    Receiving diarrhoea messages from 
radio 
   
    No 145/300 (43.1) 1.0 0.009 
    Yes 143/191 (72.9) 4.5 (2.0, 10.2)  
IDENTIFYING AT LEAST 2 SIGNS OF SEVERE DIARRHOEA IDENTIFYING AT LEAST 2 SIGNS OF SEVERE DIARRHOEA 
Receiving diarhoea messages from CHPS    Receiving diarrhoea messages from 
neighbours 
  0.05 
No 97/389 (25.7) 1 0.02 No 120/283 (35.5) 1.0  
Yes 56/107 (44.7) 3.6 (1.4, 9.0)  Yes 144/208 (69.8) 3.3 (0.9, 11.4)  
IDENTIFYING MICROORGANISM (INFECTIONS) AS ARI CAUSE IDENTIFYING MICROORGANISM (INFECTIONS) AS ARI CAUSE 
Receiving ARI messages from hospital     Receiving ARI messages from friends    
No 64/269 (30.1) 1 0.01 No 75/303 (29.1) 1 0.05 
Yes 12/78 (14.8) 0.2 (0.1, 0.6)  Yes 77/116 (58.5) 9.1 (4.4, 18.6)  
Receiving ARI messages from leaflets    Receiving ARI messages from posters    
No  74/344 (27.1) 1 0.002 No 147/393 (38.6) 1 0.05 
Yes 2/3 (75.0) 19.4 (7.4, 50.7)  Yes 5/8 (70.8) 8.5 (0.9, 76.9)  
IDENTIFYING AT LEAST 2 SIGNS OF SEVERE PNEUMONIA IDENTIFYING AT LEAST 2 SIGNS OF SEVERE PNEUMONIA 
Receiving ARI messages from TV    Receiving ARI messages from CBA     
No 35/312 (6.8) 1 0.02 No 127/380 (32.9) 1.0 0.01 
Yes 5/35 (48.1) 9.4 (1.9, 45.6)  Yes 15/21 (69.3) 7.7 (2.2, 26.5)  
    Receiving ARI messages from friends    
    No 81/303 (26.8) 1.0 0.006 
    Yes 61/98 (62.3) 5.3 (2.4, 11.6)  
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5.6.3. Carers’ health behaviour  
The proportion of carers that reported to have a mosquito net hanging was 43.0%, (95%CI 35.0, 
51.3) in the Volta Region and 70.1% (95%CI 45.2, 87) in the Northern Region. However, 80% of 
carers of both regions reported that their children under- five slept under mosquito net the night 
before the survey (80.4%, 95%CI 69.4, 88.1 and 79.2%, 95%CI 57.5, 91.5 in the Volta and 
Northern Region, respectively). Almost all carers interviewed in both regions reported that they 
would accept spraying the house if offered (Table 18).  
 
Table 18. Carer’s health behaviour in the Volta and Northern Regions 
 Volta Region Northern Region 
Indicator N %* N % 
At least 1 mosquito net hung 297/664 43.0 422/685 70.1 
Children sleeping under mosquito net last night 535/670 80.4 482/684 79.2 
Adult sleeping under mosquito net last night 516/665 77.7 469/683 77.8 
Carers want to spray the house 642/666 98.0 675/683 98.3 
Improved sanitation facilities 460/670 64.8 37/685 3.6 
Promptness in seeking care if visiting a CBA 58/90 56.0** 6/8 79.9 
Promptness in seeking care if visiting CHPS 22/61 36.3 163/228 76.9** 
Promptness in seeking care if severe malaria signs are identified 55/132 38.2 110/190 64.0 
Promptness in seeking care if severe diarrhoea signs are identified 83/179 42.2 212/315 67.4 
Promptness in seeking care if severe pneumonia signs are identified 23/52 43.2 116/161 85.4** 
Adherence to 3 days ACT treatment when visited CBA 16/18 93.2 0/0 0.0 
Adherence to CBA ACT prescription 86/90 96.31 8/8 100 
CHPS’ staff did not inform about No of days to take ACT 53/61 90.1 201/228 93.5 
Adherence to 3 days ACT treatment when visited CHPS 6/6 100 5/7 90.4 
Adherence to CHPS ACT prescription 60/61 98.4 220/227 99.28 
*Weighted estimates; **p<0.05 
5.6.4. Predictors of carers’ health behaviour  
Predictors of children sleeping under mosquito nets were explored in the univariate and multivariate 
analysis. Age of child, age of respondent, sex of child, education of respondent, SES, HBC and 
CHPS utilization, identifying mosquitos as malaria vectors, and receiving malaria education 
messages from all different sources was not found to be associated with children under-five 
sleeping under mosquito nets in the Volta Region. 
In the Northern Region, the multivariate analysis showed a borderline association between 
receiving malaria preventive messages from CBAs [adjusted OR= 4.4 (95%CI 0.6, 26), p=0.09] and 
from friends [adjusted OR= 0.4 (95%CI 0.1, 1.2), p=0.09] and sleeping under mosquito nets. No 
other predictors were found (Table 19). 
Table 19. Predictors of children under- five sleeping under mosquito nets in the Northern Region 
Predictors n/N %* Adjusted OR (95%CI) P 
Receiving malaria messages from CBAs     
No  375/529 79.5 1 0.08 
Yes 38/43 93.8 4.3 (0.7, 27.0)  
Receiving malaria messages from friends     
No  342/463 82.8 1  
Yes 71/109 71.6 0.4 (0.1, 1.2) 0.09 
*Weighted estimates 
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Only 64.8% and 3.6% of carers in the Volta and the Northern Region reported to have an improved 
sanitation facility. The association between having an improved sanitation facility and age of 
respondent, education of respondent, SES, identification of causes of diarrhoea and receiving 
diarrhoea messages from any source was explored in the Volta Region (there were insufficient 
numbers to do the analysis on the Northern Region data). Socioeconomic status was found to be 
associated with having an improved sanitation facility [adjusted OR lower middle SES 5.0 (95%CI 
2.0, 12.0), p=0.01; adjusted OR middle SES 3.1 (95%CI 1.0, 9.7), p=0.04; adjusted OR upper 
middle 7.9 (95%CI 1.8, 34.1), p=0.02; adjusted OR upper 23.8(95%CI 5.0, 112), p=0.007]. 
Receiving malaria preventive messages from CBAs and from friends each had a borderline 
association with having an improved sanitation facility [adjusted OR messages from CBAs 1.9 
(95%CI 0.8, 4.5), p=0.07, adjusted OR messages from family 0.4 (95%CI 0.2, 1.1), p=0.07] (Table 
20). 
 
Table 20. Predictors of having an improved sanitation facility in the Volta Region 
Predictors n/N % Adjusted OR (95%CI) P 
Socioeconomic status     
Lower 27/133 30.2 5.0 (2.0, 12.0) 0.01 
Lower middle  93/132 68.6 3.1 (1.0, 9.7) 0.04 
Middle 95/132 64.2 7.9 (1.8, 34.1) 0.02 
Upper Middle 114/132 79.0 23.8(5.0, 112) 0.007 
Upper 124/132 92.9   
Receiving diarrhoea messages from CBAs   1 0.07 
No 304/441 66.0 1.9 (0.8, 4.5)  
yes 45/55 69.0   
Receiving diarrhoea messages from family   1 0.07 
No 322/457 65.3 0.4 (0.2, 1.1)  
yes 27/39 91.7   
 
Promptness in seeking care is vital to reduce child mortality and morbidity. In the Volta Region, 
iCCM had a positive association with care seeking in the first 24 hours of onset of symptoms: 
56.0% of carers visiting a CBA did so on the same day or the day after of the onset of symptoms 
while only 36.3% of carers that visited a CHPS did this. When comparing iCCM versus all other 
appropriate providers, this difference was significant (56.0%, 95% CI 48.7, 63.08 versus 39.4%, 
95% CI 29.2, 50.5, p=0.03). When comparing promptness in seeking care when visiting a CHPS 
versus other appropriate providers together, the differences were not significant (36.3%, 95%CI 
17.1, 61.3 versus 43.5%, 95%CI 36.8, 50.5, p=0.4). In the Northern Region, 79.9% and 76.9% of 
the carers that visited a CBA and a CHPS did it in the first 24hours of onset of symptoms. In the 
case of visiting a CHPS versus the other appropriate providers, the differences were significant 
(77.0%, 95%CI 70.2, 82.7 versus 63.6%, 95%CI 50.2, 75.2, p=0.02). Due to the low number of 
carers visiting a CBA in the Northern Region, this analysis was not done.  
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Identifying signs of severe pneumonia was associated with promptness in care seeking in the 
Northern Region. Eighty five percent of the carers that identified chest in-drawing and noisy 
breathing as severe signs of pneumonia sought care in the first 24 hours of onset of symptoms 
(p=0.04). No other association was found in the Northern Region or in the Volta Region regarding 
the identification of severe signs and promptness in seeking care.  
Adherence to treatment, following the instructions received from providers, is an important step to 
obtain optimal treatment outcome. A high proportion of carers reported not being told for how 
many days they should take ACT treatment. In Volta Region, 45.4% and 90.1% of carers visiting a 
CBA and a CPHS respectively, and in the Northern Region, 87.1% and 93.5% of carers visiting a 
CBA and a CHPS reported not being told about the duration of the treatment. A possible reason for 
this lack of explanation is because a full treatment is packed in one box or envelope. Then, 
providers often ask users to take the treatment “until it is finished” rather than saying the number of 
days for which the treatment has to be taken. Of the few carers that were told to take the ACT 
treatment for 3 days, more than 90% of carers reported having adhered to these 3 days treatment in 
the Volta and Northern Region when visiting a CBA or a CHPS. Also, when carers were asked if 
they took the treatment as told, more than 90% of carers in both regions reported to have followed 
the instructions received in both regions.  
 
5.7. Discussion 
 
HBC and CHPS service delivery strategies at community level have an important health promotion 
and disease prevention component in terms of programme costs and potential health outcomes. In 
this chapter I assessed the effectiveness of the HBC and CHPS health education messages in terms 
of disease knowledge and healthy behaviour of carers of children under- five years old.  
Few studies assessing the effectiveness or efficacy of HBC considered the preventive component. 
Three studies in Mali (192), Uganda (193) and Ethiopia (194) and one multi-country study 
conducted in Ghana, Burkina Faso, Ethiopia and Malawi (88) assessed, among other outcomes, the 
improvement of care’s disease knowledge. Although not much detail on the communication 
strategy used was given by the authors, it seems that interpersonal communication was the 
communication channel reported as the one to which carers of children under-five were more 
exposed. Interpersonal communication was also the main source of health information found in my 
study (80.5% and 93.0% of carers in the Volta and Northern Region received any malaria message 
from interpersonal communications). Interpersonal communication was considered the source that 
gave the highest success rate in a study conducted in Ghana analysing four health campaigns (Stop 
TB, malaria HBC, integrated child health and life choices-family planning campaigns) although it is 
  
97 
 
not clear how the author evaluated this success (195). Community health workers (CHW) in Mali 
(192) used visual aids for explaining to carers symptoms such as convulsions and difficulty 
breathing which require immediate referral. In the study in Uganda (193), CHWs advised carers of 
children on how to continue treatment at home and on danger signs that will require referral to a 
health facility. In Ethiopia (194), communities were first trained to identify general childhood 
danger signs just before the deployment of CHW and were further educated by the CHW using IEC 
materials. The multi-country study (88) described that CHW in Malawi provided vaccinations and 
growth monitoring for children younger than 5 year-olds, supervision of sanitation, water source 
protection and treatment and nutrition advice among other things. No other details were given on 
how health education was delivered in Malawi or in the other 3 countries.   
The multi-country evaluation of IMCI (49) conducted in  Bangladesh, Brazil, Peru, Tanzania and 
Uganda evaluated the preventive component. These studies also reported that the main channel used 
to deliver health education messages were interpersonal communications, in groups or individually. 
The study in Tanzania did not report on prevention activities because health education messages as 
part of community IMCI had not been implemented at the time of the study (52). In Bangladesh, 
approximately 33% of carers in the IMCI areas received health messages through community 
theatres, about 33% received feeding advice from individual counselling, 12% of men received 
health education messages from the imam in the mosque and only 3% of carers attended health 
community meetings (196). The study in Uganda and Tanzania only reported that carers were 
educated during consultation (197). Interestingly, Peru and Brazil trained CHWs to implement 
community- IMCI (or the promotion of community and family practices) (50, 198).  
My study showed that a high percentage of carer’s received health education messages regarding 
malaria, diarrhoea and respiratory infections. More carers reported to have received messages in the 
Northern Region when compared with the Volta Region and malaria messages were more common 
than messages on diarrhoea and respiratory infections. These results are similar to the 2008 Ghana 
Demographic and Health Survey (DHS): 83.8% of carers in my study received malaria messages 
versus 89.8% in the 2008DHS in the Volta Region and 89% versus 83.3% in the Northern Region 
(145). The source of messages followed a similar pattern as the 2008DHS: radio was a predominant 
source of health information, higher than health workers and community volunteers (145). More 
carers in the Volta Region reported to have received malaria, diarrhoea and respiratory illness 
messages from CBAs and CHPS than the Northern Region. These results are coherent with the 
lower IEC activity reported on the DHIMS2 in 2014 by the HBC programme in the Northern 
Region compared with the Volta Region: less than 1 IEC activity in a population of 1000 children 
under five was conducted in the Northern Region versus 390 IEC activities per 1000 children under 
five in the Volta Region (199).  
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Health messages sent by different sources had an association with different disease knowledge and 
health behaviour outcomes explored. However, carer’s education level or their SES was not 
associated with any of the outcomes explored. Health education messages from CBAs, even though 
they were not the predominant source of health information (between 15% to 18.5% and 4.6% to 
8.5% of carers in the Volta and Northern Region received health education messages on malaria, 
diarrhoea and respiratory infections), were associated with several health knowledge and healthy 
behaviour outcomes, particularly in the Northern Region. A possible explanation for this higher 
effect in the Northern Region when compared with the Volta Region could be that, even though the 
proportion of carers exposed to CBA messages were lower than in the Volta Region, carers might 
have been exposed more times to CBA messages (this evaluation came 2 years and 8 years after the 
implementation in the Volta and Northern Region). Improving knowledge and changing behaviour 
takes time (200-202). 
Health messages from CBAs was the predictor explored that had more positive associations with 
the disease knowledge and health behaviour outcomes explored, particularly in the Northern 
Region: receiving messages from CBAs were found to be associated in the Northern Region with 
the identification of at least 2 signs of severe malaria, 2 practices that can cause diarrhoea, 2 signs 
of severe pneumonia, and a borderline association with children sleeping under mosquito nets. 
Although the association between HBC utilization and prompt care seeking behaviour could not be 
explored due to low numbers (Chapter 3), identifying 2 signs of severe pneumonia was found to be 
associated with prompt care seeking behaviour in the Northern Region. However, these positive 
results found in the Northern Region could decrease in the next few years if the low number of IEC 
activities conducted in 2014 continue to be the same for several years. In the Volta Region, 
receiving diarrhoea messages from CBAs had a borderline association with having an improved 
sanitation facility and HBC utilization was associated with prompt care seeking behaviour.  
The MICS, the DHS and the LQAs surveys reported on the carers’ knowledge of the cause of 
malaria, signs of severe pneumonia, the use of mosquito nets and the prevalence of improved 
sanitation facilities in Ghana (145, 153, 203). However, the association between those outcomes 
and receiving health messages or treatment from CBA or CHPS was not assessed. Studies reporting 
on the efficacy or effectiveness of HBC in Ghana do not report on the preventive component: they 
focus on the therapeutic component of the HBC strategy. The only study found in Ghana that 
reported on IEC activity of the HBC strategy, did not assess the association between the knowledge 
and behaviour and the source of messages received (153). This study, conducted in the three 
northern regions of Ghana, reported on the correct content of the message sent by CBAs and nurses 
from CHPS, particularly on hand washing, breastfeeding practices and caring of a sick child. It 
concluded that CBAs had similar knowledge to nurses from CHPS on washing hand practices but 
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less knowledge on breastfeeding practices and caring of a sick child which I did not assess in this 
current study. With regards to adherence to treatment, my study showed a similar and high 
adherence to ACT treatment when visiting both, a CBA or a CHPS. When compared with other 
appropriate providers, HBC in the Volta Region contributed to prompt treatment seeking behaviour 
as was also found in other studies (84, 127, 170) (Chapter 3). Other HBC studies that reported on 
carers’ disease knowledge in Mali (192), Uganda (193), Ghana (88), Burkina Faso (88), Ethiopia 
(88, 194) and Malawi (88) also found positive results. Carers’ in Mali in the HBC intervention arm 
were significantly more likely to recognise fever lasting more than one day after treatment and 
convulsions as danger signs than carers in the control group. In Uganda, more carers in the 
intervention arm significantly recognised convulsions as a sign to seek care immediately (45 %) 
compared to the non-intervention districts (22 %). Carers in Kumasi (Ghana), Lilongwe (Malawi) 
and Ougadougou (Burkina Faso) improved their knowledge on signs of severe malaria but not those 
in Bolgatanga (Ghana) and Jimma (Ethiopia) (88). Finally, a longer study (9 years) conducted in 
Ethiopia showed an increase in the recognition of fast and difficulty in breathing as signs of 
suspected pneumonia and other childhood danger signs (194). 
My study also suggests that CHPS had some influence on disease knowledge and behaviour but less 
than the HBC strategy: receiving messages from CHPS was associated with the identification of at 
least 2 signs of severe diarrhoea in the Volta Region and with promptness in seeking care in the 
Northern Region. The Multi-Country Evaluation of the IMCI conducted in Tanzania and 
Bangladesh reported on knowledge of severity of signs and care seeking behaviour (52, 204). These 
2 studies (a non-randomised controlled trial in Tanzania and a cluster randomised controlled trial in 
Bangladesh) showed that, when compared with areas without IMCI, carers in the IMCI areas that 
perceived severity of signs (fast or difficulty in breathing, convulsions, extreme sleepiness, 
excessive vomiting or inability to drink/breastfeed) were more likely to seek care for their children 
(p<0.05). Other outcomes reported in studies evaluating the community component of IMCI, were 
advice given on (i) fluids and feeding given when child is sick (50, 52, 196, 197, 205), (ii) 
breastfeeding and complementary feeding (52), (iii) how to take the prescribed medicines (196, 197, 
205), (iv) when to return when child is sick (50, 196, 197, 205) and (v) caring for children with very 
low weigh(196). However, my study did not report on these outcomes: Focusing on the preventive 
messages of the 3 diseases and on seeking prompt treatment when symptomatic better addresses my 
study objectives. 
Globally, the community component of the IMCI strategy (community-IMCI) started later than the 
other 2 IMCI components (the case management and health system) and it has been more neglected 
(204, 206). As presented in Table 14, the objectives of community-IMCI are similar to those of the 
preventive component of HBC. Evaluations of HBC normally do not report on the preventive 
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component but this study suggests that the preventive component is actually being implemented and 
is associated with disease knowledge and behaviour. Evaluations of community –IMCI gave more 
emphasis on family health practices to be implemented when the child is already sick (such as 
increasing fluids if child is sick or when to return for care seeking immediately), with less emphasis 
on disease prevention practices with the exception of the promotion of vaccination. The manuals of 
community-IMCI state that for the implementation of community- IMCI, health facilities need to (i) 
partner with the community, (ii) increase appropriate and accessible health care and information 
from community-based providers, and (iii) integrate promotion of key family practices critical for 
child health and nutrition (181, 206, 207). Based on these points, it seems that HBC could be an 
ideal strategy for implementing community-IMCI as the Ghana case study shows and the studies in 
Peru and Brazil suggested (50, 198). Actually, iCCM in Burkina Faso, Malawi, Niger, and 
Mozambique is also called community-IMCI (208-211) although iCCM adds a curative component 
which community-IMCI does not have. This interchange of names shows integration and 
complementarity within strategies which is beneficial for both, iCCM and IMCI. Under this 
integrated approach, CHPS not only supervise CBAs but also partner with them on the 
implementation of the Community- IMCI. However, policy documents in Ghana unfortunately no 
longer reflect this integration or complementarity between iCCM and IMCI and their coordination 
is placed in different programmes (iCCM in the National Malaria Control Programme and IMCI in 
the Reproductive and Child Health Department of the Ghana Health Service).  
 
Limitations of the study 
This study assessed the effectiveness of the preventive component of the HBC and CHPS strategy 
based on the responses of carers of children who were sick in the two weeks preceding the survey. 
Therefore, the results are not representative of the entire population. In the case of the Volta 
Region, these results represent the population that had sick children in the previous two weeks in 
the areas where HBC and CHPS were implemented (which are rural communities with less access 
to health facilities). 
Effectiveness was measured based on the association found between the source of message and the 
desired outcome. Therefore, I cannot say that HBC was more effective than other strategies. I can 
only say that HBC was a predictor or was associated to better disease knowledge and healthy 
behaviours.  
Carers were asked about health education messages received during the last year on malaria, 
diarrhoea and respiratory infections. One year was considered good timing to allow a 
communication strategy to be implemented and to avoid problems in recall. However, recall bias 
should still be considered, as carers can forget some sources, or remember others that were received 
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more than one year ago. However, it is likely that the carers remember the messages that had a 
higher impact on them. The MICS limit the period of receiving health education to the previous 6 
month before the survey (203). The DHS did not mention the timing where carers needed to recall 
health education messages (145). The other studies reporting on HBC and CHPS preventive 
component did not report on sources of health education messages or on the timing receiving the 
messages to avoid recall bias: they only report on the improvement of disease knowledge or 
practice (50, 52, 88, 192, 193, 197, 198, 204, 205).  
I mentioned in section 5.4 that, when carers were asked about knowledge and practices, multiple 
answers were allowed. If one correct and one incorrect answered was given, the carer was included 
in the group of correct knowledge. Even though I believed this was the best approach, this could 
have resulted in an overestimation in adequate knowledge.  
Some of the results had large confidence intervals. A bigger sample size would have been desirable, 
particularly considering a design effect of 2 instead of 1.5.  
 
4.8. Conclusions 
 
HBC and CHPS were effective in improving family and community practices. Health messages 
delivered by CBAs were not the most common source of health information, but they were 
associated with disease knowledge and appropriate health behaviour outcomes, particularly in the 
Northern Region. This association was more important (in terms of number of outcomes found to be 
associated with the health message) than that found with CHPS or other health information sources 
explored. HBC should continue to be considered as the strategy through which community-IMCI is 
implemented. This could boost the effectiveness of both strategies, both in terms of performance 
and more efficient use of available resources. However, emphasis must be done in increasing the 
IEC activities in the Northern Region to maintain these positive results. 
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Chapter 6. HBC and CHPS cost analysis 
 
 
6.1. Introduction    
 
In December 2014 a new global coalition of more than 500 leading health and development 
organizations worldwide was launched to urge governments to accelerate reforms that ensure 
everyone, everywhere, can access quality health services without being forced into poverty (22). 
This global coalition, called the Universal Health Coverage (UHC), comprises two main 
components: quality essential health service coverage and financial coverage – both extended to the 
whole population (24).  
With UHC on the global health agenda, governments of many low and middle-income countries are 
under pressure to scale up essential health services to meet the needs of their people. This means 
that governments need to prioritise effective interventions to scale up. Health technology 
assessments (HTAs) have been recognised as a tool for priority setting particularly useful in this 
UHC context (212). HTA examines the cost-effectiveness of an intervention as well as the 
organizational implications and social consequences, bridging the gap between the evidence and 
policy making (213). HTA can be used to prioritise an intervention in a particular context as 
mentioned before (ex-ante HTA) or it can be used as a monitoring tool, providing information to 
governments and funders to continue or discontinue certain interventions, helping to address 
sustainability (ex-post HTA) (212, 213).   
As mentioned in section 1.6, Ghana has developed two main community based strategies that aim to 
reduce barriers to physical access to quality treatment: the HBC and CHPS.   
When assessing these two strategies, financial sustainability, particularly of HBC should be 
considered. In sub-Saharan African countries, HBC current funding is primarily reliant on external 
multilateral and bilateral donors. Case studies conducted in Malawi, Niger, Kenya, Mozambique, 
Burkina Faso and Mali showed that external funding is a common denominator and all these 
countries are struggling in finding a sustainable solution (93, 210, 211, 214-216). Like these 
countries, the long term financial plan for HBC in Ghana is not clear. In contrast, the CHPS 
strategy, it is being financed through government money. 
When addressing financial sustainability of an intervention, one needs to question the affordability 
of the intervention and the appropriate financing strategies. This question can be answered with a 
cost-analysis followed by an assessment of financing options. Therefore, I decided to analyse the 
cost per malaria, diarrhoea and suspected pneumonia case appropriately diagnosed and treated in 
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children under-five under the HBC and CHPS strategies. This study is an approach to ex-post HTA 
which considers the real costs and effectiveness of both interventions which is key to policy 
decisions. This information may be used to improve performance and to guide decisions on 
sustainable financing strategies particularly regarding HBC.  
 
6.2. Brief note on economic evaluations 
 
Economic evaluation is the comparative analysis of alternative courses of action in terms of both 
their cost and consequences (108). Economic evaluation is one of the tools available to help choose 
wisely from a range of alternatives and to implement efficiently the resources available. It addresses 
one criteria of health care programme decisions. There are other criteria that need to be addressed 
also when deciding to finance or not an intervention. Those are the affordability, acceptability and 
feasibility of the intervention and health equity (108). 
Four types of economic evaluations have been described: cost- minimisation analysis, cost- benefit 
analysis, cost- effectiveness analysis and cost- utility analysis. Cost- minimisation analysis 
compares different strategies that have shown identical effect but different costs. Therefore, cost-
minimisation analysis is only a comparison of costs (217), and some authors do not consider this 
modality as a full economic evaluation (108).  
Cost- benefit analysis measures cost and benefits, all in monetary terms. There are three main 
approaches to value the economic benefits of an intervention: the human capital approach (to value 
improved health, using for example the value of the increased productivity of individuals through 
fewer work-loss days), revealed preferences (the value of what an individual would have to give up 
to obtain something-for example, lower risk job at a lower wage rate) and contingent valuation 
(which uses survey methods to elicit willingness to pay values for goods in a hypothetical market) 
(108, 218). This type of economic evaluation receives “ethical” critiques due to the fact of 
translating health benefits into monetary terms (health benefits are more than just money).   
According to Drummond (108), in cost- effectiveness analysis benefits are measured in the most 
obvious units of effects, depending on the field being studied, such as years of life gained. Even 
though intermediate outcomes and intermediate outputs are admissible, in general one should 
choose an effectiveness measure related to a final output. However, the most important issue to 
consider is whether the measure is relevant given the objectives of the decision- maker concerned 
(108). When several benefits are measured at the same time (for example years of life gained, 
reduction in anaemia and reduction in hypertension) the analysis is called cost-consequences 
analysis. This type of economic evaluation has some challenges: results can be only compared with 
studies using the same benefit measure and often they cannot be compared with different diseases. 
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In addition, the trade-offs where one can consider if an intervention is most cost-effective that 
another is not explicit. To address this point, a new form of cost-effectiveness analysis was 
developed: cost- utility analysis. Cost- utility analyses uses utility measures (DALYs and QALYs) 
to measure the benefits, and allow comparison across different diseases and interventions.  
Because my effectiveness measure was an intermediate outcome in addition to the importance of 
having information about affordability of HBC to guide long term financing of HBC, I decided to 
conduct a cost analysis.  
To ensure that the methodology used to conduct the cost analysis was appropriate and that the 
results were valid, I applied a recognised check list (Table 21) which can also be used when 
conducting critical assessment of cost analysis (108).   
 
Table 21. Check list to ensure quality of reporting of results of cost analysis  
Elements of a sound cost analysis Comments 
1. Well defined question posed in an answerable form 
1.1. The study involves a comparison of alternatives 
1.2. It is stated the view point for the analysis and the study is placed in any 
particular decision-making context.  
Addressed in Chapter 1, 
Section 8; Chapter 2, 
Section 8 and Chapter 
6, Section 1 
2. There is a comprehensive description of the competing alternatives Addressed in Chapter 1, 
Section 6 
3. All the important relevant costs for each alternative are identified Addressed in Chapter 6, 
Section 4 
4. All costs are measured accurately in appropriate physical units 
4.1. Sources of resource utilization are described and justified 
4.2. If identified items are omitted, adequate measures are taking place in the 
analysis  
4.3 If there are special circumstances that made the measurement difficult, these 
are handled appropriately 
Addressed in Chapter 6, 
Section 4 
5. Costs are valued credibly 
5.1. Sources of all values are clearly identified 
Addressed in Chapter 6, 
Section 4 
6. Costs are adjusted for differential timing 
6.1. Costs that occur in the future are discounted to their present values 
6.2. There is a justification for the discount rate used 
Addressed in Chapter 6, 
Section 4 
7. There is an incremental analysis of costs conducted Addressed in Chapter 6, 
Section 4 
8. Uncertainty of cost is considered 
8.1. If patient level data, appropriate statistical analysis is performed 
8.2. If sensitivity analysis is performed, a justification is provided for ranges or 
distribution of values and for the form of sensitivity analysis performed 
8.3. Results include the sensitivity analysis 
Addressed in Chapter 3, 
Section 8.2 and Chapter 
6, Section 6.4 
9. The presentation and discussion of the study results include all issues of concern 
to users 
9.1. Results are compared with those of others  
9.2. The generalizability of the results to other settings is discussed 
9.3. The study takes into consideration other important factors in the choice or 
decision under consideration 
9.4 The study discusses issues on implementation, such as feasibility of adopting 
“preferred” programmes given financial or other constraints  
Addressed in Chapter 6, 
Section 7 
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6.3. Unit of the cost analysis 
 
The unit cost was defined as total cost incurred in diagnosing and treating one case of malaria, 
diarrhoea or suspected pneumonia.   
The measure of the cost analysis was the cost of a malaria, diarrhoea or suspected pneumonia case 
appropriately diagnosed and treated. This refers to a malaria, diarrhoea or suspected pneumonia 
case that received treatment according to guidelines or a child without malaria, diarrhoea or 
suspected pneumonia that was not prescribed the recommended drugs to treat malaria, diarrhoea or 
pneumonia (Section 3.6). Definitions of a malaria, diarrhoea and suspected pneumonia case can be 
found in Table 1 (Chapter 3).  
 
6.4. Measurement of costs 
 
Economic costing was done from the societal perspective, which considers costs from the 
perspective of households and the health system. This approach is the broadest compared with the 
health system or government budget perspective (219), and allows comparison with previous 
studies. Considering household costs is important because they can be significant, they may deter 
caregivers from using a service and they might be a cause of poverty (catastrophic cost). Data on 
cost was collected from the household survey, from the Health Administration and Support Services 
division (HASS) of the Ghana Health Service, from the National Malaria Control Programme, from 
CHPS and from the NGO, Plan International, which supports HBC in the Volta Region.  
Two activities were used to calculate the cost per case diagnosed and treated: (i) estimation of unit 
cost for treating a malaria, diarrhoea and suspected pneumonia case from CHPS, HBC and 
households and (ii) combination of unit cost for treating malaria, diarrhoea and suspected 
pneumonia case under the HBC and CHPS strategies with the household costs to obtain unit cost 
from the societal perspective.   
 
6.4.1 Estimation of unit costs for diagnosing and treating a malaria, diarrhoea and suspected 
pneumonia case from HBC, CHPS and household  
HBC costs 
Costs per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case under the 
HBC strategy were divided into direct and indirect costs (Table 22). Direct costs refer to those 
involved directly in the service being analysed. Indirect costs refer to productivity loses due to the 
time CBA spent away from their usual activities (attending a sick child). Direct recurrent costs 
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included training of CBAs (according to policy it happens every two years), training of supervisors 
(according to policy it happens every two years), supervision (every year), training material for 
supervisors and CBAs and IEC material for CBAs (last several years), registers (every year) and 
cost of drugs (every year). Direct capital costs included ARI timers (to measure the breathing rate to 
diagnose suspected pneumonia cases), box to keep CBA items and the incentive package (includes 
bicycles, raincoats, boots, torchlights and t-shirts) which, according to policy, is given once at the 
beginning of the intervention to motivate CBAs.  
With regards to the Volta Region, Plan International provided information on cost for training 
CBAs and supervisors. Training expenditures were annualised using the expected life time of two 
years and the recommended discount rate of 3% (220). Annualising capital costs means that even 
though a good has been purchased at a specific point in time, one needs to consider that its benefits 
will be enjoyed over several years, and therefore, its costs will be spread over these years. The 
directorate of the Volta Region provided information on the quantities of training material, 
registers, boxes and incentive package received from the national level, while the national level 
provided information about the cost per item sent to the regions. A10% of freight costs were added 
to the unit costs. The training and IEC materials, the boxes and the incentive package are supposed 
to last several years, and therefore, they were annualised using the expected life time of 8 years and 
the discount rate of 3% (220). The NMCP reported no ARI timers in the Volta Region. The number 
of drugs used in 2014 was obtained from the DHIMS2. The cost of drugs used was the median price 
from a list of suppliers obtained from the International Drug Price Indicator Guide (221) with an 
addition of 10% freight costs as when calculating CHPS costs.  
The regional directorate of the Northern Region provided information about costs of training CBAs 
and supervisors. Training expenditures were annualised using the expected life time of two years 
and the recommended discount rate of 3% (220) considering that, according to policy, these 
trainings happen every two years. The directorate of the Northern Region provided information on 
the quantities of training material, registers, boxes and incentive package received from the national 
level, while the national level provided information about the cost per item sent to the regions. To 
these item cost, a 10% of freight costs were added. The training materials, the boxes and the 
incentive package were annualised using the expected life time of 8 years and the recommended 
discount rate of 3% as I did for the Volta Region. The unit cost of ARI timers used was US$3.5 plus 
a 10% of freight costs as recommended by UNICEF. The number of drugs used in 2014 was 
obtained from the DHIMS2. The cost of drugs used was the median price from a list of suppliers 
obtained from the International Drug Price Indicator Guide (244) with an addition of 10% freight 
costs as when calculating CHPS costs and HBC costs in the Volta Region.  
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As indirect cost, the time of the CBAs attending a sick child was included. The opportunity cost to 
their time was estimated from interviews with four CBAs, two in each region. CBA time was 
assigned a monetary value based on the agricultural labour wage  which was 0.41 GHC/hour (222, 
223) which is the main occupation of the population, particularly in rural areas (224).  
All costs were estimated for 2014 and were converted to US dollars. If the source of a cost belonged 
to a year different than 2014 with a different currency, I first estimated the cost for the year 2014, 
taking into account the inflation (225). To do this, I multiplied the cost by the annual inflation rate. 
Secondly, I converted the currency to US dollars based on the change rate at December 2014 (226).  
Direct and indirect cost were then allocated to malaria, diarrhoea and suspected pneumonia case 
management based on the percentage of HBC activity reported in 2014 through the DHIMS-II.  
 
CHPS costs 
Two CHPS compounds were visited in each region to collect information during the 5th to 16th 
April 2014 in the Volta Region and during the 23rd June to 3rd July 2014 in the Northern Region. 
The criteria used to select these facilities was average performing facilities based on their activity 
(outpatient visit per nurse). This information was provided by the person responsible for health 
information at the regional directorates. In addition, and as cost information was collected during 
the household survey, the criteria of feasibility was also considered. This means that to select two 
CHPS among average CHPS, I considered those that were closer to the communities being 
surveyed. The CHPS compounds selected in the Volta Region were Fodome Woe and Likpe 
Agbozome in the Hohoe district. In the Northern region, Mankpang (Central Gonja district) and 
Gbulahagu (Tolon-Kumbugu district).  
Direct costs were considered from the CHPS perspective, including recurrent and capital costs 
(Table 22). As recurrent cost, salaries of personnel including any allowances received, medicines, 
disposables, stationary, utilities and maintenance costs were considered. 2014 recurrent 
expenditures were obtained from the financial officer at the respective health districts. Capital cost 
included the building, vehicles, furniture and equipment that were annualised using the expected 
life time of 30, 8, 10 and 8 years respectively and the recommended discount rate of 3% (220). The 
size of the CHPS facilities was estimated based on plans of standard CHPS facilities available from 
the HASS division. The information on construction cost per m2 for such buildings was obtained 
from the same division. An inventory of equipment and furniture was developed during the field 
visits at the two CHPS in each region. These items were valued using a price list from the HASS 
division. If the cost of an existing equipment or furniture was not in the list provided by the HASS 
division, market surveys were conducted to value these items. To do this, the average of a sample of 
at least 3 different prices were considered for one equipment or furniture as suggested in the 
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guidelines for cost data collection in the field in ACT consortium projects (227). These sample 
prices were mainly obtained online in the case of equipment and in Ghanaian shops in the case of 
furniture. All costs were estimated for 2014 (taking into account the inflation rates when needed) 
and were converted to US dollars.  
The allocation of recurrent and capital costs to outpatient visits was performed using the standard 
step down costing methodology (108). First, all resources were allocated to all cost centres using 
different allocation criteria suggested in the guidelines of ACT consortium projects (227) (step 1). 
Cost centres refer to groups of activities serving a similar purpose. Three groups of cost centres can 
be defined in a CHPS facility: overhead cost centres (which include administration, accounting, 
health information, cleaning, security and stores services), support centres (diagnosis and pharmacy 
services) and final services cost centres (outpatient visits, antenatal, postnatal, maternity, 
vaccination, outreach services and health education). To allocate salaries and training costs to the 
different cost centres, I considered the value of staff time involved in the different activities and the 
annual activities reported in the health information system. To allocate stationaries costs, 10% of 
these costs were allocated to administration, accounting, health information and pharmacy cost 
centres while the 60% remaining was allocated to final services based on the annual activity 
produced. Utilities and cleaning costs were allocated to cost centres based on the percentage of the 
floor area used by each cost centre. All medicine’s costs were allocated to pharmacy services, 
disposables’ costs to diagnostic services and maintenance cost to administration cost centre.  
Then, the overhead costs were allocated to support and final centres also using relevant allocation 
criteria (step 2). Administration, accounting, security and stores costs were allocated to support and 
final services using the same proportion of costs allocated to support and final services at the end of 
step 1 (227). Health information costs were distributed among final cost centres based on the 
percentage of the annual activity reported. Cleaning costs were distributed among support and final 
centres based on the proportion of floor used in by each cost centre. Finally, support centres costs 
were allocated to outpatient visits (step 3). To do so, pharmacy costs were distributed among final 
services based on the total annual activity produced by each final service adjusted by a weight (1 for 
outpatient and antenatal visits, 3 for deliveries and 0.5 for vaccines and postnatal). Diagnostic 
services costs were distributed among final services based on the reported diagnosis activity by the 
staff interviewed. The main diagnostics services were rapid diagnostics test (RDT) for malaria and 
pregnancy test in antenatal services.  
To differentiate cost per malaria, diarrhoea and suspected pneumonia diagnosis and treatment in 
children under- five from the rest of the outpatient visits, a bottom up costing method was done to 
supplement the standard step-down costing methodology. Interviews with staff captured self-
reported time for doing an RDT and treating a case of malaria, diarrhoea and suspected pneumonia 
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in children under- five years of age. The average cost of an RDT was taken from two market 
surveys done by the Global Fund and the Program for Appropriate Technology in Health (PATH) 
(228, 229) which gave an average cost of US$0.35 plus a 10% of freight costs. Details of the drugs 
given were taken from a sample of patients (between 6-12 cases per disease in each CHPS). The 
cost of drugs used was the median price from a list of suppliers obtained from the International 
Drug Price Indicator Guide (221) with an addition of 10% freight costs as recommended by the 
guide.  
 
Household costs 
Household costs incurred when visiting a CBA or a CHPS facility were also divided into direct and 
indirect cost. Direct costs included cost per transport to provider and any other direct cost involved 
at the provider. Indirect costs relate to productivity loses and refer to time travelling to CBA/CHPS 
and time spent at/with the provider. Cost of carers time was calculated based on the agricultural 
wage labour.  
These household costs were obtained from the household survey conducted in 2014. Carers seeking 
care when their child was sick, were asked about the different cost involved based on the different 
providers they visited. Therefore, household costs when visiting a CBA or a CHPS (or any other 
provider) were different and were included in the analysis 
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Table 22. Direct and indirect costs involved for diagnosing and treating a malaria, diarrhoea and suspected pneumonia case, considered by HBC, CHPS and households 
HBC CHPS 
Costs Sources Value * Costs Sources Value* 
PROVIDER PERSPECIVE PROVIDER PERSPECIVE 
1) Direct cost  1) Direct cost  
Recurrent Recurrent 
-Training CBAs  
NMCP and Plan 
International 
Reported expenditures annualized 
using 2 years at 3% discount rate 
Salaries, 
including 
allowances 
District financial officer  2014 expenditures 
-Training 
supervisors and 
supervision 
NMCP and Plan 
International 
Reported expenditures  -Medicines District financial officer 2014 expenditures 
-Training materials 
and educational 
material 
NMCP 
Reported expenditures annualized 
using 8 years 
-Disposables District financial officer 2014 expenditures 
-ACT, ORS, zinc 
and paracetamol 
plus transport 
DIMS, List of 
drugs price 
Median price for 2014 -Stationary District financial officer 2014 expenditures 
 
  -Utilities District financial officer 2014 expenditures 
   -Maintenance cost District financial officer 2014 expenditures 
Capital costs Capital costs 
-ARI timers 
NMCP, 
UNICEF 
Reported expenditures annualized 
using 8 years at 3% discount rate 
-Building 
Plans of standard CHPS facility and 
cost for m2 from the MoH 
2014 expenditures annualized using 30 
years at 3% discount rate 
-Drugs Box NMCP 
Reported expenditures annualized 
using 8 years at 3% discount rate 
-Vehicles 
Inventory from the field visits, prices 
from MoH and survey market 
2014 expenditures annualized using 8 
years at 3% discount rate 
-Incentive package NMCP 
Reported expenditures annualized 
using 8 years at 3% discount rate 
-Furniture 
Inventory from the field visits, prices 
from MoH and survey market 
2014 expenditures annualized using 10 
years at 3% discount rate 
   -Equipment 
Inventory from the field visits, prices 
from MoH and survey market 
2014 expenditures annualized using 8 
years at 3% discount rate 
Indirect cost Indirect cost 
-CBAs productivity 
loses  
CBA interviews 
Reported time spent equivalent to 
agricultural labor wage 
   
HOUSEHOLD PERSPECIVE  HOUSEHOLD PERSPECIVE  
-Time to provider HH survey 
Reported time spent equivalent to 
agricultural labor wage 
-Time to provider HH survey 
Reported time spent equivalent to 
agricultural labor wage 
-Travel cost  HH survey Reported cost spent -Travel cost HH survey Reported cost spent 
-Time in provider HH survey 
Reported time spent equivalent to 
agricultural labor wage 
-Time in provider HH survey 
Reported time spent equivalent to 
agricultural labor wage 
-Food in provider HH survey Reported cost spent -Food in provider HH survey Reported cost spent 
-RDT payment HH survey Reported cost spent -RDT payment HH survey Reported cost spent 
-Cost of drugs if out 
of pocket money 
HH survey Reported cost spent 
-Cost of drugs if 
out pocket money 
HH survey Reported cost spent 
*All costs were estimated for 2014 and converted to USD. 
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6.4.2. Estimation of unit costs for diagnosing and treating a malaria, diarrhoea and 
suspected pneumonia case under the HBC and CHPS strategy from the societal perspective  
Facility and programme costs were added to the household costs to obtain costs from the societal 
perspective under the HBC and CHPS strategies.  
Data from the survey showed no reported deaths after visiting a CBA or a CHPS in the Volta and 
Northern Regions. Reported referrals after visiting a CBA were 14.1% and 20.1% in the Volta and 
Northern Region, respectively, and 5.9% and 4.3% after visiting a CHPS compound. However, 42% 
and 63% of carers sought care elsewhere after using HBC and 28% and 7.9% after using CHPS in 
the Volta and Northern Regions, respectively. This high proportion of carers visiting a second 
provider (particularly for the HBC strategy) is important as it represents an extra cost to diagnose 
and treat a case. Therefore, costs due to this second visit to a provider were also taken into 
consideration and added to the unit cost for the diagnosis and management of malaria, diarrhoea and 
suspected pneumonia. To do this, I multiplied the proportion of carers that sought care elsewhere 
after visiting a CBA or a CHPS facility because of malaria, diarrhoea or suspected pneumonia with 
the cost of the second visit. The cost of the second visit was calculated by adding 
programme/facility costs to household costs (as I did for the first visit). This included, (i) the 
average iCCM cost for diagnosing and treating a malaria, diarrhoea and suspected pneumonia case 
(if second provider was a licensed chemical seller or a drug peddler), or average CHPS cost (if 
second provider was a health facility); (ii) the average cost for traveling to the second provider and 
(iii) the average money spent at the second provider visited. Taking into account that CHPS were 
the health facility more often used in this second visit, and that expenditures from other health 
facilities, from licensed chemical sellers or from drug peddlers were not available, it was believed 
that using CHPS and CBA cost was the best approach to calculate the cost for diagnosis and 
treating a case in the second visit (Figure 8).  
 
 
 
 
 
 
 
Figure 8. Scheme on how costs from societal perspective were calculated 
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6.5. Cost-analysis  
 
The cost analysis was done based on a sample of 100 eligible children for treatment, using the data 
obtained from the household survey. This analysis gave information about how much it costs to 
appropriately diagnose and treat a malaria, diarrhoea and suspected pneumonia case under HBC and 
CHPS, which may be useful for planning purposes.  
 
6.6. Results 
 
This results section will firstly describe the unit cost for diagnosing and treating a malaria, diarrhoea 
and suspected pneumonia case in children under-five years of age from the health system, 
household and societal perspective. This will follow with the cost analysis and the sensitivity 
analysis.  
 
6.6.1. Unit cost for diagnosing and treating a malaria, diarrhoea and suspected pneumonia 
case from HBC, CHPS and household perspective 
Unit costs per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case under the 
HBC strategy in the Volta and the Northern Region are described in Table 23, Figure 9. Average 
HBC programme costs in the Volta Region were lower when compared with those of the Northern 
Region: diagnosing and treating a malaria case costs US$1.54 and US$7.77, a diarrhoea case costs 
US$0.38$ and US$6.72 and a suspected pneumonia case costs US$1.12 and US$7.80 in the Volta 
and Northern Region, respectively. The much higher HBC costs in the Northern Region when 
compared with those of the Volta Region (particularly in the case of diarrhoea and suspected 
pneumonia cases) was mainly due to (i) higher costs for training and for the incentive package in 
the Northern Region (due to a higher number of CBAs); (ii) a lower number of visits to sick 
children in the Northern Region (30,830 and 17,898 visits in the Volta and the Northern Region) 
and (iii) a much lower number of IEC activities (177,484 and 99 IEC activities conducted in the 
Volta Region and the Northern Region). If we look at the contribution to HBC costs by the different 
cost drivers, drugs cost in the Volta Region represent the higher percentage, while in the Northern 
Region and because of the low activity and the high number of CBAs, training and incentive 
package cost represent the highest contribution to HBC cost.   
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Table 23. Cost per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case under the HBC 
strategy in the Volta and Northern Region in 2014 (US$) 
  Volta Region Northern Region 
  Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia 
Program costs  N(%) 
N(%) N(%) N(%) N(%) N(%) 
Training CBAs   881.43 (2.2)  125.57 (8.4)   40.73 (2.7)  18,756.66 (27.0)  25,024.98 (31.2)   9,579.92 (26.9)  
Training supervisors   446.84 (1.1)  63.66 (4.3)   20.65 (1.4)   7,062.53 (10.1)  9,422.77 (11.7)   3,607.17 (10.1)   
Supervision  -     -     -     1,473.76 (2.1)  1,966.28 (2.4)   752.72 (2.1)   
Training and IEC materials  60.93 (0.1)   8.68 (0.5)  2.82 (0.2)  1,069.25 (1.5)  1,426.58 (1,7)   546.11 (1.5)  
CBA drugs  36,088.88 (88.9)  837.48 (56.3)   1,266.76 (85.7)   12,698.00 (18.2)   4,343.24 (5.4)  5,966.96 (16.7)   
ARI timers 
  
 -    
  
 658.15 (1.8)   
Registers  430.25 (1.0)  61.29 (4.1)  19.88 (1.3)  5,961.00 (8.5)  7,953.11 (9.9)   3,044.57 (8.55)   
Time of CBAs   1,426.16 (3.5)  210.89 (14.2)   68.40 (4.6)  484.11 (0.7)  645.90 (0.8)   247.26 (0.6)   
Drugs Box  86.39 (0.2)  12.31 (0.8)   3.99 (0.2)  1,448.60 (2.1)   1,932.72 (2.4)   739.87 (2.0)   
Incentive package  1,167.01 (2.8)  166.25 (11.2)   53.92 (3.6)   20,478.34 (29.5)  27,322.03 (34.1)  10,459.27 (29.3)   
Total programme costs  40,587.89 (100)  1,486.12 (100)   1,477.14 (100)  69,432.25 (100)   80,037.61 (100)    35,602.01 (100)   
Average cost per case  1.54   0.38   1.12   7.77   6.72   7.80  
 
 
Figure 9. Percentage of contribution to HBC costs to diagnose and treat a malaria, diarrhoea and pneumonia case by the 
different cost drivers in the Volta and the Northern Region in 2014 
 
Unit cost per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case in the four 
CHPS visited from the health system perspective are presented in Table 24, Figure 10. Across the 
Volta and the Northern Regions, the cost per diagnosing and treating a malaria case varied from 
US$4.65 to US$9.95; the cost per treating a diarrhoea case varied from US$3.05 to US$8.16 and the 
cost per treating a suspected pneumonia cased varied from US$3.11 to US$8.79. Results from the 
Volta Region had the lower and higher costs per malaria, diarrhoea and suspected pneumonia case 
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diagnosed and treated across both regions. These differences in the Volta Region were mainly due 
to the existence of a bigger facility with smaller reported activity compared to a smaller facility with 
higher reported activity. In the Northern Region, the micro-costing exercise showed that the large 
differences observed in diagnosing and treating a malaria case in the two CHPS analysed were 
mainly due to the use of ACT in syrup in Mankpan CHPS (which costs US$ 0.1/ml) instead of ACT 
tablets in Gbulahu CHPS (which costs US$ 0.01/tablet).  
Diagnosing and treating malaria was found to be more costly than treating diarrhoea or suspected 
pneumonia in 3 out of 4 CHPS facilities. All three diseases needed similar resources in terms of 
building, furniture and equipment. However, in the case of malaria the cost increased because of the 
time invested in doing the RDT and the laboratory costs. In addition, and as mentioned above, the 
cost of ACT in syrup was higher than the cost of ACT in tablets and higher than ORS (0.07/sachet), 
zinc (0.02/tablet) or amoxicillin (0.004/ml). Major contribution to costs among all CHPS were 
salaries (ranges between 34% and 55%), dispensary (ranges between 12% and 40%) and diagnostic 
services (ranges between 5% and 17%).  
  
Figure 10. Percentage of contribution to CHPS costs by the different cost drivers in the Volta and the Northern Region in 
2014  
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Table 24. Cost per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case in four CHPS facilities in the Volta and Northern Region in 2014 (US$) 
  VOLTA REGION NORTHERN REGION 
  Fodome Woe Likpe Agbozome Gubulahu Mankpan 
 
Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea 
Pneumoni
a 
Recurrent 
expenditures  
N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  
Salaries 625.15 (34.9) 338.48 (53.1)  43.72 (52.1)  582.09 (37.5)  119.4 (45.8) 104.48 (42.4)  745.52(51.7)  342.01 (62.7)  9.84 (48.8)  1386.98(31.7)  290.05(48.8)  7.91 (44.5)  
Stationery 9.15 (0.5) 4.96 (0.8)  0.64 (0.8)  4.84 (0.3)  0.99 (0.4)  0.87 (0.4)  2.16 (0.1)  0.99 (0.2)  0.03 (0.1)  56.08 (1.3)  11.73 (2.0)  0.32 (1.8)  
Utilities 0 (0)  0 (0)  0 (0)  2.04 (0.1)  0.42 (0.2)  0.37 (0.2)  0 (0)  0 (0)  0 (0)  2.24 (0.1)  0.47 (0.1)  0.01 (0.1)  
Training 12.46(0.7) 6.75 (1.1)  0.87 (1.0)  3.02 (0.2)  0.62 (0.2)  0.54 (0.2)  54.83(3.8)  25.15 (4.6)  0.72 (3.6)  35.33 (0.8)  7.39 (1.2)  0.2 (1.1)  
Capital 
expenditures  
                        
Buildings 15.73(0.9)  8.52 (1.3)  1.1 (1.3)  34.81 (2.2)  7.14 (2.7)  6.25 (2.5)  12.86(0.9)  5.9 (1.1) 0.17 (0.8)  17.55 (0.4)  3.67 (0.6)  0.1 (0.6)  
Equipment 54.3 (3.0)  29.4 (4.6)  3.8 (4.5)  9.41 (0.6)  1.93 (0.7)  1.69 (0.7)  82.78(5.7)  37.97 (7.0)  1.09 (5.4)  18.06 (0.4)  3.78 (0.6)  0.1 (0.6)  
Furniture 7.32 (0.4)  3.96 (0.6)  0.51 (0.6)  10.43(0.7)  2.14 (0.8)  1.87 (0.8)  4.15 (0.3)  1.9 (0.3)  0.05 (0.2)  1.82 (0.0)  0.38 (0.1)  0.01 (0.1)  
Overhead                          
Administration 37.32(2.1)  20.21 (3.2)  2.61 (3.1)  86.54(5.6)  17.75 (6.8)  15.53 (6.3)  30.75(2.1)  14.11 (2.6)  0.41 (2.0)  60.82 (1.4)  12.72 (2.1)  0.35 (2.0)  
Accounting 10.41(0.6) 5.64 (0.9)  0.73 (0.9)  92.1 (5.9)  18.89 (7.2)  16.53 (6.7)  15.41(1.1)  7.07 (1.3)  0.2 (1.0)  118.9 (2.7)  24.86 (4.2)  0.68 (3.8)  
Health information 20.38(1.1) 11.04 (1.7)  1.43 (1.7)  113.58 (7.3)  23.3 (8.9)  20.39 (8.3)  10.36(0.7)  4.75 (0.9)  0.14 (0.7)  345.8 (7.9)  72.32 (12.2)  1.97 (11.1)  
Cleaning 71.27 (4.0)  38.59 (6.1)  4.99 (5.9)  61.16(3.9)  12.55 (4.8)  10.98 (4.5)  7.48 (0.5)  3.43 (0.6)  0.1 (0.5)  26.9 (0.6)  5.63 (0.9)  0.15 (0.8)  
Laundry 0 0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  47.4 (1.1)  9.91 (1.7)  0.27 (1.5)  
Stores 28.22(1.6)  15.28 (2.4)  1.97 (2.3)  26.38(1.7)  5.41 (2.1)  4.73 (1.9)  0 (0)  0 (0)  0 (0)  134.51 (3.1)  28.13 (4.7)  0.77 (4.3)  
Security 0 (0) 0 (0)  0 (0)  52.08(3.4)  10.68 (4.1)  9.35 (3.8)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  
Support centres                          
Dispensary drugs 499.06 (27.8) 115.27 (18.1)  16.52 (19.7)  33.07(2.1)  19.91 (7.6)  35.23 (14.3)  365.31 (25.3)  102.18 (18.7)  7.42 (36.8)  1739.20 (39.7)  99.70 (16.8)  4.30 (24.2)  
Dispensary overhead 71.98 (4.0)  38.97 (6.1)  5.03 (6.0) 96.7 (6.2)  19.84 (7.6)  17.36 (7.1)  0 (0)  0 (0)  0 (0)  111.46 (2.5)  23.31 (3.9)  0.64 (3.6)  
Diagnostics 330.36 (18.4) 0 (0)  0 (0) 344.65 (22.2)  0 (0)  0 (0)  109.81 (7.6)  0 (0)  0 (0)  273.11 (6.2)  0 (0)  0 (0)  
Total  1793.12 (100) 637.06 (100)  83.93 (100)  1552.9 (100)  260.97 (100)  246.16 (100)  1441.42 (100)  545.47 (100)  20.17 (100)  4376.15 (100)  594.04 (100)  
17.79 
(100)  
Average cost per 
case 
4.65 3.05 3.11 9.95 8.16 8.79 4.76 3.92 5.04 8.32 5.4 5.93 
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Household costs for diagnosing and treating a malaria, diarrhoea and suspected pneumonia case are 
described in Table 25, Figure 11. Household costs represent the cost of time used to travel to 
provider, the money spent on travel, the cost of time spent with the provider and the money spent at 
the provider in terms of food. Other costs involved such as paying for the service or for drugs were 
also considered to show the burden of out of pocket money spent when visiting a CBA or a CHPS 
facility. As expected, household costs were higher when visiting a CHPS facility than when visiting 
a CBA, particularly because of longer distances from household to a CHPS facility than to a CBA, 
higher cost of transport and longer time at a CHPS facility than with a CBA. Household costs 
ranged from US$0.04 when visiting a CBA in the Northern Region (corresponding to a 0.4% of the 
total cost per case) to US$1.54 when visiting a CHPS in the Volta Region (corresponding to 20.6% 
of the total cost per case). 
 
 
Figure 11. Percentage of contribution to household costs to diagnose and treat a malaria, diarrhoea and pneumonia case 
by the different cost drivers in the Volta and the Northern Region in 2014 
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Table 25.  Cost per diagnosing and treating a malaria, diarrhoea and suspected pneumonia cases from the household perspective under the HBC and CHPS strategy in the 
Volta and Northern Region in 2014 (US$) 
  
 
VOLTA REGION NORTHERN REGION 
  CBA CHPS CBA CHPS 
Variables Malaria Diarrhoea Pneumonia Malaria Diarrhoea Pneumonia Malaria Diarrhoea Pneumonia Malaria Diarrhoea Pneumonia 
 N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  
Value of time lost to provider (1) 0.03(36.5)  0.03 (30.3)  0.0(42.4)  0.12 (6.6)  0.12 (7.8)  0.12 (8.1)  0.02 (44.5) 0.02 (14.1)  0.02 (44.5)  0.08 (8.8)  0.08 (11.2)  0.08 (6.50)  
Travel cost (2) 0 (0)  0 (0)  0 (0)  1.10 (60.6)  1.10 (71.3)  1.09 (73.8)  0 (0)  0 (0)  0 (0)  0.18 (20.2)  0.18 (25.8)  0.18 (15.0)  
Value of time lost at provider (3) 0.03(36.4)  0.03 (30.2) 0.03 (42.2)  0.05 (2.7)  0.05 (3.2)  0.05 (3.3)  0.02 (55.5)  0.02 (17.5)  0.02 (55.5)  0.07 (7.9)  0.07 (10.1)  0.07 (5.8)  
Food in provider (4) 0.01(13.2)  0.01 (11.0)  0.01 (15.4)  0.22 (12.1)  0.22 (14.3)  0.22 (14.8)  0 (0)  0 (0)  0 (0)  0.35 (38.7)  0.35 (49.4)  0.35 (28.6)  
RDT cost (5) 0.00 (0.6)  0 (0)  0 (0)  0.07 (3.9)  0 (0)  0 (0)  0 (0)  0 (0)  0 (0)  0.10 (10.9)  0 (0)  0 (0)  
Drug cost (6) 0.01(13.4)  0.03 (28.5)  0 (0)  0.25 (14.1)  0.05 (3.4)  0 (0)  0 (0)  0.08 (68.4)  0 (0)  0.12 (13.4)  0.03 (3.6) )  0.54 (44.0)  
Average cost per case  0.07 (100)  0.09 (100)  0.06 (100)  1.81 (100)  1.54 (100)  1.49 (100)  0.04 (100)  0.11 (100)  0.04 (100)  0.91 (100)  0.72 (100)  1.24 (100)  
(1) Refers to the value of time carers spent travelling to provider to sick care for their children; (2) Money spent on transport to provider by carers when seeking care; (3) Value of time spent at provider by carers when seeking care; (4) 
Money spent by carers buying food at provider when seeking care for their children; (5) Money spent paying for RDT; (6) Money spent paying for drugs. 
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6.6.2. Unit cost for diagnosing and treating a malaria, diarrhoea and suspected pneumonia 
case from the societal perspective 
To obtain unit costs from the societal perspective, household costs were added to programme costs 
of the HBC and CHPS strategies (Table 26, Figure 12). 
Costs involved due a second visit to a provider after visiting a CBA or a CHPS facility were added 
to programme/facility costs. These costs were higher under the HBC strategy when compared to 
CHPS, as more carers sought care after the first visit to a CBA than to a CHPS. In the Volta Region, 
average costs for this second visit correspond to US$3.34 and US$0.41 per a malaria case 
diagnosed and treated under the HBC and CHPS strategy respectively; US$0.41 and US$0.11 per 
diarrhoea case diagnosed and treated under the HBC and CHPS strategy and US$0.14 and US$0.02 
per suspected pneumonia case diagnosed and treated under the HBC and CHPS strategy 
respectively. In the Northern Region, average costs for the second visit to a provider was US$1.56 
and US$0.61 per malaria case diagnosed and treated under the HBC and CHPS strategy 
respectively; US$1.53 and US$0.16 per diarrhoea case diagnosed and treated under the HBC and 
CHPS strategy and US$0.66 and US$0.001 per suspected pneumonia case diagnosed and treated 
under the HBC and CHPS strategy respectively. 
After adding household costs and those of the second visit to a provider, to the cost per diagnosing 
and treating a malaria case under the HBC strategy was US$4.96 and US$9.37 in the Volta and 
Northern Regions and US$9.52 and US$8.07 in a CHPS in the Volta and the Northern Regions; to 
diagnose and treat a diarrhoea case costs US$0.88 and US$8.36 under the HBC in the Volta and 
Northern Regions and US$7.25 and US$5.54 in a CHPS in the Volta and the Northern Regions. 
Finally, diagnosing and treating a suspected pneumonia case costs US$1.33 and US$8.50 under the 
HBC strategy in the Volta and the Northern Regions and US$7.45 and US$6.73 in a CHPS in the 
Volta and the Northern Regions respectively. Therefore, diagnosing and treating a malaria case was 
the most expensive, followed by a suspected pneumonia case and a diarrhoea case, mainly because 
of laboratory costs and drugs costs (as mentioned in section 6.6.1) in both, HBC and CHPS.  
Looking at the contribution to these costs by the different drivers (Figure 11), programme and 
facility cost are the main contributors (costs ranging from 43% to 85%), with the exception of the 
HBC in the Volta Region. HBC costs in the Volta Region are comparatively lower than other 
facility and programme costs. In addition, costs related to the second provider visit, after visiting a 
CBA in the Volta Region, were higher than in the Northern Region. Even though a higher 
percentage sought care after visiting a CBA in the Northern Region than in the Volta Region, 
average CHPS costs and household costs were higher in the Volta Region than in the Northern 
Region. Finally, and as mentioned above, household costs were higher when visiting a CHPS than a 
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CBA due to longer distances and more time spent at the provider (corresponding to 20% and 14% 
of the total cost under CHPS in the Volta and the Northern Region, respectively).  
 
 
Figure 12. Percentage of contribution to societal costs to diagnose and treat a malaria, diarrhoea and pneumonia case by 
the different cost drivers in the Volta and the Northern Region in 2014. VR: Volta Region; NR: Northern Region 
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Table 26. Cost per diagnosing and treating a malaria, diarrhoea and suspected pneumonia case from the societal perspective under the HBC and CHPS strategy in 
the Volta and Northern Region in 2014 (US$) 
   
 
VOLTA REGION NORTHERN REGION 
 
CBA CHPS CBA CHPS 
 Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia Malaria  Diarrhoea Pneumonia 
PROVIDER PERSPECTIVE N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  N (%)  
Programme cost per case 1.54(31.1) 0.38 (43.6) 1.12 (84.8)  7.30(76.7) 5.60 (77.3) 5.95 (79.8) 7.77 (83.0)  6.72 (80.4) 7.80 (91.8)  6.54(81.1) 4.66(84.2)  5.49 (81.6)  
If second provider was sought 3.34 (67.4) 0.41 (46.3) 0.14 (10.4) 0.41 (4.3) 0.11 (1.5) 0.02 (0.2) 1.56 (16.7)  1.53 (18.3) 0.66 (7.7)  0.61(7.6)  0.16 (2.9)  0.00 (0.1)  
Total Facility/programme cost per 
case 
4.88 (98.5) 0.79 (89.9) 1.26 (95.2) 7.71(81.0)  5.71 (78.8) 5.97 (80.1) 9.33 (99.6) 8.24 (98.6) 8.46 (99.6)  7.15(88.7)  4.82(87.1)  5.49 (81.6)  
HOUSEHOLD PERSPECTIVE 
            
Value of travel time lost to 
provider 
0.03 (0.5) 0.03 (3.1) 0.03 (2.0) 0.12 (1.3) 0.12 (1.7)  0.12 (1.6) 0.02 (0.2) 0.02 (0.2)  0.02 (0.2)  0.08 (1.0)  0.08 (1.5)  0.08 (1.2)  
Cost to provider 0.00 (0) 0.00 (0)  0.00 (0)  1.10(11.5) 1.10 (15.1) 1.10 (14.7) 0.00 (0) 0.00 (0)  0.00 (0)  0.18 (2.3)  0.18 (3.3)  0.18 (2.7)  
Value of time lost at provider 0.023 (0.5) 0.03 (3.0) 0.03 (2.0)  0.05 (0.5) 0.05 (0.7) 0.05 (0.7) 0.02 (0.2) 0.02 (0.2) 0.02 (0.2)  0.07 (0.9)  0.07 (1.3)  0.07 (1.1)  
Food in provider 0.01 (0.2)  0.01 (1.1) 0.01 (0.7) 0.22 (2.3) 0.22 (3.0) 0.22 (2.9) 0.00 (0)  0.00 (0)  0.00 (0) 0.35 (4.4)  0.35 (6.4)  0.35 (5.3)  
RDT 0.00 (0)  0.00 (0) 0.00 (0)  0.07 (0.7)  0.00 (0)  0.00 (0) 0.00 (0)  0.00 (0) 0.00 (0)  0.10 (1.2)  0.00 (0)  0.00 (0)  
Drugs 0.01 (0.2) 0.03 (2.9)  0.00 (0) 0.25 (2.7) 0.05 (0.7) 0 (0)  0.00 (0)  0.08 (0.9)  0.00 (0)  0.12 (1.5)  0.03 (0.5)  0.54 (8.1)  
Total household cost per case 0.07 (1.5) 0.09 (10.1) 0.06 (4.8) 1.81(19.0) 1.54 (21.2) 1.49 (19.9) 0.04 (0.4) 0.11 (1.4) 0.04 (0.4) 0.91(11.3)  0.72(12.9)  1.24 (18.4) 
Average cost per case  4.96 (100)  0.88 (100)  1.33 (100)  9.52 (100) 7.25 (100)  7.45 (100)  9.37 (100)  8.36 (100)  8.5 (100)  8.07(100)  5.54 (100)  6.73 (100)  
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6.6.3. Cost-analysis 
Tables 27, 28 and 29 presents the average cost per case appropriately treated (average cost per 
malaria, diarrhoea and suspected pneumonia cases appropriately diagnosed and treated according to 
protocol in a group of 100 eligible children, meaning that those that need the treatment received it, 
and those that do not need it do not receive it). Due to the low numbers of carers visiting a CBA in 
the Northern Region (Chapter 3), I excluded the HBC data of the Northern Region from this 
analysis. 
In the Volta Region, HBC was less costly than CHPS not only for the appropriate diagnosis and 
treatment of malaria, but also for the appropriate diagnosis and treatment of diarrhoea and suspected 
pneumonia (Tables 27, 28, 29 and Figure 13). Note that even though the GFATM only provides 
ACT drugs for the HBC strategy in the Volta Region, CBAs received training for the management 
of the three diseases (Chapter 4). If no drugs were available to treat a diarrhoea and pneumonia case 
(CBAs were provided with ORS, zinc and amoxicillin in 2013), CBAs were supposed to refer cases 
for further management, and this referral was also considered as appropriate treatment. 
The average cost per case appropriately diagnosed and treated was lower under the HBC than under 
the CHPS strategy. HBC had lower costs than CHPS to diagnose and treat malaria, diarrhoea and 
suspected pneumonia cases while the number of children appropriately diagnosed and treated was 
similar or slightly higher under the HBC strategy (Tables 27, 28 and 29). The cost per case 
appropriately diagnosed and treated was lower for the management of malaria (US$4.25 versus 
US$6.12), for the prompt management of malaria (US$5.58 versus 12.24), for the management of 
diarrhoea with ORS or referred (US$0.12 versus US$1.45) for the management of diarrhoea with 
ORS and zinc (US$0.18 versus US$1.12), and for the management of suspected pneumonia 
(US$0.27 versus 1.69) under the HBC strategy when compared with CHPS.  
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Table 27. Cost-analysis for appropriately diagnose and treat a malaria per 100 eligible children from de societal 
perspective in 2014 (US$) 
 Volta Region Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 100 100   100 
Number treated with ACT or quinine* 24 19   30 
Number treated with prompt ACT or quinine 17 4   23 
Number treated according to protocol (ACT or quinine) 28 30   35 
Number treated according to protocol (prompt ACT or quinine) 21 15   27 
Cost per 100 children (ACT or quinine) US$119.04 US$182.30   US$244.57 
Cost per child treated according to protocol (ACT or quinine) US$4.25 US$6.12   US$7.09 
Cost per child treated according to protocol (prompt ACT or quinine) US$5.58 US$12.24   US$8.92 
*Source: Annex 2  
 
Table 28. Cost analysis for appropriately diagnose and treat a diarrhoea per 100 eligible children from de societal 
perspective in 2014 (US$) 
  Volta Region** Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 100 100   100 
Number treated with ORS (or referred)* 8 11   7 
Number treated with ORS and zinc (or referred) 11 7   4 
Number treated according to protocol (ORS or referred) 59 57   62 
Number treated according to protocol (ORS and zinc) 54 43   59 
Cost per 100 children (ORS) US$6.84 US$83.20   US$38.88 
Cost per 100 children (ORS and zinc) US$9.78 US$47.54   US$19.44 
Cost per child treated according to protocol (ORS or referred) US$0.12 US$1.45   US$0.62 
Cost per child treated according to protocol (ORS and zinc) US$0.18 US$1.12   US$0.33 
* Source: Annex 3; **Appropriate treatment for diarrhoea under the HBC strategy in the Volta Region includes those treated with ORS and 
zinc or referred for further management. The cost per treatment of those referred is included to allow comparison with CHPS. 
 
Table 29. Cost analysis for appropriately diagnose and treat a suspected pneumonia per 100 eligible children from 
de societal perspective in 2014 (US$) 
  Volta Region** Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 100 100   100 
Number treated with amoxicillin or co-trimoxazole* 15 16   23 
Number treated according to protocol  72 72   73 
Cost per 100 children  US$19.87 US$122.13   US$156.44 
Cost per child treated according to protocol  US$0.27 US$1.69 
 
US$2.13 
* Source: Annex 3; **Appropriate treatment for diarrhoea under the HBC strategy in the Volta Region includes those treated with ORS 
and zinc or referred for further management. The cost per treatment of those referred is included to allow comparison with CHPS. 
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Figure 13. Average cost per malaria, diarrhoea and suspected pneumonia case appropriately diagnosed and treated under 
the HBC and CHPS in the Volta Region in 2014  
 
6.6.4. Sensitivity analysis  
The one way sensitivity analysis explored how varying specific values influenced the average cost 
per case appropriately diagnosed and treated from the societal perspective in both strategies For 
simplicity in presenting the data, I only included one cost per disease. HBC in the Volta Region 
remained less costly than CHPS for the appropriate diagnosis and treatment of malaria, diarrhoea 
and suspected pneumonia cases when using different facility costs, different discount rates, different 
HBC and CHPS utilization and different HBC effectiveness (Table 30). However, when the HBC 
effectiveness is reduced by 50%, the number of children appropriately diagnosed and treated was 
lower for the management of malaria (11 versus 15 children appropriately diagnosed and treated in 
a sample of 100 children) and suspected pneumonia (65 versus 72 children appropriately diagnosed 
and treated) than CHPS (data not shown in Table).  
Modifying the HBC effectiveness and the HBC and CHPS utilization had the highest effect on the 
cost per case appropriately diagnosed and treated. When increasing, and reducing, by 50% the 
number of cases appropriately diagnosed and treated, the cost for the management of malaria 
ranged from US$2.75 to US$6.03 and from US$0.12 to US$0.29 in the case of the management of 
diarrhoea. With respect to suspected pneumonia, the cost varied from US$0.20 to US$0.50 when 
increasing and reducing by 50% HBC and CHPS utilization.  
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Table 30. Sensitivity analysis to selected parameters of the cost per malaria, diarrhoea and suspected pneumonia case 
appropriately diagnosed and treated in children under-five under HBC and CHPS in the Volta Region (cost in US$) 
Indicators HBC CHPS HBC CHPS HBC CHPS 
 Average facility cost  More costly facility Less costly facility   
Costs per 1 child (ACT or quinine) 4.25 6.12 5.04 7.86 3.46 4.38 
Cost per 1 child (ORS and zinc) 0.18 1.12 0.21 1.51 0.15 0.71 
Costs per 1 child (amoxicillin) 0.27 1.69 0.28 2.30 0.26 1.05 
  3% discount rate 5% discount rate 7% discount rate 
Costs per 1 child (ACT or quinine) 4.25 6.12 4.33 6.30 5.56 6.8 
Cost per 1 child (ORS and zinc) 0.18 1.12 0.18 1.14 0.18 1.17 
Costs per 1 child (amoxicillin) 0.27 1.69 0.27 1.73 0.27 1.77 
  Average utilization  Higher utilization  Lower utilization  
Costs per 1 child (ACT or quinine) 4.25 6.12 3.94 5.58 5.14 7.62 
Cost per 1 child (ORS and zinc) 0.18 1.12 0.16 1.02 0.23 1.18 
Costs per 1 child (amoxicillin) 0.27 1.69 0.20 1.55 0.50 1.79 
  Average effectiveness Higher effectiveness Lower effectiveness 
Costs per 1 child (ACT or quinine) 4.25 6.12 2.75 5.99 6.03 6.25 
Cost per 1 child (ORS and zinc) 0.18 1.12 0.12 1.11 0.29 1.12 
Costs per 1 child (amoxicillin) 0.27 1.69 0.24 1.69 0.31 1.70 
 
 
 6.6.5. Affordability 
Table 31 shows the HBC average budgetary requirements from the provider perspective that should 
be consider for planning purposes at the actual performance level in the Volta Region. This cost 
could be lower if HBC utilization and the appropriate diagnostic and treatment given increases. To 
get an estimate of total HBC cost in the whole country per year (understanding that costs varies 
between regions as we observed regarding the Northern Region) similar exercise could be done 
using data from the other regions reported in the DHMDII and taking into consideration the lowest 
and highest cost obtained in the sensibility analysis. 
 
Table 31. HBC average budgetary requirements from the provider perspective in the Volta Region in 2014 (US$) 
  Malaria Diarrhoea Suspected pneumonia Total 
Average cost per case appropriately diagnosed and treated  4.19   0.16   0.26   
Number of cases treated in 2014  25,788.68   3,813.47   1,236.85   
Total in 2014  108,054.57   610.15   321.58  108,986.31 
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6.7. Discussion  
 
Before the adoption of the HBC and CHPS strategies in the Ghana Health System, RCT were 
conducted to assess their efficacy in Ghana (86, 230). In addition, another study was conducted to 
assess the cost-effectiveness of two strategies of HBC (ACT alone versus ACT and amoxicillin) 
(95), although without presenting the cost per fever treated under the standard care. My study used 
data from an observational study to analyse the cost per a malaria, diarrhoea and suspected 
pneumonia case appropriately diagnosed and treated in children under- five under the HBC and 
CHPS strategies after 2 and 8 years of HBC implementation in the Volta and the Northern Region 
respectively, and 10 years of CHPS implementation in both regions. Results from this evaluation 
might be used to improve HBC and CHPS implementation and to guide policy makers in the 
discussion about long term financing of HBC in Ghana.  
My results showed that HBC in the Volta Region was less costly than CHPS for the management of 
malaria, diarrhoea and suspected pneumonia, even after the sensitivity analysis modifying health 
facility costs, discount rates, HBC and CHPS utilization and HBC effectiveness. However, if the 
HBC effectiveness is reduced by 50% (understood as the number of children appropriately 
diagnosed and treated), HBC remains less costly but fewer cases were appropriately treated when 
compared with CHPS. Different HBC effectiveness and different HBC and CHPS utilization were 
the factors explored that most affected the cost.  
Although these results are country specific and cannot be generalised to other countries, they are 
coherent with the study conducted in Zambia (98) which concluded that the cost per case 
appropriately diagnosed and treated was US$4.22 in 2009 which was less than the cost at a health 
facility in the same year (US$6.61). Some differences however can be seen between the Zambia 
study and my study: the Zambia analysis was done from the provider perspective, used registries 
instead of survey data to assess the effectiveness, and RDTs were used within the HBC strategy. 
Excluding household costs could bias results in favour of CHPS (my study showed that household 
costs were higher when visiting a CHPS than a CBA). Using registries instead of surveys to collect 
effectiveness data could also introduce differences as discussed in Chapter 3: registers might suffer 
from uncompleted reporting and survey data might suffer from recall bias and misinterpretation of 
symptoms. Using RDT for the malaria HBC could increase HBC cost (due to staff time and 
laboratory costs) but drug costs might be reduced (if CHW adhere to RDT results).  
The cost per case appropriately diagnosed and treated was not conducted in the Northern Region 
due to the low numbers of carers visiting a CBA. However, the assessment of the curative 
component, the preventive component and the cost analysis showed differences in the HBC 
management, implementation and strategy between the Northern and Volta Region worth 
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mentioning. HBC programme costs in the Northern Region were higher than in the Volta Region, 
particularly due to the higher number of CBAs registered doing few preventive and curative 
activities (chapter 4, chapter 5 and DIMS II). In Chapter 4, I described the low HBC utilization in 
the Northern Region with about 41% of carers reporting that they do not know or they do not have a 
CBA in the community. In addition, I also mentioned that stock out of drugs could be a reason for 
the low HBC utilization and the low HBC and CHPS effectiveness. In Chapter 5, I showed that a 
lower proportion of carers in the Northern Region received health education messages from CBAs 
than carers in the Volta Region, in coherence with the annual activity reported in 2014 in the 
DHIMS2. Another difference with the Volta Region is the strategy of the HBC: HBC in the Volta 
Region targets only the most remote areas, while in the Northern Region all communities are 
targeted for HBC. As described in Chapter 4, carers having a health facility close to the house were 
less likely to visit a CBA, reducing HBC utilization and therefore increasing the cost per case 
appropriately diagnosed and treated. The Markov Model conducted in the study in Uganda also 
concluded that malaria HBC is attractive in areas with no access to standard care (96). These points 
determined the higher average costs per diagnosing and treating a malaria, diarrhoea and suspected 
pneumonia case under the HBC strategy in the Northern Region compared to the Volta Region, 
which were similar to those of the CHPS strategy in the Northern Region. If we consider the scale 
of the project, without considering the incentive package as this only happens at the beginning of 
the intervention, HBC in the Northern region remains more costly than HBC in the Volta Region.  
To reduce HBC cost in the Northern Region a focus must be done on improving the level of activity 
of CBAs by replacing inactive CBAs, increasing IEC activities and ensuring availability of drugs 
(as utilization of HBC or CHPS is a carers decision). In addition, targeting the rural areas to 
implement HBC in the Northern Region could be an option to reduce costs and to increase HBC 
utilization. However, the positive results of the preventive component particularly in the Northern 
Region (Chapter 5) should also be considered before deciding to target only remote areas.  
Long term financing is a cornerstone of HBC, often financed by health partners without a clear 
sustainability strategy. However, if HBC is affordable and its benefits worth it, other financial plans 
must be considered. In Ghana, the NHIS pays health providers for services included in the 
insurance benefit package. A criteria to include a service or strategy into the NHIS benefit package 
is its affordability and its potential value in paying these costs. My study provides information about 
how much it costs to appropriately diagnose and treat a malaria, diarrhoea and pneumonia case 
under the HBC and CHPS strategy in the Volta Region. These costs can be extrapolated to the 
whole Volta Region and to the rest of the country. Then, based on the available money and the 
potential value of paying these costs, a decision could be made on the long term financial plan. In 
Chapter 4 and 6 I showed that the curative component of the HBC strategy in the Volta Region 
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provided appropriate treatment to more people in need than CHPS (although still at unacceptable 
levels). In addition, HBC was able to reach the poorest, contributing to health equity. In Chapter 5 I 
described the association between the HBC preventive component and disease knowledge and 
healthy behaviours, such as identifying signs of severe pneumonia, children sleeping under 
mosquito nets, prompt seeking care and having safe faeces disposal in the Northern Region. In this 
Chapter I showed that household costs were lower under the HBC when compared to CHPS in both 
the Volta and the Northern Region. All these points should make the HBC strategy “attractive” to 
be included in the NHIS benefit package. However, the NHIS must have the money to finance this 
strategy without increasing too much the already high expenditure. I mentioned in Section 1.5 that 
in 2009-2013 the NHIS expenditures exceeded revenues (61-63). The 2014 and 2015 reports are not 
available on the website. Revising the whole NHIS benefit package as planned in 2014 (Concept 
Note for Stakeholder Dialogue on NHIS Benefits Package) and considering the HBC among the 
possible benefits based on the results of this study could be the right approach. From the point of 
view of implementation, it is important to reflect on how the NHIS could reimburse HBC activities. 
CHPS are facilities registered under the NHIS. CBAs curative activities reported to CHPS could be 
reimbursed by the NHIS as activities related to CHPS, which is informally happening already in 
some districts. If we also consider the preventive component of HBC (which is likely to be cost-
effective when compare to CHPS, although we only have data on its effectiveness), some IEC 
activities, particularly those done in partnership with CHPS under the Community- IMCI could also 
be reimbursed by the NHIS. This could help the sustainability of HBC, retain CBAs and improve 
the quality of the intervention. However, control measures must be put in place to avoid reporting 
false activity. Another issue to be considered is the acceptability, particularly of the CHPS and the 
NHIS. An acceptability study should be conducted to see how different actors see that approach.  
 
Limitations of the study 
The number of cases appropriately diagnosed and treated was obtained from a cross sectional study. 
Effectiveness data in economic evaluations are often recommended to be from RCT although there 
are limitations such as the comprehensiveness (only one source of data) and the short time horizons. 
To overcome these limitations, there is now a tendency to use data from systematic reviews or even 
better, from decision analytic modelling (108). This is true if one wants to prove the efficacy and 
efficiency of a new intervention. But if one wants to evaluate the effectiveness and cost-
effectiveness of a proven intervention in a real life, meaning evaluating its actual implementation 
like an ex-post HTA does, then data from a observational studies is more relevant (108, 212, 213) 
and it has been used in several studies in the UK, Asia and Africa (98, 231-235). 
  
128 
 
In chapter 2 I explained that I am conducting a cost analysis instead of a cost-effectiveness analysis 
for two reasons. First, because I needed to answer the question about how much it cost to assess the 
affordability of the programme for the NHIS. Secondly, because the effectiveness measure available  
is an intermediate outcome which might not be accepted to all economists (108). Using appropriate 
diagnosis and treatment as the effectiveness measure might bring some difficulties when 
summarizing results from each of the three diseases evaluated. In addition, this intermediate 
outcome doesn’t have a threshold to say that an intervention is cost-effective. Ideally, the 
government should be questioned about their willingness to pay per extra case appropriately treated. 
Case appropriately diagnosed and treated measures the quality of care given as it refers to 
adherence to guidelines. However, it doesn’t consider the outcome of death or disability (although I 
considered the cost of visiting a second provider in case the child didn’t recover). Even though I 
don’t expect that not considering death and disability might influence my results- no deaths or 
disability were reported-, using DALYs or QALYs might have solved the issue of the different end 
points of treatment. In addition, the use of DALYs/QALYs might allow comparison of my results 
with other diseases and studies.  
Case appropriately diagnosed in this study refers to adherence to guidelines and not to adherence to 
microscopy results (which cannot be performed at this community level). This means that the 
appropriate diagnosis of malaria under the HBC strategy refers to a child with fever, while in the 
CHPS refers to a child with a positive RDT or a child with fever if an RDT was not performed. 
Although some fever cases might be misclassified as malaria cases, this is something to consider 
when revising the HBC guidelines but not in this current study (which objective is to assess the 
HBC and CHPS implementation and the adherence to guidelines). 
Data from the cross-sectional study brought relevance to the evaluation but also brought limitations. 
Carers of sick children chose their providers based on different criteria (such as proximity, trust, 
availability or perceived severity of disease), reflecting the actual utilization of the services. This 
self-selection also affected the cost analysis: few carers of sick children chose to visit a CBA in the 
Northern Region. Due to these low numbers of carers visiting a CBA in the Northern Region it was 
not possible to conduct the cost per case appropriately diagnosed and treated. Self-selection is a 
factor to be considered when addressing cost analysis. Children with signs of more severe disease 
could have reached CHPS more often than HBC and received a more expensive treatment, reducing 
the cost per case appropriately diagnosed and treated of CHPS compared to HBC. However, this 
study aimed to conduct the cost analysis in the routine system, and therefore, this self-selection 
should be considered as part of the system and not as a source of bias. 
Sources of facility costs came from data of 2 CHPS in the Volta Region and 2 in the Northern 
Region. Although the analysis took into consideration average costs, and higher and lower facility 
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cost for the sensitivity analysis, it would have been better to have at least one more CHPS in each 
region to have a better representation of CHPS costs. Unfortunately, it was not possible to add 
another CHPS to the cost analysis. Finally, I mentioned in section 5.4.1 that the selection criteria for 
the CHPS facilities was average CHPS based on the activity reported and the number of personnel. 
In addition, being close to the communities being surveyed was also considered for logistic reasons. 
Considering that districts and communities were selected using probability proportional to size, I 
believed that the CHPS selected represent average CHPS facilities without introducing selection 
bias.  
 
6.8. Conclusions 
 
This study brought more light to the scarce evidence on the cost of appropriately diagnosing and 
treating a case under the HBC strategy. Diagnosing and treating a malaria, diarrhoea and suspected 
pneumonia case in children under-five was less costly than under CHPS in the Volta Region. High 
programme costs in addition to low curative and preventive activities made the HBC strategy in the 
Northern Region more costly than in the Volta Region. A revision of the HBC strategy in the 
Northern Region is needed to reduce HBC costs. This study brings necessary information to 
consider the inclusion of HBC in the NHIS benefit package as a long-term financing strategy. 
However, a revision of the NHIS benefit package and an acceptability study must be conducted 
before making such a decision.  
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Chapter 7. Discussion  
 
 
This study aimed to assess the programme implementation of two community- based interventions 
in Ghana (HBC and CHPS) to (i) improve national performance, (ii) guide discussions on the long-
term financing of HBC and (iii) contribute to the global evidence on community based 
interventions.  
In Chapter 2 I revised the current evidence about HBC for the prevention and management of 
malaria, diarrhoea and pneumonia, as well as methods and frameworks to evaluate health 
interventions. This review of evidence showed that there is extensive literature assessing the effect 
of HBC in Africa, mainly addressing the curative component of malaria HBC, under controlled 
circumstances and reaching few districts. The preventive component has been less explored and its 
cost-effectiveness has been barely addressed. There are limited but promising results on the effect 
of malaria HBC in reducing child mortality, but no evidence regarding diarrhoea and pneumonia 
HBC and child mortality in Africa. HBC can contribute to increasing appropriate treatment and 
prompt treatment even when diarrhoea and suspected pneumonia cases are integrated in the 
strategy. The few studies looking at the preventive component and the cost-effectiveness showed 
positive results regarding disease knowledge, adequate administration of drugs and on its cost-
effectiveness when compared with the standard care. Based on this evidence, I believed that 
assessing HBC under programme conditions, in large areas and after several years of 
implementation to be the appropriate next step, understanding that implementation issues may 
decrease the expected outcomes of the strategy. This should be a comprehensive evaluation, without 
focusing on only one aspect of the intervention and considering its continuity and coordination with 
other interventions. As HBC (and CHPS) are implemented throughout Ghana, the design of the 
study should ensure the attribution of results to the intervention. Therefore, I conducted an 
observational study, post implementation and without controls in two regions of Ghana to assess 
service utilization, appropriate treatment given, users’ satisfaction, carers’ disease knowledge, 
carers’ health behaviour and cost analysis. To attribute the outcomes to the delivery strategies under 
study, the questionnaire included question such us “where did you seek care”, “from where did you 
receive the drug”, “from where did you receive health promotion and preventive messages”, 
Chapter 3 describes in detail the methods used. 
 
In Chapter 4, 5 and 6 I presented the results of the study. Chapter 4 analysed the HBC and CHPS 
utilization, appropriate treatment given and user’s satisfaction with the services. Chapter 5 assessed 
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the association between health education messages from CBAs and CHPS’ nurses and carer’s 
disease knowledge and health behaviour. Chapter 6 presented the cost analysis for the appropriate 
diagnosis and treatment of a malaria, diarrhoea and suspected pneumonia case in children under- 
five under the HBC and CHPS strategies in Ghana. The summary of these results can be found in 
Table 32.  
 
Table 32. Summary of results of HBC and CHPS strategies by outcomes explored 
Indicators HBC CHPS 
Utilization of HBC/CHPS strategies associated with children from 
the poorest households 
In the Northern 
Region 
 
Strategy that provided appropriate treatment for malaria to the 
highest percentage of children that visited a CBA or a CHPS 
In the Volta Region  
Strategy that provided appropriate treatment for diarrhoea to the 
highest percentage of children that visited a CBA or a CHPS 
In the Volta Region  
Strategy that provided appropriate treatment for suspected 
pneumonia to the highest percentage of children that visited a 
CBA or a CHPS 
 In the Northern 
Region 
Strategy associated to the highest number of disease knowledge 
and health behaviour indicators explored 
In the Northern 
Region 
 
Strategy with the lowest household costs per malaria, diarrhoea 
and suspected pneumonia case diagnosed and treated  
In the Volta and 
the Northern 
Region 
 
Strategy with the lowest total costs per malaria, diarrhoea and 
suspected pneumonia case diagnosed and treated 
In the Volta Region  
Strategy with the lowest total cost per case appropriately 
diagnosed and treated (analysis only conducted in the Volta 
Region) 
In the Volta Region   
 
7.1. HBC and CHPS utilization 
 
This study showed (i) an increased trend in care seeking behaviour in Ghana when compared with 
previous surveys, (ii) an important use of community health interventions, with 30% of carers using 
HBC or CHPS (iii) a surprising low HBC utilization in the Northern Region and (iv) the capacity of 
HBC in the Volta Region to reach the poorest, improving equity on health care utilization.  
Care seeking behaviour for children presenting with fever, diarrhoea or cough in the two weeks 
prior to the survey was high, (about 93% in both regions). If only seeking care from formal health 
facilities (public or private) is considered, 52.2% and 72.7% of cares in the Volta and Northern 
Regions sought care. If CBAs and licensed chemical sellers are also considered appropriate 
providers, about 89% of carers in both regions sought care from an appropriate provider. This study 
found a higher care seeking behaviour than the 2011MICS and 2014DHS (57, 203) while being 
coherent with the increased trend in care seeking behaviour in Ghana. It also had a higher care 
seeking behaviour when compared with other studies conducted about 15 years ago in Africa that 
showed that fewer than 20% of febrile episodes and deaths arrive at any formal health system, and 
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more than 70% of malaria episodes in rural areas and more than 50% in urban areas are self-treated 
in Africa (236-239). 
About 30% of carers went to a community health provider when their child was sick in both 
regions, contributing to the increase in care seeking behaviour in Ghana. However, important 
differences can be seen between HBC and CHPS utilization in the Northern and the Volta Region. 
HBC was reasonably used in the Volta Region although with large variations between districts 
(17.3% of carers of sick children went to a CBA) while CHPS was slightly less used (11.8%). HBC 
utilization in the Northern Region was surprisingly low (1%) although HBC was implemented for a 
longer time than in the Volta Region, while CHPS compounds were the provider more utilised 
(31.3%). A qualitative study to identify barriers and enablers of HBC utilization could help to 
explain why HBC utilization is low in the Northern Region, but unfortunately, this study was not 
possible to conduct. This low HBC utilization in the Northern Region was also found in the LQAS 
survey conducted in the 3 northern regions of Ghana (153). Recent HBC evaluations conducted in 
Ethiopia, Burkina Faso and Malawi also showed low HBC utilization, ranging from 2 to 11.5% 
(240, 241). Authors of these studies believe that the reason for this HBC low utilization was low 
implementation coverage (in terms of deployment of community health workers and drugs) and 
weak strategy on community entry and sensitization on HBC. Other studies conducted in Africa 
showed a higher malaria HBC utilization, ranging from 21% to 76% (87, 88, 193, 242), probably 
due to shorter time implementing the strategy and a focus on few districts instead of the whole 
region. In terms of CHPS utilization in the Northern Region, the LQAS survey showed a lower 
utilization than my study (between 6-10% of carers visited a CHPS when the child was sick) (153), 
probably due to differences in the sampling (the LQAS survey purposely selected some districts 
while our study included all districts in the Northern Region).  
HBC was able to reach the poorest in coherence with its pro- poor intervention. In addition, carers 
of children older than 6 months more often visited a CBA than carers of children younger than 6 
months as the national guideline states. Lastly, carers that lived far from any type of health facility 
were more likely to use HBC, which has implications for HBC planning. In the Northern Region, 
proximity to a CHPS was found to be associated to CHPS utilization. Based on the utilization of 
these community strategies and on the predictors of HBC and CHPS utilization, one would wonder 
if both HBC and CHPS are needed in the Northern Region. The effect of the curative and 
preventive component of both strategies and the cost analysis will help to answer this question.  
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7.2. Appropriate treatment given and carers’ satisfaction 
 
Appropriate treatment given for fever, diarrhoea and suspected pneumonia was low in both, HBC 
and CHPS, in the Volta and Northern Regions. The effectiveness of HBC and CHPS 
implementation in the programme context, with less supervision and at a larger scale can be lower 
than expected. 
The proportion of children that received appropriate treatment was highest for the management of 
non-complicated malaria cases for those visiting a CBA in the Volta Region and a CHPS compound 
in the Northern Region, where 36.7% and 35.9% of cases receive ACT or quinine respectively. This 
was followed by the management of suspected pneumonia cases under the CHPS strategy in the 
Northern Region where 33% of cases received amoxicillin or co-trimoxazole. When other 
antibiotics with an effect on the respiratory tract infections are considered, then 50% of cases 
received an antibiotic. Prescribing both ORS and zinc, for the treatment of malaria was almost non-
existent.  
The low appropriate treatment found in my study contrasts with results of many studies described in 
Annex 1 showing that malaria HBC has the potential to provide appropriate treatment at community 
level. Most of these studies however were well supervised being in the context of RCTs (84, 167, 
170, 243-245), had shorter implementation periods, or had been implemented in small areas (87, 88, 
98, 246, 247). However, my results suggest that the effectiveness of HBC implementation in the 
programme context, with less supervision and at a larger scale can be lower than expected. Another 
study conducted in Burkina Faso (126) with less supervision had similar results (54% of febrile 
children received ACT from a CBA). With regards to diarrhoea treatment, my results were similar 
to those of the LQAS survey (153), 2011 MICS (203) and 2014 DHS (57). With regards to the 
management of suspected pneumonia, two studies conducted in Kenya (post studies without control 
of 1 year and 5 years of duration) showed similar low results as my study (248, 249)  while other 
studies, (4 RCT and one post study without control of 1 year) showed better results (167, 175, 244, 
245, 250). Although methods and data collection tools might influence results (household surveys 
versus CMD distributers registers and observation), studies with stronger supervision often have 
better results as mentioned above.  
Recognising that 30% of the population used these community interventions which are actually 
reaching the poorest (particularly the HBC), it is imperative to increase the appropriate treatment 
given in both interventions if a reduction in mortality and morbidity of children under- five is 
desired. This means that a focus on quality of care is key. Some recommendations can be made 
based on the results described above to improve HBC performance. It seems that there is a problem 
with the availability and recognition of CBAs in the Northern Region. Districts should make more 
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efforts in monitoring CBAs and in replacing them if they are not actively working. The CBAs 
monthly reports and the district quarterly monitoring visits planned according to policy, might help 
to monitor HBC utilization and CBA performance. Ensuring the availability of drugs for the HBC 
and CHPS is another critical problem that must be addressed. Training and supervision will not be 
effective if drugs are not available. Once availability of CBAs and drugs are addressed, integrated 
supervision should always be promoted and coordinated (251).    
 
7.3. Carers’ disease knowledge and health behaviour 
 
This study showed that exposure to both ice and CHPS health education messages were associated 
with disease knowledge and health behaviour, with health messages from CBAs being the predictor 
associated with a higher number of outcomes, particularly in the Northern Region.  
 Exposure to health messages from CBAs in the Northern Region were associated with the 
identification of at least 2 signs of severe malaria and pneumonia, the latter was also found to be 
associated with prompt care-seeking, and 2 practices that can cause diarrhoea. HBC utilization was 
associated with prompt care seeking behaviour in the Volta Region. CHPS were associated with the 
identification of at least 2 signs of severe diarrhoea in the Volta Region and with prompt care 
seeking behaviour in the Northern Region. Regarding other healthy behaviours, CBA messages had 
a borderline association with children under- five sleeping under mosquito nets in the Northern 
Region and with having an improved sanitation facility in the Volta Region. Even though, there are 
other study designs to better assess the effect of an intervention (such as RCT, quasi experimental 
studies and cohort studies), the numerous associations found between CBAs messages and disease 
knowledge and health behaviour after adjusting for known potential confounders suggest the 
plausibility of this findings.  
HBC studies tend to focus more on the curative component than on the preventive component. 
However, the few studies that have reported on carers’ disease knowledge also found increased 
carers’ knowledge of signs of severe disease (88, 192-194). Studies evaluating the IMCI strategy 
considered the 3 components of the strategy, which are case management, supply chain and family 
practices. On the family practices component, carer’s disease knowledge was also assessed in 
Bangladesh and Tanzania, concluding that carers in IMCI areas that perceived signs of severe 
disease were more likely to seek prompt treatment (52, 204). The preventive component of HBC 
and the family practices component (also called Community-IMCI) have many aspects in common. 
Actually, HBC in Burkina Faso, Malawi, Niger and Mozambique is also called community- IMCI. 
Peru and Brazil used community health workers to implement the community-IMCI in the same 
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way that HBC is implemented by community health workers. In the case of Ghana, HBC in its 
origins in the Northern Region was also called community- IMCI.  
Results from this study contribute to evidence of the importance and the benefits of health 
communication. It also highlights the importance of including the preventive component in HBC 
evaluations which also contributes to its costs and to the impact on health outcomes. Integration of 
interventions could be beneficial: HBC is the ideal partner or delivery strategy for community-
IMCI. HBC could help the facilities implementing IMCI to promote the household and family 
practices. This partnership could also benefit HBC as the communication between both (CBAs and 
nurses) might increase, bringing an opportunity for CBAs to be more recognised and to find more 
spaces to address the difficulties encountered implementing HBC, such us supply chain, availability 
of IEC materials or any challenge in case management or in reporting. Finally, and to increase 
integration and coordination of both community interventions, the Ghana Health Service could 
revise its organisation and consider one programme to be in charge of both iCCM and IMCI 
strategies. 
  
7.4. HBC and CHPS cost analysis 
 
This cost analysis has the same approach as the ex-post HTA that aim to assess an ongoing 
intervention to help policy makers decide to continue or discontinue it. Knowing the cost per case 
appropriately diagnosed and treated under programme conditions is critical when discussing about 
affordability and the long-term financing of HBC.  
HBC in the Volta Region was found to be less costly than CHPS for the management of non-
complicated malaria, diarrhoea and suspected pneumonia cases even after adjusting for different 
discount rates, different facility cost, different HBC and CHPS utilization and different HBC 
effectiveness (understood as number of children appropriately diagnosed and treated). Different 
HBC and CHPS utilization and different HBC effectiveness were the factors explored that most 
affected the cost, reducing or increasing it. Therefore, and as mentioned above, ensuring that CBAs 
are active and have a supply of drugs is a priority if one wants to ensure the affordability and 
sustainability of HBC. 
Due to the low number of carers visiting a CBA in the Northern Region it was not possible to 
conduct the cost per case appropriately diagnosed and treated. However, the unit cost per case 
diagnosed and treated showed that a higher number of CBA combined with lower curative and 
preventive activity made the intervention more costly than the HBC in the Volta Region and than 
CHPS. However, household costs were lower under HBC than under CHPS in both regions, 
reducing the burden of health care cost on families.  
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7.5. Conclusions 
 
The community was an important source of treatment for children with fever, diarrhoea and cough, 
contributing to an increased trend in care seeking behaviour when compared with previous surveys. 
However, the utilisation of HBC was almost non-existent in the Northern Region. HBC in the Volta 
Region was more used by the poorest and when households were far from a health facility. 
Appropriate treatment was low in both strategies and less than 50% of the sick children received 
appropriate treatment for malaria, diarrhoea and suspected pneumonia. Both HBC and CHPS had a 
positive influence in improving disease knowledge and healthy behaviour. However, this influence 
was higher for the HBC strategy, and higher in the Northern Region. The cost per case 
appropriately diagnosed and treated was lower under the HBC when compared with CHPS in the 
Volta Region. HBC unit costs to diagnose and treat a case in the Northern Region were higher than 
those in the Volta Region (and higher than CHPS), mainly due to higher number of CBA 
performing less preventive and curative activities. However, household costs were lower under 
HBC than under CHPS in both regions, reducing the burden of health care cost on families. 
These findings have different programme and policy implications. From a programme perspective, 
several actions should be undertaken to improve HBC and CHPS performance. Availability of 
drugs and availability of CBAs (particularly in the Northern Region) seem to be the main 
challenges that need to be urgently addressed. Secondly, the low HBC preventive activity found in 
the Northern Region should be addressed and increased to maintain the positive effect of the 
preventive component.  
From a policy perspective and with regards to the long- term financing of HBC, it seems that there 
are reasons to justify the financial support of the HBC strategy- even if it is more costly than CHPS-
based on the different benefits that I already mentioned. The contribution of HBC to equity, reduced 
household costs, disease knowledge and healthy behaviours may justify the inclusion of HBC 
(preventive and curative services) in the NHIS benefit package. A revision of the NHIS benefit 
package to assess the affordability of HBC and an acceptability study of including HBC in the 
NHIS should be the next steps to evaluate.  
Finally, it is important to be aware that the utilization of HBC to obtain treatment might be reduced 
with the improvement in CHPS coverage or with carers’ preference for CHPS services. In this 
scenario, and acknowledging the results of the preventive component, HBC could focus on the 
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preventive component, becoming a strategy to promote healthy community and family practices 
without providing treatment. In other words, HBC would remain as implementer of the community 
-IMCI. The close relationship between HBC and community-IMCI and the need for coordination 
made obvious the next recommendation: a revision of the Ghana Health Service organogram, 
assigning the HBC and CHPS strategies under the same umbrella.   
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Annex 1. Summary of studies showing Malaria Home- based Care effect on under- five morbidity and mortality. 
Systematic review 2007. Studies with presumptive treatment with chloroquine. Inclusion criteria: (i) antimalarial treatment administered presumptively; (ii) administered by 
local community members; (iii) outcomes measures were specific health indicators; (iv) Africa. 
 
Country/ Year/ Study design 
and duration/ Data collection 
Epidemiology  Drug distribution  Incentive  Outcomes measured Results 
Kenya, 1987 (252) 
Before and after study with 
control (1 year):  Health 
demographic surveillance and 
parasitemia/antibodies surveys 
• Rural 
• Hyper- to holo-
endemic 
 
Community Health 
Workers (CHWs) 
provided presumptive 
chloroquine (CQ) 
treatment for free 
Volunteer CHWs 
supported by the 
village 
•Overall and malaria-
specific mortality 
• Birth and fertility rates 
• Parasite rates 
No obvious effect of providing CQ 
for treatment of malaria on mortality, 
fertility, or parasite rates 
The Gambia, 1988(69);  
Before and after study with 
control (5 years): Health 
demographic surveillance and 
parasitemia/hemogram surveys 
• Rural 
• Seasonal 
Transmission 
CHWs sold CQ alone 
versus CQ with 
chemoprophylaxis for 
presumptive 
Treatment 
Volunteer CHWs 
supported by the 
village 
 
• Overall and malaria-
related mortality 
• Frequency of clinical 
malaria 
• Packed cell volume, 
parasite rates, 
splenomegaly 
Treatment alone had no significant 
effect on morbidity and mortality 
from malaria 
 
Zaire (DRC), 1996 (253) 
Before and after study with 
control (2 years):  Health 
demographic surveillance and 
parasitemia surveys 
• Rural 
• Meso-endemic 
• Continuous 
transmission with 
seasonal 
fluctuations  
CHWs sold CQ at 
cost for presumptive 
treatment  
 
CHWs received 
"symbolic monetary 
reward"   
 
• Malaria mortality 
• Malaria incidence and 
prevalence 
• Proportion of fever 
episodes receiving 
antimalarial treatment  
• No impact on malaria mortality, but 
two-fold reduction in malaria 
prevalence and incidence. 
• Number of malaria episodes that 
remained untreated decreased 
significantly by 7% points.  
 
Burkina Faso, 1997 (242) 
Before and after study without 
control (2 years): HHsurveys, 
Health Facility registers 
• Rural 
• Seasonal 
transmission 
 
• CHWs sold pre-
packaged 
CQ for presumptive 
treatment 
CHWs kept US$0.6 
for each package 
sold 
 
• HBC utilization 
•% of under-5 severe 
malaria cases recorded in 
health facilities. 
• Availability of drugs at 
peripheral level 
• 76% went to CHW. 
• The % of severe cases decreased in 
the first year of the program; in the 
second year, the proportion decreased 
only in health facilities with drug 
coverage ≥50%. 
• 51.2% health facility drug coverage. 
Ethiopia, 2000 (254). 
RCT (2 years): health 
demographic surveillance 
• Rural 
• Seasonal 
transmission 
Mother coordinators 
provided presumptive 
CQ treatment for free 
None mentioned Malaria-related mortality 
in children under 5 years 
old 
Intervention associated with 40.6% 
reduction in overall under-5 mortality 
(95%CI 29.2–50.6, p < 0.003). 
Burkina Faso, 2003 (126) 
Post study without control (2 
years): HHsurveys 
• Rural 
• Hyperendemic 
• Seasonal 
transmission 
• Mothers trained to 
recognize illness and 
make decision to treat 
• CHWs sold CQ for 
presumptive treatment 
• Drugs sold with 
10% incentive 
margin for CHW. 
• Incentive provided 
to some drug store 
managers. 
• Proportion of malaria 
cases progressing to 
severe  
• Prompt treatment 
•Appropriate dose 
• Risk of progression to severe 
malaria was lower in children treated 
promptly with pre-packaged CQ (5%) 
than not treated (11%); (RR 0.47, 
95%CI:  0.37– 0.60, p < 0.0001) 
• 56% prompt treatment 
• 52% appropriate dose 
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Systematic review 2013. Studies with presumptive treatment with chloroquine, SP, ACT or after a positive RDT. Inclusion criteria: RCT and non-RCT (controlled before-
after studies and interrupted –time-series) that evaluated the effects of HBC.  
Kenya, 1987. 
Before and after study with 
control 
Included in the first systematic review 
 
 
 
Zaire (DRC), 1996 
Before and after study with 
control 
Included in the first systematic review 
Ethiopia, 2000. RCT Included in the first systematic review 
Burkina Faso, 2008 (243) 
RCT (2 years): Community 
drug distributers (CDD) 
registers and HH surveys 
• Rural 
• Holoendemic 
• Seasonal 
transmission 
Women leaders sold 
CQ 
Not mentioned • Anaemia prevalence 
• Appropriate treatment 
 
• No effect on anaemia prevalence. 
• Increase in treatment from 36.9% to 
86% (p=0.002) in intervention group. 
P=0.71 in control group. 
Uganda, 2007 (127). 
Before and after study with 
control (2 years); HHsurvey 
Rural 
Malaria 
transmission from 
holoendemic to 
hyperendemic 
CHWs giving pre-
packaged 
CQ/Sulphadoxine- 
Pyrimethamine (SP) 
for free 
Not mentioned • Appropriate treatment 
• Prompt treatment. 
• Proportion of fevers 
treated with adequate 
dosage of antimalarials 
• Proportion of fevers 
treated with adequate 
duration of antimalarials 
• Improvement in the proportion of 
patients completing all steps: treated, 
treated within 24 h of illness onset, 
treated with the recommended 
antimalarials, treated at an adequate 
dosage and treated for the correct 
duration. In global, 10.4% 
improvement in the community 
effectiveness of malaria treatment 
Uganda, 2009 (170) 
Cluster RCT (2 years): 
HHsurveys 
Urban 
Meso endemic, 
perennial 
Caregivers giving 
ACT 
Not mentioned • Proportion of fevers 
receiving any 
antimalarial 
• Proportion of fevers 
that received prompt and 
effective treatment. 
• Prevalence of 
parasitemia 
• Prevalence of anaemia 
• Mortality 
• 97% versus 42% in the intervention 
and control (p<0.0001) received any 
antimalarial. 
• 58% versus 8% % in the 
intervention and control (p<0.0001) 
received prompt and effective 
treatment.  
• 2% versus 10% parasitemia 
prevalence in the intervention and 
control (p<0.006). 
• No differences in anaemia 
• Not possible to assess mortality 
Tanzania, 2010 (255) 
Cluster RCT (1 year): HH 
surveys 
• Rural 
• Holoendemic 
• Seasonal 
transmission 
CHWs and women 
leaders giving SP for 
free 
Women leaders were 
paid US$20 per 
month 
Anaemia prevalence Decrease in anaemia prevalence 
slightly more in the intervention 
(from 43.9% to 0.8%) than in the 
control (30.8% to 0.17%) group 
(p=0.038). 
Tanzania, 2011(171) 
Cluster RCT (6 months): CDD 
• Rural 
• High malaria 
CHWs with RDT and 
ACT for free versus 
US$15 per month • Proportion of fever 
treated (using RDT or 
• ACT was provided to 53.2% 
patients during RDT weeks and to 
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registers with lab test. endemicity 
• Seasonal 
transmission 
ACT for clinical 
diagnosis (CD) 
clinical diagnosis) with 
ACT 
•Mortality 
96.5% patients during CD weeks (OR 
0.039, 95%CI 0.029–0.053). 99.3% of 
positive cases received appropriate 
treatment. 
•No mortality observed due to 
negative RDT 
Zambia, 2010 (167). 
Cluster RCT (1 year): CDD 
registers, HH surveys. 
Rural 
Hyper endemic  
Seasonal 
transmission 
CHWs doing RDT 
and giving ACT and 
amoxicillin for free 
compared to CHWs 
giving ACT with CD 
and amoxicillin 
Not mentioned • Appropriate treatment 
• Mortality 
 
• 27.5% and 99.1% of children with 
fever received appropriate treatment 
in the intervention and control arm 
(RR 0.23, 95%CI 0.14–0.38). 68.2% 
and 13.3% of children classified with 
non-severe pneumonia received early 
appropriate treatment in the 
intervention and control arm (RR 
5.32, 95%CI 2.19–8.94). 
• No power to detect effect on 
mortality. 
Kenya, 2011(34) 
Cluster RCT (1.5year)  
HH surveys. 
• Rural 
• High malaria 
endemicity 
Retail outlet staff 
giving subsidized 
ACT 
Same salary they 
were having 
• % of children with 
fever that received AL 
• % of children with 
fever that receive AL 
within 24 hours 
• Difference of 26.4% points between 
arms receiving AL (p<0.05).  
• Difference of 25% points between 
arms receiving AL in the first 24h 
(p<0.05). 
Systematic review 2014. Studies were included if they involved evaluation of an intervention to introduce or improve community-based management.  
Inclusion criteria: (i) studies conducted in sub-Saharan Africa; (ii) From 2000; (iii) randomized controlled trials (RCT), clustered RCTs, pre-post studies with or without 
control, interrupted time series designs, qualitative and cost effectiveness studies. Only studies reporting performance are included in this table. 
Ethiopia, 2000 RCT Included in the first and second systematic review 
Kenya, 2001(248). Post study 
without control (3 years): 
observation.  
Rural  CHW provided 
cotrimoxazole, SP and 
ORS 
 Appropriate treatment % of children receiving an antibiotic, 
antimalarial or oral rehydration 
solution, depending on the child’s 
disease classifications) were 57.8%, 
35.5%, and 
38.9%, respectively, for children with 
a severe classification 
Burkina Faso, 2003 Included in first systematic review 
Mali, 2003 (192) 
Cluster RCT (1 year): 
additional training and IEC 
materials to improve 
performance. HHsurvey and 
CDD registries. 
Rural CHW distribute CQ  •Disease knowledge 
 
 
•Counselling 
•Appropriate treatment 
 
 
•Compliance with 
• Fever more than 1 day and 
convulsions more often recognised as 
severe signs in the intervention group 
(p<0.001). 
• 82% and 57% of carers knew how to 
administer the drug in the intervention 
and control group.  
• 59% and 48% (p<0.05) gave 
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referrals appropriate treatment in the 
intervention and control group. 
• 64% and 86% complied with 
referrals in the intervention and 
control group. 
Uganda, 2004(193) 
Before- after with control (1 
year):  household survey, 
health facility survey and CDD 
registers. 
Rural  
High malaria 
endemicity 
CHW distribute 
CQ/SP 
Not mentioned •Disease knowledge. 
 
 
•Use of ITN 
 
•Prevalence of malaria 
 
•Prevalence of anaemia 
 
•HBC utilization 
•Prompt care seeking  
•Counselling received 
•Appropriate treatment 
• 45% versus 22% (p<0.5) recognise 
convulsions as sign to seek care 
immediately in intervention and 
control arm. 
• Increase in used of ITN in 
intervention areas from 2002 to 2003 
(p < 0.01). 
• 10% point reduction in malaria 
prevalence (p>0.05) in intervention 
group. 
• Decline in severe anaemia levels in 
the interventions areas (p<0.01) 
• 21% HBC utilization in intervention 
areas 
• No differences between groups 
• No differences between groups 
• 37% and 7% of sick children 
received treatment in the intervention 
and control group 
Ghana, 2006(84) 
Before-after without control 
(less than 1 year): FGD, 
survey, CMD registers. 
Rural  
High malaria 
endemicity 
CHW distribute ACT Not mentioned •Promptness in seeking 
care 
•Appropriate treatment 
•Seeking care elsewhere 
after HBC 
• 89.5% sought care after 1 day of 
symptoms. 
•92% of sick children visiting HBC 
received appropriate dose. 
• 3.9% sought care elsewhere. 
 
Uganda, 2006(256) 
Post study without control (5 
months): CDD registers and 
carers interview, health facility 
records.  
Rural CHW distribute 
CQ/SP 
Not mentioned • Promptness in seeking 
care 
• % referrals 
• Compliance with 
referrals 
• 68% sought care promptly 
• 8% were referred 
• 87% complete referral 
Uganda, 2007 Included in second systematic review 
Four African sites (Ghana, 
Nigeria and Uganda), 2008(87) 
Post study without control (1 
year): survey, CDD registers, 
focus group discussions (FGD) 
and interviews.  
Rural and urban 
High malaria 
endemicity 
CHW distribute ACT Between US$4.5-8 
every quarter. 
• HBC utilization 
• Appropriate treatment 
• Prompt treatment 
 
Average results from the 4 sites: 
• 59% of carers with sick children 
used HBC  
• 85% of those receiving ACT from 
HBC received correct dose and 
duration. 
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• 90% of those receiving ACT from 
HBC were promptly treated. 
Burkina Faso, 2008(243) Included in the second systematic review 
Rwanda, 2008(246) 
Post study without control (1 
year): CDD survey, FGD, 
observation, exit interviews, 
simulation clients, interviews. 
Rural 
Endemic and non-
endemic areas 
CHW distribute ACT  Revenues from sales •Referrals with form 
•Appropriate treatment 
•Carers advice 
 
•Carers satisfaction 
• 70% 
• 92% received appropriate dose 
• High in how to take the drug, lower 
in when to come back 
• 7% dis-satisfied 
Sudan, 2008(257) 
Before- after study without 
control (8 months):  household 
survey, FGD, interviews and 
CDD registers. 
Rural  
Hypo to meso-
endemic malaria 
prevalence 
CHW distribute ACT 
with RDT 
Consultation fee of 
US$0.5 
•Treatment seeking 
behaviour. 
 
 
•Appropriate treatment 
•Use of preventive 
measures 
 
•  83.3% and 100% of the mothers 
sought treatment for their febrile child 
at the beginning and at the end of the 
study (p=0.099) 
•  70% treated accordingly to RDT 
results 
• 65% of CHW carried out awareness 
activities. 
 
Zambia, 2008(258) 
Post study with control 
(different type of RDT 
instructions) (3h): observation. 
Rural  
Endemic malaria 
prevalence 
CHW distribute ACT 
with RDT 
Not mentioned •RDT performance 
 
 
 
•RDT interpretation 
• 57%, 80% and 90% of CHW that 
received only instruction, job-aid and 
job-aid plus training respectively 
performed the 16 steps correctly 
(p<0.05). 
• 54%, 82% and 93% of CHW that 
received only instruction, job-aid and 
job-aid plus training respectively read 
RDT results correctly (p<0.05). 
Cameroon, Nigeria and 
Uganda, 2008(259). Post study 
with control (3 years): 
Quantitative and qualitative 
methods including surveys. 
Rural 
High endemicity 
ACT in Cameroon 
and Nigeria and CQ-
SP in Uganda 
 •Prompt appropriate 
treatment 
 
•Having ITN and 
sleeping under ITN 
 
• Children receiving Vit 
A 
•Population receiving 
ivermectin 
•DOTS completion rate 
 
• 69% and 16.4% of sick children 
received prompt treatment in the 
intervention and control group 
(p<0.05). 
• 33.4% and 16% of children under 5 
slept under mosquito nets in the 
intervention and control group 
(p<0.05). 
• 90% and 81% Vit A coverage in the 
intervention and control group 
(p=0.01). 
• 73.7% and 63.8%of population 
receiving ivermectin in the 
intervention and control group 
(p<0.5). 
• No significant differences: 87.6% 
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and 90% DOTS completion rate in the 
intervention and control group.  
Rwanda, 2009(247). Post study 
without control (3 months): 
CDD registers, observation, 
interviews. 
Rural CHW distribute ACT, 
ORS and Amoxicillin 
 •Appropriate treatment • 84.8%, 72.1% and 79% of children 
with fever, diarrhoea and pneumonia 
received appropriate treatment. 
DR Congo, 2009(260). 
Post study without control (1 
week): test and observation. 
Rural  
High malaria 
endemicity 
CHW distribute ACT 
with RDT 
% profit of activities •RDT performance 
•RDT cost effectiveness 
• Median of 100% performed and 
interpreted correctly the test.   
• Because malaria prevalence was 
high (87% with RDT and 88% with 
microscopy), RDT were not cost-
effective. 
Uganda, 2009 Included in second systematic review 
Tanzania, 2010.  
Cluster RCT 
Included in the second systematic review 
Ethiopia, 2010(91) 
Before- after with control 
group (2 years): CDD registers, 
health facility registers and HH 
survey. 
Hypoendemic 
Rural and urban 
CHW distribute ACT 
with RDT and without 
RDT  
Not mentioned • Malaria prevalence 
 
 
• All-cause mortality 
 
• Malaria mortality 
• Lower malaria prevalence in 
intervention group (7.4% (95% CI: 
6.1–8.9%) versus 20.8% (95% CI: 
18.7–23.0%) in the control group. 
• No difference in both groups (RR= 
1.03, 95%CI 0.87–1.21, P = 0.751). 
• Lower mortality in intervention (RR 
0.60, 
95%CI 0.40–0.90, P = 0.013). 
Zambia, 2010(167) 
Cluster RCT 
Included in second systematic review 
Five African sites (Ghana, 
Burkina Faso, Ethiopia and 
Malawi), 2011(88) 
Before- after without control (1 
year): Survey, CDD registers, 
FGD and interviews 
Urban 
High malaria 
endemicity 
CHW distribute ACT, 
2 sites with RDT 
Not mentioned •Malaria signs 
knowledge 
•HBC utilization 
•Appropriate treatment 
•Prompt treatment 
Average results from the 5 sites: 
• 3/5 sites improved in disease 
knowledge 
• 40% of carers with sick children 
used HBC 
• 82% of sick children visiting HBC 
received ACT  
• 69% of those receiving ACT from 
HBC were promptly treated 
Zambia, 2011(98) 
Cost effective analysis, HBC 
versus health facility-based (1 
year): CDD and facility 
registers 
Rural 
Moderate malaria 
transmission 
CHW distribute ACT 
with RDT 
Not mentioned •Appropriate treatment 
(ICER reported in table 
2) 
•100% in HBC and 43% in health 
facility-based 
Tanzania, 2011(261) 
Post study without controls (1 
Rural  
High malaria 
CHW distribute ACT 
with RDT 
Not mentioned • Parasite cure rate (using 
PCR) 
• PCR corrected parasitological cure 
rate by day 42 was 93.0% (95%CI 
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year): CDD registers and 
parasitological cure rate 
endemicity • AL blood levels 
 
88.3%-95.9%).  
• Median AL concentration was 
statistically significantly lower in 
patients with recrudescence (97 
ng/mL [IQR 0-234]; n = 10) 
compared with reinfections (205 
ng/mL [114-390]; n = 92), or no 
parasite reappearance (217 [121-374] 
ng/mL; n = 70; p ≤ 0.046). 
Tanzania, 2011(262) 
Post study, no control (children 
visiting CHW, 4.5 years) and 
HH survey (3 years) 
Rural  CHW distribute ACT 
with RDT 
 •RDT sensitivity and 
specificity 
 
•Pre and post RDT 
appropriate treatment 
• 88.6% and 88.2% sensitivity and 
specificity of RDTs in the cohort 
study.  63.4% and 94.3% in the HH 
survey. 
• 98.6% and 96.6% of children 
received appropriate treatment. 
Tanzania, 2011. Included in second systematic review 
Sierra Leone, 2011(263) 
Post study without control (2 
years): CDD and HF registers 
Rural 
High malaria 
endemicity 
CHW distribute ACT 
with RDT 
Not clear •Compliance with 
referrals 
•1.5% referral completion rate 
 
Zambia, 2012(264) 
Post study without controls (1 
year): observation 
Rural  CHW distribute ACT 
with RDT 
 • RDT performance 
 
 
 
 
• RDT interpretation 
• 88% performed correctly the 8 steps 
at 3-month post training and 100% at 
6 and 12 months. 
• 96.5% of positive tests were 
correctly identified at 3 months, 
98.3% at 6 months and 90.5% at 12 
months. 
Senegal, 2012(92) 
Before after with controls (1 
year): CDD registers and 
routine data  
Rural  
High malaria 
endemicity 
CHW distribute ACT 
with RDT 
Non-monetary 
incentives 
• Appropriate treatment 
•All cause child mortality 
 
• Malaria mortality 
• 96.6% of + tests were treated and 
cured. 
• Significant decrease in intervention 
area (-5.4%, 95%CI -25.4, -5.4). 
• Significant decrease in intervention 
area (-62.5%, 95%CI −81.2, -43.8). 
Ghana, 2012(86) 
Cluster RCT (3 years): health 
demographic surveillance, 
parasitemia surveys 
Rural  
Moderate malaria 
prevalence 
CHW distribute ACT 
or ACT+Amoxicillin 
Non-monetary 
incentives 
•Child mortality • Mortality reduced significantly by 
30% (RR = 0.70, 95% CI 0.53–0.92, 
P = 0.01) in AAQ clusters and by 
44% (RR = 0.56, 95% CI 0.41–0.76, 
P = 0.01) in AAQ+AMX.  
Differences in mortality between 
AAQ and AAQ+AMX not 
significant: RR = 0.79, 95% 
CI = 0.56–1.12, P = 0.195. 
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Malawi, 2012(265) 
Post study without control 
(18months): observation, gold 
standard re-assessment and exit 
interviews. 
Rural  CHW distribute ACT, 
ORS and Amoxicillin 
 •Appropriate 
classification 
•Appropriate treatment 
 
 
•Referrals 
•Stock out of drugs 
•Supervision received 
•Adequate counselling 
• 92.5% correctly assessed and 
classified as malaria and 79.3% 
correctly treated; 51.7% correctly A 
&C as pneumonia and correctly 
treated; 90.3% correctly A&C as 
diarrhoea and 68.8% correctly treated. 
• 55% with danger signs were 
referred. 
• 69% had all essential drugs. 
• 38% received supervision in 
previous 3 months. 
• 81% of carers knew how to take 
drugs. 
Uganda, 2012(244) 
Cluster RCT (2 years): survey, 
CDD registers, observation, 
follow up children and FGD. 
Rural  CHW distribute ACT 
or ACT+ Amoxicillin 
Not mentioned • Appropriate treatment 
 
 
 
 
 
•Equity 
• 100% of febrile children received 
AL in the AL only group and 98.5% 
in the AL+AMX group. 
81.7%of children with fast breathing 
received AMX. 12% of children 
without fast breathing received AMX. 
• Poorest quintiles used more HBC 
than least poor. 
Burkina Faso, Ghana, and 
Uganda, 2012(245). 
Cluster RCT, intervention arm: 
RDT and ARI timers; control 
arm: clinical diagnosis (1 year). 
CDD registers. 
Rural  
High malaria 
endemicity with 
(minimal) seasonal 
malaria 
transmission 
CHW (and 
community nurses in 
Ghana) distribute 
ACT with RDT and 
Amoxicillin or 
cotrimoxazole with 
ARI timers. 
Community nurses in 
Ghana have salary. 
• Appropriate treatment 
 
 
 
 
 
•Fever clearance 
• Compliance with RDT results was 
high across the three countries. Only 
4.9% RDT-negative children received 
an ACT.  
Antibiotic overuse was more 
common: 0.9% in Uganda, 38.5% in 
Burkina Faso, and 44.6% in Ghana.  
• Fever clearance was high in both 
arms (97.8% versus 96.9%, P = 0.17 
in day 3). 
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Annex 2. Summary of studies on Malaria Home- based Care Cost- effectiveness 
Country/ Year/ 
Study design 
Epidemiology Drug distribution/ intervention Outcomes measured Results 
Kenya, 2006 (97) 
Before-after study 
Rural 
Stable and endemic 
malaria transmission 
Training of shopkeepers on the use of CQ versus 
no training 
• Cost per additional 
febrile episode 
treated 
• Cost per DALY 
averted 
• ICER: US$4 
• ICER <US$18.38 
Uganda, 2010 (96) 
Markov model 
Adjustment for 
different transmission 
CHW versus standard care (mid-size hospital).  
Adjustment for different drugs; CQ+SP, AQ+AS, 
AL and DP  
• Cost per DALY 
averted 
Cost effective in: 
• High transmission areas. 
• Medium transmission areas if access to 
care is low. 
• Low transmission areas only if no 
access to care. 
Zambia, 2011 (98) 
Before-after study 
Rural 
Moderate 
transmission 
CHW using RDT and ACT versus standard care 
(low-size health facility) 
• Cost per additional 
febrile episode 
treated 
•  
• ICER: US$4.18 
Ghana, 2012 (95) 
Cluster RCT 
Rural 
Endemic 
CHW using ACT alone or in combination with 
Amoxicillin versus standard care (low/mid-size 
health facility). Cost of treating a malaria case at 
the primary care was not measured. 
• Cost per DALY 
averted 
• ICER using ACT alone: US$90.25 
• ICER using ACT +Amoxicillin: 
US$114.21 
 
  
  
159 
 
Annex 3. Summary of studies showing Diarrhoea and Pneumonia Home- based Care effect on under- five morbidity and 
mortality 
Country/ Year/ Study design and 
duration/ Data collection 
Drug distribution/ intervention Outcomes measured Results 
Systematic review 1992. Inclusion criteria: (i) intervention studies on community case management of pneumonia; (ii) studies reporting on under- five mortality. 
Tanzania, 1986 (266) 
Cluster RCT (2 years. In the 
second year the control group 
became Intervention): HH surveys 
CHW provide co-trimoxazole • Child Mortality 
• Pneumonia specific 
child mortality 
• Overall mortality rate reduced from 40/1000 to 35/1000 and from 
32.4/1000 to 29.2/1000 in the control and in the intervention group (no 
statistical significance).  
• Pneumonia specific child mortality reduced by 30.1% (p value not 
given).  
India, 1987 (267) 
Post study with controls (study 
duration not specified- from birth 
to first year of age): Demographic 
surveillance and verbal autopsy 
Primary health care staff 
provided oral penicillin for 
pneumonia in low-birth-weight 
infants. 
CHW sensitized the community 
and collected information. 
• Seeking care 
• Infant Mortality 
• Pneumonia specific 
infant mortality 
• Case fatality rate 
• 15.1% and 13% of carers of low-birth weight infants in the control and 
intervention group did not seek care when child had mild symptoms. 
• Overall Infant Mortality was 210/1000 and 275/1000 in the intervention 
and control group (95%CI and P value not given). 
• Pneumonia specific infant mortality was 30/1000 and 71/1000 in the 
intervention and control group. (95%CI and P value not given). 
• Pneumonia case fatality rate was 8.7% and 24.6% in the intervention 
and control group (p<0.05). 
Nepal, 1989 (268) 
Before-after without control 
(baseline and 3 years after): 
Demographic surveillance and 
verbal autopsy. 
CHW provide ampicillin (first 
line) and chloramphenicol (second 
line). CHW provide ORS for 
diarrhoea 
• Child Mortality • Pneumonia specific mortality reduced by 59% in year 1 and a further 
reduction of 25% between year 1 and 2 (p<0.01 if intervention years 1 
and 2 are combined).  
Pakistan, 1990 (269) 
Before-after with control (baseline 
and 3 years after). Control group 
became intervention in last year. 
Demographic surveillance and 
verbal autopsy 
CHW provide IM procaine 
Penicillin or co-trimoxazole 
• Child Mortality 
• Pneumonia specific 
child/infant mortality 
• Difference in overall mortality at the end of the intervention between the 
intervention and control group was 26% (p<0.01). (However, baselines 
were different).  
• Reduction in pneumonia related child mortality by 55% (p=0.06) in 
control group when became intervention group. 
• Reduction in pneumonia related infant mortality by 47% (p=0.12) in 
control group when became intervention group. 
India, 1990 (270) 
Before- after with control (baseline 
and 1 year after). 
Demographic surveillance, verbal 
autopsy and HH survey, 
CHW provide co-trimoxazole • Appropriate treatment  
• Child Mortality 
• Pneumonia specific 
child mortality 
• Overtreatment in under one years- or cases misclassified- (146% cases 
treated) and 53% of cases between 1-4 years treated.  
• Difference in overall infant and child mortality at the end of the study 
between the intervention and control group was 27% and 30% 
respectively (p<0.001), (for the period 1987-1989?). 
• Difference in child mortality at the end of the study between the 
intervention and control group was 54% (p<0.001), (for the period 1987-
1989?). 
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Bangladesh, 1992 (271) 
Before-after with controls (2 years 
before and 2 years after). 
Demographic surveillance and 
verbal autopsy 
CHW provide IM procaine 
penicillin 
• Child Mortality 
• Pneumonia specific 
child mortality 
• Pneumonia specific child mortality reduced by 32% (p<0.05) in the 
intervention area and by 6% (p>0.05) in the control area. 
Systematic review 2003. Inclusion criteria: (i) intervention studies on community case management of pneumonia; (ii) studies reporting on under- five mortality and (iii) Having 
a control group. 
India, 1978 (272) 
Before-after with control (1 year 
before and 3.5 years after). 
Longitudinal HH surveys 
Family health workers (not 
specified if nurse or CHW) 
provides vaccine, treatment (not 
specified) and nutrition services 
• Infant mortality 
• Child mortality 
 
 
• Differences in infant mortality rate between the intervention were lower 
than in the control group for the period 1970-1973 (p=0.005).  
• Differences in mortality rate in the 2nd and 3rd year of life was lower in 
the intervention group than in the control group for the period 1970-1973 
(p=0.025).  
Tanzania, 1986  
 
Included in first systematic review 
Pakistan, 1990 Included in first systematic review 
Philippines, 1998 (273) 
Before-after study with control: 
Demographic surveillance and 
verbal autopsy 
Midwife provide treatment • Child Mortality • Overall child mortality rate reduced by 13% and 10% and overall infant 
mortality rate reduced by 20% and 0% from baseline to end of project in 
the intervention and in the control group (p value not available). 
• Pneumonia specific mortality rate in under-5 reduced by 28% and 10% 
(p=0.07) and Pneumonia specific infant mortality reduced by 30% and 
1% from baseline to end of project in the intervention and in the control 
group (p value not available). 
India, 1990 Included in first systematic review 
Nepal, 1991 (274) 
Before- After study (3 Years). 
Control group became intervention 
in 2nd year. Demographic 
surveillance and verbal autopsy. 
HH survey 
CHW provide co-trimoxazole as 
first line and chloramphenicol as 
second line. 
• Appropriate diagnosis 
and treatment. 
• Child Mortality 
• 80% of children were appropriately diagnosed and treated. 
• Overall child mortality rate reduction between baseline and third year: 
RR= 0.72 (95% CI 0.63, 0.82, p=0.02). 
Bangladesh, 1992 Included in first systematic review 
Nepal, 1989 Included in first systematic review. Not included in the meta-analysis (no control) 
Indonesia, 1998 (275) 
Before-after without control 
(baseline and 2 years after). 
Demographic surveillance and 
verbal autopsy. HH survey  
CHW provide ARI treatment (not 
specified) 
• Care seeking 
behaviour. 
• Child Mortality 
• Pneumonia specific 
infant mortality 
• Reduction in seeking care from traditional healers from 52.3% to 39.5%. 
• Child Mortality reduced by 67% after 2 years of intervention. 
• Pneumonia specific infant mortality reduced by 60% after 2 years of 
intervention. 
 
Systematic review 2010. Inclusion criteria: (i) RCTs, Cluster RCT, quasi-experimental studies and observational studies; (ii) pneumonia mortality and other pneumonia related 
outcomes; (iii) control arm; (iv) clear definition of pneumonia. 
Tanzania, 1986 
 
Included in first and second systematic review 
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Nepal, 1989 Included in first systematic review 
India, 1990 Included in first and second systematic review 
Pakistan, 1990 Included in first and second systematic review 
India, 1991(276) 
Before-after with controls (baseline 
and 2 years after).  
Demographic surveillance and 
verbal autopsy. 
CHW provide amoxicillin or co-
trimoxazole (plus vaccination and 
education). 
• Appropriate treatment 
• Child Mortality 
• Pneumonia specific 
infant mortality 
• Appropriate treatment was 57% and 23% for moderate and severe 
pneumonia.  
• Child Mortality was higher in the intervention group than in the control 
group at the beginning of the study (p<0.05) and were similar at the end 
of the study (p>0.05). Possibly due to measles vaccine 
• No statistical differences in Pneumonia specific child mortality 
Nepal, 1991 Included in second systematic review 
Bangladesh, 1992 Included in first and second systematic review 
India, 1993 (277) 
Before- after without control. 3 
years. Demographic surveillance 
and verbal autopsy. 
CHW and medical officer were 
trained to provide Ampicillin and 
sulphametoxazol 
• Pneumonia specific 
child mortality 
• Reductions in pneumonia specific child mortality: RR=0.78, 95%CI 
0.38, 1.59. 
Philippines, 1998 Included in second systematic review 
Systematic review 2013. Inclusion criteria: (i) RCTs, Cluster RCT, quasi-experimental studies and observational studies; (ii) care seeking, uptake of treatment and 
pneumonia/diarrhoea and all cause of child mortality; (iii) clear definition of pneumonia and diarrhoea.  
On Pneumonia  
India, 1978 Included in second review   
Tanzania, 1986 Included in all previous reviews 
India, 1987 Included in first review 
Nepal, 1989 Included in first and third reviews  
India, 1993 Included in 3rd systematic review 
China and Fiji, 1995 (278)  
Post study without controls.  
Demographic surveillance and 
records. 3 years 
Training of doctors and education 
of mothers 
• Prompt care seeking 
behaviour if pneumonia 
symptoms 
• Use of antibiotics if 
pneumonia 
• Pneumonia specific 
child mortality 
• Increased by 75% 
• Almost 100% 
• Reductions in infant and child mortality rate (p<0.05) 
Malaysia, 1996 (279) 
RCT, HH surveys, 1 year 
 
Mothers trained in identifying 
signs of disease and seeking care 
(and health workers received 
training on management as well) 
• Incidence of severe 
pneumonia.  
• Pneumonia specific 
child mortality 
• Higher reductions on incidence of severe pneumonia in the intervention 
group (p<0.05)  
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Bangladesh, 2001 (280) 
Before-after with control. 
Demographic surveillance, GIS. 5 
years 
CHW were trained to provide 
treatment (not specified which one) 
• Under 2 years old 
pneumonia related 
mortality 
• Under 2 mortality was 54% lower in the interventions area (although 
characteristics between intervention and control area were different).  
Bangladesh, 2009 (196) 
CRT, 7 years (2 before and 5 
after). HH census and periodic 
HH surveys 
IMCI strategy: CHW provide 
IEC messages and health facility 
staff provided treatment 
• Child Mortality 
• Child pneumonia 
related mortality 
 
• Reductions in child mortality by 13.4% (95%CI -14.2, 34.3) in the 
intervention group.  
• Increase in pneumonia related child mortality: RR 1.26 (95%CI 0.28 
1.94) in the intervention group 
India, 1990  Included in all previous reviews 
Nepal, 1991 Included in all previous reviews 
India, 1991 Included in third review 
Bangladesh, 1992 Included in all previous reviews 
Pakistan, 1990 Included in all previous reviews 
Philippines, 1998 Included in 2nd and 3rd review 
Zambia, 2010 Included in Annex 1.  
68.2% of children classified with non-severe pneumonia in the intervention arm (using ARI timers) and 13.3% in the control arm (without 
ARI timers) received early and appropriate treatment (RR 5.32, 95%CI 2.19–8.94). 
No enough power to detect an effect on mortality. 
Pakistan, 2012 (281) 
Cluster RCT, 
Census, community registries. 2 
years 
Lady health workers (community 
nurses) provide Amoxicillin for 5 
days versus one dose of another 
antibiotic and referral 
• Treatment failure • Risk difference treatment failure was -5.2% 995%CI-13.7%, 3.3%) 
On diarrhoea 
India, 1987 (282) 
Before-after with control. HH 
surveys. 2 years 
Nurses and CHW provide ORS • Case-fatality rates  • Lower in intervention areas (p=0.01) 
Thailand, 1988 (283) 
Before-after with control. HH 
survey. 7 months 
CHW provide ORS • Knowledge of ORS 
• Use of ORS 
• Knowledge of ORS increased in intervention area by 88.7% (34.4% in 
control group) 
• Use of ORS increased in intervention area by 74.4% (16.3 in the control 
group) 
Nepal, 1989 CHW provide ORS  • Child diarrhoea 
related mortality 
• Reduction in diarrhoea related child mortality: RR 0.26 (95%CI 0.07 
0.91) after the intervention. 
Bangladesh, 2004 (284) 
Cluster RCT, HH survey. 2 years 
CHW provide ORS+zinc versus 
ORS 
• Use of ORS 
• Use of antibiotics 
• Seeking care 
elsewhere 
• 75% and 50% use of ORS in the intervention and control arm (p<0.05) 
• 13% versus 34% use of antibiotics in the intervention and control arm 
(p<0.05) 
• Lower seeking care elsewhere in the intervention group (p<0.05) 
Mali, 2006 (285) 
Before-after with controls.  
HH survey, 2 years 
 
CHW and government prescribing 
zinc versus only government 
prescribing zinc 
• Use of zinc Efforts needed on integration of interventions 
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Mozambique, 2007 (286) 
Before-after, without control 
Census, registers. 3 years 
CHW provide health education 
(+ other components of the IMCI 
strategy) 
• Infant and Child 
mortality 
• Care seeking 
behaviour 
• Use of ORS  
• Vaccination, 
breastfeeding 
knowledges… 
• Infant and Child mortality higher reduce in the intervention area 
compared to national and provincial data 
• Improved ORS 
•Improved family and community practices  
India, 2008 (287) 
Cluster RCT, HH surveys, 1 year 
CHW and government given 
ORS+zinc versus ORS 
• Use of ORS 
• Use of antibiotics 
• Seeking care 
elsewhere 
• Diarrhoea prevalence 
• Higher use of ORS in the intervention arm 
• Lower use of antibiotics in the intervention) 
• Lower seeking care elsewhere in the intervention group 
• Lower diarrhoea prevalence in the intervention group 
Bangladesh, 2009 (196) 
CRT, 7 years (2 before and 5 
after). HH census and periodic 
HH surveys 
IMCI strategy: CHW provide 
IEC messages and health facility 
staff provided treatment 
• Child Mortality 
• Child diarrhoea 
related mortality 
 
• Reductions in child mortality by 13.4% (95%CI -14.2, 34.3) in the 
intervention group.  
• Increase in pneumonia related child mortality: RR 0.56 (95%CI 0.15 
2.11) in the intervention group 
Systematic review 2015. Inclusion criteria: (i) RCTs, Cluster RCT, quasi-experimental studies and observational studies; (ii) CHW received shorter professional training than 
professional workers, (iii) CHW provide treatment, (iv) children 1-59 months, (v) outcome could be mortality, CHW performance or impact on knowledge and (vi) conducted in 
Africa 
Tanzania, 1986 (288) Included in previous reviews 
The Gambia, 1990(289) Before-
after with controls (1 year before 
and 3 years after): verbal autopsy, 
clinical survey of cohort of 
children  
Primary health care • Child Mortality • No differences 
Kenya, 2001 Included in systematic review 2014, Annex 1 
Only 58% of child received appropriate treatment 
Senegal, 2007 (290) 
Post study without controls (1 
year). CDD registers 
CHW provide Cotrimoxazole • Child classification 
•Appropriate treatment 
 
 
• 92 % of children were correctly classified. 
• 97.7 % of suspected pneumonia were appropriately treated;  
88% of severe pneumonias were referred;  
88% of cases were follow up on the 3rd or 4th day. 
Ethiopia, 2006 (194) 
Post study without controls: 
surveys (9 years), registers, 
interviews, FGD and simulation 
cases (1 year) 
CHW provide cotrimoxazole, CQ-
SP, tetracycline eye ointment; 
ORS; paracetamol; vitamin A 
• Carers Knowledge 
• Child management 
• 39% and 92% of carers recognised fast or difficult 
breathing as signs of pneumonia in 1997 and 2006. 94% knew at least two 
childhood danger signs in 2006. 
Seeking care for cough and difficult or rapid breathing 
increased from 30% in 1997to 84% in 2006. 
• 32/40 CHW scored above 80%, and 24/32 scored above 90% on the 
management of the 3 diseases. 
Uganda, 2006 (291) 
Post study without control (2nd day 
after training). Observation- CDD 
Skills after training for diagnosing 
pneumonia 
•Child classification 
 
• 71% of the assessments were within ±5 breaths/min from the gold 
standard;  
The sensitivity of CHW classification was 75% and the specificity was 
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performance versus gold standard 
(mean rate between two 
researchers), FGD 
83%. 
Kenya, 2006, 2007 (249, 292, 293) 
Post study without control (5 
years). CDD Registries and 
observation 
CHW provide treatment for 
malaria, diarrhoea and suspected 
pneumonia (SP, ORS, co-
trimoxazole and Vit A). 
 
•Comparison between 
evaluation methods: 
hospital observations 
versus registries(293). 
• Appropriate 
treatment(249) 
•Factors associated with 
CHW adherence to 
guidelines(292). 
• 34.3% and 50.7% of treatment error at hospital observation versus 
registries. Observation overestimate the quality of care provided: hospital 
minus community= -16.4 (95%CI -25.6, -7.1). 
• The longitudinal study (1997-2002) showed 79.4% of appropriate 
treatment.  
•In 2001, intervention-related factors (refresher training, supervision, 
CHW selection process, medicine supplies and guideline flipchart) was 
not associated with guideline adherence.  
Zambia, 2010 (167) Included in Annex 1.  
68.2% of children classified with non-severe pneumonia in the intervention arm (using ARI timers) and 13.3% in the control arm (without 
ARI timers) received early and appropriate treatment (RR 5.32, 95%CI 2.19–8.94). 
No enough power to detect an effect on mortality. 
Uganda, 2011(294) 
Post study without control (3nd day 
after training). Part of a RCT(168, 
245). Observation  
Included in Annex 1. 
96% of adequate use of timers and RDT. 87% adequate in classification. 96% with +RDT received antimalarials, 40% with fast breathing 
(gold standard) received antibiotic and 91% with both were prescribed both medications. 
 
Uganda, 2012(244) Included in Annex 1. 
100% of febrile children received ACT in the ACT only group and 98.5% in the ACT+ amoxicillin group. 
81.7%of children with fast breathing received amoxicillin. 12% of children without fast breathing received amoxicillin. 
Poorest quintiles used more HBC than least poor 
Zambia, 2012(175). Part of 
RCT(167). Registries (1 year) 
CHW distribute ACT and 
Amoxicillin using RDT 
•Classification 
•Appropriate treatment 
•Stock of drugs 
•Adverse events 
•Resolved case 
• 94–100% of cases appropriately classified.  
• Appropriate treatment in 94–100% of episodes.  
• Over 98% stocks of RDTs, amoxicillin, and  
• Minor adverse events.  
• Most febrile children (90%) with negative RDT results recovered after 
being treated with an antipyretic alone. 
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Annex 4. Sampling 
 
Regions Districts implementing HBC First stage: 2 districts selected 
per area using PPS  
Second stage: Four clusters 
per district selected using PPS  
Northern 
Region 
East area:  
Kpandai 
Nanumba South 
Nanumba North 
Zabzugu/ Tatali 
Yendi 
Gushiegu 
Saboba 
Cheperoni 
Bunkpurugu Yonyo 
East mamprusi 
East Mamprusi 
 
 
 
 
 
 
Saboba 
 
 
 
Dagbiribo-ari A 
Kolinvai A 
Samini A 
Gurugu 
 
 
Bubruni  
Kpalba   
Lower butune  
M-ninkondo 
Central area:  
East Gonja 
Tamale south 
Tamale central  
Tamale North 
Tolon Kumbugu 
Saveligu Nanton 
Karaga 
West Mamprusi 
East Gonja  
 
 
 
 
Tolon Kumbugu 
Kakrunji 
NbawdoNo.2 
Water works 
Dabogshei 
 
Tolon 
Kpendua 
Zantani 
Zangbalun 
West area:  
West Gonja, 
Central Gonja, 
Bole, 
Sawla-Tuna-Kawla 
Sawla- Tuna- Kalba 
 
 
 
 
Central Gonja 
Gbinyiri 
Gurunyiri 
Kulmasa 
Soma 
 
Agunatupe  
Kopedeke  
Kpenjipe    
Morokura 
Volta 
Region 
North area: 
Krachi east and  
KrachiWest 
Krachi east  
 
 
 
 
 
KrachiWest 
Yariga 1 
Ayisu Kra 
Ayirafie Battor 
Nansu 
 
Sabaja 
Onaninja 
Ankaase 
Nkenkyene 
Central area: 
Hohoe municipality 
Jasikan 
Hohoe municipality 
 
 
 
 
 
Jasikan 
Likpe Kukurantumi 
Alavanyo Agoxoe 
Fodome Amele 
Lolobi  Ashambi 
 
Dzoku 
Oseikrom 
Gabusu village 
Apenkwa 
South area*: 
North Tongu,  
Akatsi,  
Keta  
Ketu North 
Ketu North** 
 
 
 
 
 
North Tongu 
 
Torfoe 
Tamekope 
Atitteti 
Agorvie 
Blah 
Venu kope 
MAFI ZONGO 
Mafi Atitekpo 
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Annex 5. Supporting data for Table 27. Effect and cost for malaria diagnosis and 
treatment under HBC and CHPS strategy in the Volta and the Northern Regions 
MALARIA 
  Volta Region Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 75 47 6 197 
Number of non-complicated malaria cases 70 40 5 183 
Number of non-complicated malaria cases treated with ACT 17 7 1 26 
Number of non-complicated malaria cases treated with ACT or quinine 17 8 1 57 
Number of non-complicated malaria cases treated with prompt ACT or quinine 12 1 1 43 
Number of no malaria cases treated with antimalarial 1 1 0 3 
Number of no malaria not treated with antimalarial 4 6 1 11 
Number of cases treated according to protocol (ACT or quinine) 21 14 2 68 
Number of cases treated according to protocol (prompt ACT or quinine) 16 7 2 54 
% of cases treated according to protocol (ACT or quinine) 0.28 0.30 33.33 34.52 
% of cases treated according to protocol (prompt ACT or quinine) 0.21 0.15 33.33 27.41 
Cost per malaria treatment* 4.96 9.52 9.37 8.03 
*Source: Table 26 
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Annex 6. Supporting data for Table 28. Effect and cost for diarrhoea diagnosis and 
treatment under HBC and CHPS strategy in the Volta and the Northern Regions 
DIARRHOEA 
  Volta Region Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 90 61 8 228 
Number of diarrhoea cases 38 31 4 86 
Number of diarrhoea cases treated with ORS (or referred) 4 6 1 8 
Number of diarrhoea cases treated with zinc (or referred) 6 6 1 3 
Number of diarrhoea cases treated with ORS and zinc 3 0 0 0 
Number of no diarrhoea cases treated with ORS 3 1 0 8 
Number of no diarrhoea cases treated with zinc 4 3 0 0 
Number of no diarrhoea cases treated with ORS or zinc 7 4 0 8 
Number of no diarrhoea cases not treated with ORS  49 29 4 134 
Number of no diarrhoea cases not treated with zinc 48 27 4 142 
Number of no diarrhoea cases not treated with ORS or zinc 46 26 4 134 
Number of cases treated according to protocol (ORS and zinc) 49 26 4 134 
Number of cases treated according to protocol (ORS) 53 35 5 142 
Number of cases treated according to protocol (zinc) 54 33 5 145 
% of cases treated according to protocol (ORS and zinc) 0.54 0.43 0.50 0.59 
% of cases treated with ORS 0.59 0.57 0.63 0.62 
% of cases treated with zinc 0.60 0.54 0.63 0.64 
Cost per diarrhoea treatment (giving zinc or ORS)* 0.88 7.25 8.36 5.55 
*Source: Table 26 
  
  168 
Annex 7. Supporting data for Table 29. Effect and cost for suspected pneumonia 
diagnosis and treatment under HBC and CHPS strategy in the Volta and the 
Northern Regions 
SUSPECTED PNEUMONIA  
  Volta Region Northern Region 
Variables HBC CHPS HBC CHPS 
Number of eligible children for treatment 87 61 7 228 
Number of suspected pneumonia cases 25 9 1 15 
Number of suspected pneumonia cases that received amoxicillin (or referred) 7 1 0 3 
Number of suspected pneumonia cases that received amoxicillin or cotrimoxazole (or referred) 7 1 0 4 
Number of no suspected pneumonia treated with amoxicillin or cotrimoxazole 6 9 0 50 
Number of no suspected pneumonia not treated with amoxicillin or cotrimoxazole 56 43 6 163 
Number of cases treated according to protocol 63 44 6 167 
% of cases treated according to protocol 0.72 0.72 0.86 0.73 
Cost per suspected pneumonia treatment* 1.33 7.45 8.50 6.73 
*Source: Table 26  
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Annex 8. Household survey questionnaire 
 
“ASSESSMENT OF THE MALARIA, DIARRHOEA AND PNEUMONIA HOME BASED 
CARE STRATEGY IN THE VOLTA AND NORTHERN REGIONS OF GHANA” 
 
 
Household Survey 
 
Questionnaire for caregivers of children under five 
 
2014 
 
The objective of this questionnaire is to collect information on the knowledge of caretakers about 
the existence of the HMMAD programme at the communities, its utilization and their satisfaction 
when using the programme.  
 
 
Household ID:  
 
 
INFORMED CONSENT 
 
Introduction and interview goal:  
Good morning. My name is _________________________________. 
I work with the Ghana Health Service. We are here today to discuss your possible participation in a 
study that will help us improve the health of people in Ghana. 
 
Malaria, diarrhoea and pneumonia are important causes of disease and deaths in your district. The 
Ghana Health Service started a programme called HOME BASED CARE to help you treat your 
child with fever and/or diarrhoea at the community, so you do not need to travel long distances and 
you can get good and quick treatment for your child. We would like to know how this HOME-BASED 
CARE programme is working at your community and understand how we can improve it so your 
kids are happy and healthy. For that, we are carrying out interviews with people that have a young 
child who was sick in the previous 2 weeks. 
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Procedures: Your participation in this study is entirely voluntary and no one will be penalized if you 
decide not to participate. If you are willing to participate, we will ask you a few questions on what 
you do to treat malaria, pneumonia and or diarrhoea. You are free to ask questions and to end this 
interview at any time. The interview will last approximately 15 to 20 minutes.   
  
Risks: This study bears no risk for you or your family members. You may feel uneasy while 
explaining how you treat malaria, pneumonia and or diarrhoea. Don’t worry, honest answers are 
important for us and will permit us to know how best the programme can help you to stop malaria, 
pneumonia and or diarrhoea affecting your child. Please remember that you do not have to answer 
any questions that make you feel uneasy. 
 
Benefits: If you participate in this study, you will help us find ways to improve access and use of 
malaria, pneumonia and or diarrhoea treatment services and these interventions can ultimately be 
used to improve the health of the whole community.     
 
Confidentiality: Any information discussed will remain strictly confidential. Your name and the name 
of your family will not appear anywhere. To keep your anonymity, we will use a code rather than 
your name. We will keep the records in closed files and only the survey personnel will have the 
permission to access them. Your name and other identifying information will not appear in this 
study’s report. The results of this interview will be combined with those of at least 580 other 
respondents. 
 
Right to refuse or to withdraw from the study: As previously stated, you are free to participate in the 
study or not. If you do participate, you are free to change your mind and decide not to participate 
further at any time. Your choice to participate in this interview or your refusal to answer some 
questions will not be told to others.  
   
Contact Persons: At any moment, if you have questions concerning this study or if you think that 
this study has caused damage to you, you may contact Mrs. Hannah Frimpong (Tel: 0243235225) 
or Mrs. Abena Kwaa Addai-Donkoh, (Tel: 0244712919) from the Research and Development 
Division of the Ghana Health Service. Here is the telephone number to dial if you have any 
questions regarding your rights related to your participation in this study. (Hand the interviewee the 
study manager’s and ERC administrator names and telephone numbers). 
   
Do you want to participate in this study? [IF YES]: I’m going to read a declaration to you, and if 
you agree, I will ask you to sign this sheet to confirm your agreement. 
  DECLARATION OF CONSENT:  Please sign below once you have read this sheet (or you receive 
explanations) and: 
1. You know the reasons and subject of this study 
2. You know the risks and benefits related to participation in this study  
3. AND you have chosen to participate in this study on your own 
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Name of the interviewee  
(or legal representative) 
 
 
 
 
  
Signature of the interviewer 
 (or legal representative) or thumb 
printing 
  
Date 
Name of witness  
 
 Signature or thumb printing  Date 
 
 
I have explained the aim of the project to the interviewee. To the best of my knowledge, this person 
understands the goal, procedures, risks and benefits of this project. 
 
 
 
 
    
 
Name of the interviewer 
 
 
 
 Signature of the interviewer   
Date 
 
Name of witness 
 Signature or thumb printing   
Date 
 
NOTE: This consent form, along with the original signature, must be saved in the files by the senior 
researcher. 
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Home Based Care assessment study 
 
Dodowa Health Research Centre 
LSHTM 
                                                                                                                        
                                                                                           
Unique ID:  
(region code, Interviewer code and serial number):  
 
Section 1. IDENTIFICATION (CIRCLE CORRECT ANSWER(S) WHERE CHOICES ARE PROVIDED) 
         Interviewer’s Name  
 
_______________________________ 
Interviewer Code 
  
Date of interview  
 
Supervisor’s   Code 
 
Field Editor‘s Code  Data Entry Clerk Code   
Date               Date Date 
 
District_____________________________________ 
District code  
 
Town/Village___________________________________________ 
 Town/Village Code 
 
 
 
 
 
 
 
 
 
 
 
 
EA code: 
Cluster number: 
 
 
Section 2. CARE GIVER INFORMATION 
1.  Is the respondent: Male  
Female 
1 
2 
  
2.  How many children under five 
living in this household had 
fever OR diarrhoea OR 
cough/fast-difficult breathing 
in the past 2 weeks? 
 
 
Number of children        
  
3.  IF MORE THAN 2 SICK 
CHILDREN UNDER-5 IN 
HOUSEHOLD, BY LOTERY 
(Pick 1 from a number of pieces 
of paper with a number on it 
linked to a specific child) 
Name of the Child   
4.  Relation to child NAME Mother 
Grand Mother 
Father 
Other relative 
(Specify:______________________________ 
1 
2 
3 
4 
 
 
5.  Age of respondent   
Age in years   
 
  
6.  Marital status  
 
Single 
Married 
Separated 
Widowed 
1 
2 
3 
4 
 
FORM ID 
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Divorced 
Co-habited 
Other 
Specify….......................................…………… 
5 
6 
7 
7.  What is your highest 
education level? 
 
Primary 
JHS/Mid 
SHS/Sec 
Techical/Commercial/ Vocacional 
Tertiary 
Non Formal education 
None 
Other 
Specify…..................................………………… 
1 
2 
3 
4 
5 
6 
7 
8 
  
8.  Can you read in  
 
(MULTIPLE QUESTIONS) 
 
English 
Ewe 
Twi 
Ga 
Dagbani 
Fanti 
Other 
Specify……………………………………………. 
No, I cannot read in any language 
1 
2 
3 
4 
5 
6 
7 
 
8 
 
9.  What is currently your main 
occupation? 
Farming 
Artisan 
Trading 
Government worker 
Apprenticeship 
Housewife  
Unemployed 
Other  
Specify…........................…………..…………… 
1 
2 
3 
4 
5 
6 
7 
8 
 
 
10.  What is the main occupation 
of the head of household? 
Farming 
Artisan 
Trading 
Government worker 
Apprenticeship  
Housewife 
Unemployed 
Other  
Specify …....................................……………. 
Do not know 
1 
2 
3 
4 
5 
6 
7 
     8 
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11.  What is your religion? Christian 
Traditional African Religion 
Islam 
Athiest 
Other  
Specify…… …....... …...............……………… 
1 
2 
3 
4 
5 
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Section 3: SEEKING CARE FOR FEVER, COUGH/DIFFICULT IN BREATHING OR DIARRHOEA 
I WILL NOW ASK YOU SOME QUESTIONS ABOUT YOUR CHILD (NAME) WHEN HE/SHE WAS SICK 
12.  How old is the child 
(NAME)? 
 
(please, verify with 
any documentation) 
Years  
 
Months 
                          DD        MM        YY 
Date of birth 
 
13.  Is (NAME) male or 
female? 
Male 
Female 
1 
2 
 
14.  What signs and 
symptoms did (NAME) 
have?  
 
(Ask for each of the 
symptoms)  
 
Fever 
Chills  
Sweating  
Fast Breathing  
Head ache 
Body ache  
Not eating  
3 or more stools per day 
Blood in the stools 
Cough 
Noisy breathing 
Difficulty in breathing 
Breathing fast  
Vomiting 
Very pale skin  
Unconscious  
Convulsions 
Other (specify): ____________________ 
Not sure 
Y 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
9 
 
98 
N 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
 
  
15.  Did you seek care for 
(NAME)? 
Yes ............................................. 1 
No ............................................... 2 
Not sure .................................... 98 
IF YES, SKIP 
TO Q17 
16.  Why didn't you care for 
(NAME)? 
 
 
(Multiple responses)  
 
 
Waiting for fever to lessen 
Waiting for diarrhoea to lessen 
Didn't seem ill enough 
No money for treatment 
No money for transport 
No time 
 Already had medicines in the household 
Previous bad experience 
Didn’t know where to go 
Other  
Specify: ________________________ 
Don't know 
1 
2 
3 
4 
5 
6 
7 
 
8 
9 
10 
 
98 
SKIP TO Q36 
17.  Where did you first 
seek care for (NAME)? 
(1st facility/provider) 
CHPS compound 
Health Centre 
Hospital 
Traditional healer 
Community Based Agent 
Licensed Chemical Seller 
Drug peddler 
Private Health facility  
Other 
Specify: ___________________ 
Don't know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
98 
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18.  How long after the 
fever/diarrhoea/cough 
or difficulty breathing 
started did you first 
seek care from this 
provider for (NAME)? 
Same day 
Day after 
Two days after 
3 to 7 days 
More than 7 days 
Don't know .................................... 
1 
2 
3 
4 
5 
98 
 
19.  How did you get to this 
first provider/ facility 
Walking 
Public transport 
Community assisted transport 
Ambulance 
Other.  
Specify.................................................................. 
Don’t know 
1 
2 
3 
4 
5 
98 
20.  How much time did you 
spend in travelling to 
seek care (going and 
coming back home) at 
this first facility/provider 
you visited 
Less than 15 min  
Between 15 min- 30  
Between 30 min-1 hour  
Between 1 and 2 hours 
Between 2 and 3 hours 
More than 3 hours 
Other  
Specify.......................................................... 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
98 
21.  For how long did you 
stay at this first 
facility/provider you 
visited (waiting and 
attending your child)  
Less than 15 min  
Between 15 min- 30  
Between 30 min-1 hour  
Between 1 and 2 hours 
Between 2 and 3 hours 
More than 3 hours 
Other  
Specify....................................................... 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
98 
22.  How much money did 
you spend on travelling 
to this first provider 
(going and coming 
back home)  
Cost GHcedis: ____________ 
 
Not sure:……………………98 
 
23.  How much money did 
you spend buying food 
while in the 
facility/provider? 
Cost GHcedis: ____________ 
 
Not sure:…………………98 
 
24.  Were there any other 
costs involved at the 
facility/ provider 
(excluding buying 
drugs)? 
Yes ............................................. 1 
No ............................................... 2 
Not sure……………………....….98 
IF NO OR 
NOT SURE, 
SKIP TO Q26 
25.  What costs?  Paying for attending my child………1 
Paying for the lab…………………….2 
Paying for the NHIS………………….3 
Other…………………………………..4 
Specify_________________ 
Not sure…………………………..….98 
 
26.  Did you seek care for 
(NAME)’s 
fever/diarrhoea/cough 
or difficulty breathing 
anywhere else? 
Yes ............................................. 1 
No ............................................... 2 
Not sure .................................... 98 
 
IF NO OR 
NOT SURE, 
SKIP TO Q36 
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27.  Where was the second 
place that you sought 
care for (NAME)? 
(2nd facility/provider) 
CHPS compound ........................ 1 
Health Centre……………..….…...2 
Hospital………………………..…..3 
Traditional healer…...…………….4 
Community Based Agent ............ 5 
Licensed Chemical Seller ........... 6 
Drug peddler ............................... 7 
Private Health facility .................. 8 
Other ........................................... 9 
Specify: ___________________ 
Don't know ................................ 98 
 
28.  Why did you seek care 
elsewhere for (NAME)? 
Not getting better ........................ 1 
Symptoms getting worse ............ 2 
To buy/get medication ................ 3 
Other ........................................... 4 
Specify: ___________________ 
 
29.  How did you get to this 
second provider/ facility 
Walking 
Public transport 
Community assisted transport 
Ambulance 
Other. Specify.................................................................. 
Don’t know 
1 
2 
3 
4 
5 
98  
30.  How much time did you 
spend in travelling to 
seek care (going and 
coming back home) at 
this second 
facility/provider you 
visited 
Less than 15 min  
Between 15 min- 30  
Between 30 min-1 hour  
Between 1 and 2 hours 
Between 2 and 3 hours 
More than 3 hours 
Other. Specify................................................................... 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
98 
31.  For how long did you 
stay at this second 
facility/provider you 
visited (waiting and 
attending your child)  
Less than 15 min  
Between 15 min- 30  
Between 30 min-1 hour  
Between 1 and 2 hours 
Between 2 and 3 hours 
More than 3 hours 
Other  
Specify.................................................................... 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
 
98 
32.  How much money did 
you spend on travelling 
to this second provider 
(going and coming 
back home)? 
Cost GHcedis: ____________ 
 
Not sure:……………………98 
 
33.  How much money did 
you spend buying food 
while in the 
facility/provider? 
Cost GHcedis: ____________ 
 
Not sure:……………………98 
 
34.  Were there any other 
costs involved at the 
facility/ provider 
(excluding buying 
drugs)? 
Yes ............................................. 1 
No ............................................... 2 
Not sure…………………..….98 
IF NO OR 
NOT SURE, 
SKIP TO Q36 
  177 
35.  What costs?  Paying for attending my child……..1 
Paying for the lab…………………..2 
Paying for the NHIS………………..3 
Other………………………………....4 
Specify_________________ 
Not sure…………………………..….98 
 
36.  Did (NAME) take drugs 
for the 
fever//diarrhoea/cough 
or difficulty breathing? 
Yes ............................................. 1 
No ............................................... 2 
Herbal medication……………3 
Not sure .................................... 98 
IF NO OR 
NOT SURE, 
or herbal 
medication, 
SKIP TO Q65 
37.  Who suggested to take 
these drugs?  
I asked for drugs…………………………….…...1 
They were offered by the provider…………….2 
Other. Specify……………………………………3 
Not sure……………………………………….…98 
 
38.  How long after the 
fever/cough or difficulty 
in breathing/diarrhoea 
started did (NAME) 
take these drugs? 
Same day ................................... 1 
Day after ..................................... 2 
Two days after ............................ 3 
Three or more days .................... 4 
More than 7 days…………….5 
Don't know ................................ 98 
 
39.  What drugs did 
(NAME) take for the 
fever/cough or difficulty 
in breathing/diarrhoea 
and from where? 
(Include any drugs that 
were from self-
medication and/or from 
a health care provider) 
 
Ask if they keep the 
packages of drugs 
taken. Show examples 
of drugs 
 
RECORD THE DRUG 
CODE AND NAME 
AND FROM WHERE 
THESE DRUGS 
WERE TAKEN. 
Please, see list below: 
                                          
 Drug 
code 
Name Facility 
code* 
Drug 1    
Drug 2    
Drug 3    
Drug 4    
Drug 5    
Drug 6    
Don’t know 98 
 
 
 
 
 
 
 
 
 
 
 *CODES FOR THE FACILITIES/PROVIDERS 
CHPS compound………………………………………………………….1 
Health Centre……………………………………………………………...2 
Hospital……………………………………………………………………..3 
Traditional healer…...……………………………………………………..4 
Community Based Agent………………………………………………….5 
Licensed Chemical Seller…………………………………………………6 
Drug peddler………………………………………………………………..7 
Health facility (private)…………………………………………………….8 
Left over drug………………………………………………………….……9 
Other……………………………………………………………………….10 
Specify: ________________________________________________ 
Don't know………………………………………………………………..98  
 
GO THROUGH THE LIST IN Q37 ABOVE AND ANSWER THE NEXT QUESTIONS 
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40.  What was the first drug 
that (NAME) took? 
(CROSS CHECK 
WITH Q37) 
Drug code: ................................... 
 
Not sure .................................... 98 
 
41.  How long after the 
fever/diarrhoea/difficult
y breathing began did 
(NAME) start taking 
this first drug? 
Same day ................................... 1 
Day after ..................................... 2 
Two days after ............................ 3 
Three or more days .................... 4 
Don't know ................................ 98 
 
42.  How many times a day 
did (NAME) take this 
first drug? 
Times per day: ............................. 
Not sure .................................... 98 
 
43.  How many tablets or 
spoons or injections did 
(NAME) take each 
time? 
CIRCLE THE TYPE 
OF DRUG 
 
(1 TEA SPOON=5ML) 
Dose each time: ......................... 
 
Not sure .................................... 98 
Type: 
Tablet………………………….1 
Tea Spoon……………………2 
Injection…………………….…3 
Rectal…………………………4 
 
44.  How many days were 
you asked (NAME) to 
take this first drug? 
Number of days: .......................... 
Not sure .................................... 98 
 
45.  How many days did 
you take this first drug? 
Number of days: .......................... 
Still taken the drug…………9 
Not sure ................................... 98 
 
46.  Did (NAME) take all the 
prescribed/purchased 
tablets or syrup of this 
drug? 
Yes ............................................. 1 
No ............................................... 2 
Still taking the drug ..................... 3 
Not sure ...................................... 8 
 
 
47.  Did you buy the drug? Yes ............................................. 1 
No ............................................... 2 
Not sure ...................................... 8 
 
48.  How much did you pay 
for this drug?  
Cost Ghana Cedis   ________ 
Not sure .................................... 98 
 
49.  What was the second drug that (NAME) took? 
(CROSS CHECK WITH Q37) 
Drug code: ...................................  
Not sure .....................................98 
No other drug……………….1 
IF NO 
OTHER 
DRUG, SKIP 
TO Q65 
50.  How long after their fever/diarrhoea/difficulty 
breathing began did (NAME) start taking this 
second drug? 
Same day ................................... 1 
Day after ..................................... 2 
Two days after ............................ 3 
Three or more days .................... 4 
Don't know .................................. 8 
 
51.  How many days were you asked (NAME) to 
take this second drug? 
Number of days: ..........................  
Not sure .....................................98 
 
52.  How many days did you take this second drug? Number of days: ..........................  
Still taken the drug…………9 
Not sure ................................... 98 
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53.  How many tablets or spoons or injections did 
(NAME) take each time? 
CIRCLE THE TYPE OF DRUG 
Dose each time: .........................  
 
Not sure .....................................98 
Type: 
Tablet………………………….1 
Spoon…………………………2 
Injection…………………….…3 
Rectal………………………….4 
 
54.  Did (NAME) take all the prescribed/purchased 
tablets or syrup of this drug? 
Yes ............................................. 1 
No ............................................... 2 
Still taking the drug ..................... 3 
Not sure .....................................98 
 
55.  Did you buy the drug? Yes ............................................. 1 
No ............................................... 2 
Not sure ...................................... 8 
 
56.  How much did you pay for this drug?  Cost Ghana Cedis   ________ 
Not sure .....................................98 
 
57.  What was the third drug that (NAME) took? 
(CROSS CHECK WITH Q37) 
Drug code: ...................................  
Not sure .....................................98 
No other drug…………………1 
IF NO 
OTHER 
DRUG, SKIP 
TO Q65 
58.  How long after their symptoms began did 
(NAME) start taking this third drug? 
Same day ................................... 1 
Day after ..................................... 2 
Two days after ............................ 3 
Three or more days .................... 4 
Don't know .................................98 
 
59.  How many days were you asked (NAME) to 
take this third drug? 
Number of days: ..........................  
Not sure .....................................98 
 
60.  How many days did you take this third drug? Number of days: ..........................  
Still taken the drug………………9 
Not sure ................................... 98 
 
61.  How many tablets or spoons or injections did 
(NAME) take each time? 
CIRCLE THE TYPE OF DRUG 
Dose each time: .........................  
 
Not sure .....................................98 
Type: 
Tablet………………………….1 
Spoon…………………………2 
Injection…………………….…3 
Rectal………………………….4 
 
62.  Did (NAME) take all the prescribed/purchased 
tablets or syrup of this drug? 
Yes ............................................. 1 
No ............................................... 2 
Still taking the drug ..................... 3 
Not sure .....................................98 
 
63.  Did you buy the drug? Yes ............................................. 1 
No ............................................... 2 
Not sure .....................................98 
 
 
64.  How much did you pay for this drug?  Cost Ghana Cedis   ________ 
Not sure .....................................98 
 
65.  Did (NAME) have a blood test for  
malaria? 
Yes ............................................. 1 
No ............................................... 2 
Not sure .....................................98 
IF NO, SKIP 
TO Q71 
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66.  How was the blood taken? From the finger/heel…………1 
Using a syringe…….….……..2 
Not sure……………………...98 
 
67.  Did (NAME) have the malaria test before taking 
drugs? 
Yes ............................................. 1 
No ............................................... 2 
Not sure .....................................98 
 
68.  Where did (NAME) get the malaria test done? CHPS compound........................ 1 
Health Centre……………………...2 
Hospital……………………..……..3 
Traditional healer…...………..…..4 
Community Based Agent ............ 5 
Licensed Chemical Seller ........... 6 
Drug peddler .............................. 7 
Private Health facility .................. 8 
Other .......................................... 9 
Specify: ___________________ 
Don't know .................................98 
 
69.  What was the result of the malaria test? Positive ....................................... 1 
Negative ..................................... 2 
Don't know .................................98 
SKIP TO Q71 
70.  Why didn’t (NAME) have a blood test for 
malaria? 
Didn’t think fever was malaria ….1 
Confident it was malaria ………...2 
Don’t have money ……………….3 
Don’t know where to get test…... 4 
Wasn’t offered one………..……...5 
Did not seek care………….……..6 
Other ……………………………...7 
Specify: ___________________ 
Don’t know…………………………..98 
 
71.  How is (NAME) now? Fine, he/she recovered ............... 1 
Still sick ...................................... 2 
Ill again/new illness………..……..3 
He/she died………………….…...4 
Other…………………….………...5 
Specify: _______________________ 
Don't know .................................98 
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Section 4. EXPERIENCE WITH COMMUNITY BASED AGENTS AND OTHER HEALTH 
PROVIDERS 
THE GHANA HEALTH SERVICE IS TRYIG TO IMPROVE THE TREATMENT GIVEN TO CHILDREN UNDER FIVE.  
 
I WILL ASK YOU NOW SOME QUESTIONS ABOUT YOUR EXPERIENCE WHEN CONTACTING COMMUNITY 
BASED AGENTS AND ANY OTHER HEALTH FACILITY VISITED DURING THIS LAST 2 WEEKS 
72.  Have you ever sought care for 
(NAME) during last 2 weeks? 
Yes 
No 
Not sure 
1 
2 
98 
If 
yes, 
Skip 
to 
Q74 
73.   
If no, why you did not go to the 
CBA this time to seek care for 
your child’s illness as first option? 
I do not know what CBA are 
There are no CBAs in my community 
CBA had run out of stock with that drug 
Cannot afford the CBA drug 
Does not like the CBA drug 
Does not like the CBA service 
The CBA is not competent 
Prefer to go to the health facility 
Other  
Specify.................................................................. 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
98 
Skip 
to 
Q92 
74.  If yes, can I confirm if you went to 
a Community Based Agent (CBA) 
to seek care this time for your 
child’s illness as first option?  
 
Yes 
No 
Not sure 
 
 
1 
2 
98 
 
If no, 
not 
sure 
skip 
to 
Q76 
75.  Why did you go to the CBA this 
time to seek care for your child’s 
illness as first option? 
 
A relative /friend recommended it 
Close to me 
Flexible opening hours 
That is where I usually go to 
Competent nurses 
Competent doctors 
Better infrastructure 
Always drugs 
Other  
Specify................................................................. 
Don’t know     
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
98 
 
76.  Were you satisfied with the service 
received when you first went to 
seek care for (Name) illness? 
Very satisfied 
Satisfied 
Not very satisfied  
Absolutely not satisfied 
Not sure 
1 
2 
3 
4 
98 
 
77.  If not or absolutely not, why? Drugs not available  
Drugs not affordable 
Drugs not free 
Have to travel long distances 
I do not have time to work or to do other things 
Time to ask for advice and treatment is not flexible 
Staff not professional 
Staff is rude 
Staff do not explain anything   
Other 
Specify………………………………….................... 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
98 
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78.  If yes or little yes, why? Drugs readily available  
Drugs affordable 
Drugs free 
Don’t have to travel long distances 
I have more time to work 
Flexible time to ask for advice and treatment 
Professional staff 
Staff is friendly 
Staff also explains how to be healthy   
Other 
Specify……………………………........................ 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
98 
 
79.  Do you think the service and 
treatment received was affordable? 
Yes  
No 
Not sure 
1 
2 
98 
 
80.  Did you receive advice on dosage 
per day? 
Yes  
No 
Not sure 
1 
2 
98 
 
81.  Did you receive advice on number 
of days to take drugs? 
Yes  
No 
Not sure 
1 
2 
98 
 
 
82.  Did you receive advice on side 
effects (any reaction from the 
drug)? 
Yes  
No 
Not sure 
1 
2 
98 
 
 
83.  Did you receive advice on what to 
do if symptoms persist? 
Yes  
No 
Not sure 
1 
2 
98 
 
84.  Were you suggested to refer 
(NAME) to another level of facility?  
Yes  
No 
Not sure 
 
1 
2 
98 
 
IF 
NO, 
SKIP 
TO 
Q90 
85.  Why were you suggested to refer 
(NAME)? 
No drugs 
Child was too sick 
Child was too many days sick 
Child was too young to be treated at the 
community 
Child was not getting better 
CBA was not sure about what to do 
Other  
Specify…………………………......................... 
Don’t know  
1 
2 
3 
4 
5 
6 
7 
 
98 
 
86.  Were you given a referral 
form/card to go to another health 
facility? 
Yes  
No 
Don’t know 
1 
2 
98 
 
87.  Did your child receive an 
artesunate suppository for the 
referral (a suppository for malaria)? 
Yes  
No 
Don’t know 
1 
2 
98 
 
88.  Did your child receive one dose of 
amoxicillin for the referral (a 
medicine for the cough or difficult 
breathing)? 
Yes  
No 
Don’t know 
1 
2 
98 
 
89.  If you were advice to go to another 
health facility, did you go? 
Yes  
No 
Don’t know 
1 
2 
98 
 
90.  Did your child receive a follow up 
after the first visit? 
Yes  
No 
Don’t know 
1 
2 
98 
If no, 
skip 
to 
Q92 
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91.  When did your child receive a 
follow up after first consultancy 
The day after 
Two days after 
3 days after 
Other. Specify………………………………………… 
Don’t know 
1 
2 
3 
4 
98 
 
I WILL ASK YOU NOW SOME GENERAL QUESTIONS ABOUT CBAs AND HEALTH FACILITIES  
92.  How did you find the time 
accessibility of the CBAs in your 
community? 
Flexible 
Not always available 
Other.Specify........................................................ 
Not sure 
1 
2 
3 
98 
 
93.  How far is you house from the 
CBAs 
Less than 15 min walking 
Between 15 min- 30 walking 
Between 30 min-1 hour walking 
Between 1 and 2 hours walking 
Between 2 and 3 hours walking 
More than 3 hours walking 
Other 
Specify................................................................. 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
 
98 
 
94.  How far is you house from the 
closest health facility 
Less than 15 min walking 
Between 15 min- 30 walking 
Between 30 min-1 hour walking 
Between 1 and 2 hours walking 
Between 2 and 3 hours walking 
More than 3 hours walking 
Other 
Specify................................................................. 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
 
98 
 
95.  Which type of facility is the closest 
to your house 
CHPS compound 
Health Centre 
District Hospital 
Regional hospital 
Private clinic 
Other: 
Specify________________________________ 
Not sure 
1 
2 
3 
4 
5 
6 
 
98 
 
96.  How did you find the time 
accessibility at the closest facility? 
Flexible 
Not always available 
Other Specify…………………............................... 
Not sure 
1 
2 
3 
98 
 
97.  Where will you go next time if your 
child is sick again? 
CHPS compound 
Health Centre 
Hospital 
Traditional healer 
Community Based Agent 
Licensed Chemical Seller 
Drug peddler 
Private Health facility  
Other 
Specify: _________________________________ 
Not sure 
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
98 
 
98.  Do you have an active health 
insurance  
Yes  
No 
 
1 
2 
 
If 
yes, 
go to 
Q100 
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99.  If no, why? It is expensive 
I do not like the service at the health facility 
I did not know I can be a member 
I did not know where to go to register 
I do not think it is necessary 
The registration is far away from my house 
It takes too much time to have the NHIS card 
Other 
Specify…………………………………………………. 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
 
98 
 
 
Section 5: KNOWLEDGE OF MALARIA, DIARRHOEA AND PNEUMONIA: SIGNS AND 
PREVENTION   
100. What are the signs or symptoms of 
malaria in a child less than 5 years of 
age? 
 
 
(Multiple response) 
 
 
Fever   
Chills   
Sweating  
Headache  
Body ache/Joint pain  
Fatigue  
Bitter mouth  
Loss of appetite  
Diarrhoea  
Vomiting  
Other  
Specify:_______________ 
Don’t know 98 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
 
98 
 
 
 
 
 
 
 
 
 
 
 
101. What signs and symptoms make you 
decide that malaria is serious in a child 
less than 5 years of age? 
 
 
(Multiple response) 
 
Unconscious  
Convulsions  
Fast breathing  
Very hot  
Yellow eye colour  
Very pale skin  
Not breastfeeding  
Not eating  
Frequent vomiting  
Diarrhoea 
Vomiting  
Other  
Specify:__________________ 
Don’t know 98 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
 
98 
 
102. How do people get malaria? 
 
 
(Multiple response) 
 
Mosquito bites  
Drinking dirty water  
Not boiling water  
Bathing in river  
Bad air  
Bad talking  
Spirits  
Bad food  
Poor hygiene  
Other  
Specify:__________________ 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
98 
 
103. In the past year have you seen or 
heard any messages about malaria 
(how it is transmitted, how to avoid it, 
symptoms and what to do when sick?    
 
Yes 
No 
Not sure  
 
1 
2 
98 
If not  
skip to 
Q105 
104.  
From where did you hear messages 
about malaria?  
 
Neighbour  
Family member 
Friend 
Community Based Agent (CBA) 
1 
2 
3 
4 
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   (Multiple response) Nurse from CHPS compound 
Nurse from Health Centre 
At the hospital 
Radio 
TV 
Posters  
Leaflets  
Newspaper  
Other  
Specify:____________________ 
Don’t know 98 
5 
6 
7 
8 
9 
10 
11 
12 
13 
 
98 
105. Did [Name of child] sleep under 
mosquito net last night?   
 
Yes 
No 
Not sure 
1 
2 
98 
 
106. There is at least 1 mosquito net hanged 
up in the house?  
(VERIFY IF THERE IS AT LEAST 1 
MOSQUITO NET HANGED UP) 
Yes, I have seen it 
No, I have not seen it 
Not allowed to check 
1 
2 
3 
 
107. Did you sleep under a mosquito net last 
night?   
Yes 
No 
Not sure 
1 
2 
98 
 
 
108.  
Do you know what indoor residual 
spraying is?  
 
Yes 
No 
Not sure 
1 
2 
98 
 
 
109.  
Would you be happy to have your 
house sprayed with insecticide to kill 
mosquitoes?  
Yes 
No 
Not sure 
1 
2 
98 
 
110. Has your house ever been sprayed 
with insecticide to kill mosquitoes? 
Yes 
No 
Not sure 
1 
2 
98 
 
111. What are the signs or symptoms of 
severe diarrhoea in children less than 
5 years of age? 
 
 
(Multiple response) 
 
 
Diarrhoea present for more than 7 days 
Diarrhoea with blood in stools  
Dehydrated, dry mucosa  
Headache  
Fatigue  
Not breastfeeding, not eating  
Other  
Specify:___________________ 
Don’t know 98 
1 
2 
3 
4 
5 
6 
7 
 
98 
 
112. Which practices in the community can 
cause diarrhoea in children less than 5 
years of age? 
 
 
(Multiple response) 
 
Not cleaning hands before food preparation 
Not cleaning hands before eating  
Not cleaning hands after defecation  
Not boiling water for drinking/cooking 
Flies on food 
The sun 
Bathing in river 
Bad air 
Bad talking 
Spirits 
Bad food 
Other 
Specify____________ 
Don’t know  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
 
98 
 
113. In the past year have you seen or 
heard any health messages about 
diarrhoea?    
Yes 
No 
Not sure 
1 
2 
98 
If not  
skip to 
Q115 
114. From where did you hear messages 
about diarrhoea?    
 
 (Multiple response) 
 
Neighbour 
Family member 
Friend 
Traditional healer 
Community Based Agent 
Nurse from CHPS compound 
1 
2 
3 
4 
5 
6 
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Nurse from Health Centre 
At the hospital 
Radio 
TV 
Posters 
Leaflets 
Newspaper 
Other  Specify:_______________________ 
Don’t know 
7 
8 
9 
10 
11 
12 
13 
14 
 
98 
115. What are the signs or symptoms of 
severe acute respiratory infection? 
 
 
(Multiple response) 
 
 
Duration of symptoms (number of days with 
symptoms) 
Breathing quicker than usual 
Chest in-drawings 
Noisy breathing 
Other.Specify………………………………………… 
Don’t know 
1 
 
2 
3 
4 
 
98 
 
116. What can cause respiratory infections 
in children less than 5 years of age? 
 
 
(Multiple response) 
 
Infections (microorganisms) 
Not cleaning hands  
Not boiling water 
Bathing in river 
Being close to a person that coughs 
No vaccinating my child 
Bad talking 
Allergies 
Spirits 
Bad food 
Poor hygiene 
Other  
Specify________________________ 
Don’t’ know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
 
98 
 
117. In the past year have you seen or 
heard any messages about respiratory 
infections?    
Yes 
No 
Not sure 
1 
2 
98 
If not  
skip to 
Q119 
118. From where did you hear messages 
about respiratory infections?     
Neighbour 
Family member 
Friend 
Traditional healer 
Community Based Agent 
Nurse from CHPS compound 
Nurse from Health Centre 
At the hospital 
Radio 
TV 
Posters 
Leaflets 
Newspaper 
Other 
Specify:________________________ 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
 
98 
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Section 6:  HOUSEHOLD CHARACTERISTICS  
 
119.   
Do you (or the household head) 
own or rent your home? 
Own 
Rent 
Squatters 
Care takers 
Rent free 
Other  
Specify………………………...................... 
Not sure 
1 
2 
3 
4 
5 
6 
 
98 
 
120.   
How many rooms are in your 
household? 
      
Number of Rooms 
 
Don’t know    98 
121.   
What is the main material used for 
flooring in your house?  
 
Interviewer’s observation  
Earth/Sand/Mud/Dung 
Wood Planks 
Palm / Bamboo 
Parquet or Polished Strips 
Ceramic Tiles 
Cement 
Other  
Specify…………………..........…………… 
1 
2 
3 
4 
5 
6 
7 
 
 
 
122.   
Does your house hold have any of 
the following assets?  
Read out the list. (MULTIPLE 
RESPONSE) 
 
Electricity 
Radio 
Television 
Refrigerator 
Telephone 
 
Y 
1 
1 
1 
1 
1 
 
N 
2 
2 
2 
2 
2 
 
123.   
Does any member of your 
household own? (MULTIPLE 
RESPONSE) 
 
Bicycles  
Motorcycles  
Car 
Canoe 
Tractor 
Other. Specify……………………………..……... 
Y  
1 
1 
1 
1 
1 
 
N 
2 
2 
2 
2 
2 
 
 
124.  What is the main source of 
drinking water for members of 
your household? 
Piped Water Residence  
Piped Water in Public Taps 
Household well 
Public Well 
Borehole 
River, canal or Surface water 
Rainwater 
Tanker truck 
Water sachets 
Other  
Specify……………….......………………... 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
 
125.  What type of toilets does your 
household use? 
Flush toilet 
Pit Latrine 
Ventilated Improved pit latrine 
Bucket / Pan latrine 
Bush/ Field as latrine 
Other  
Specify……………………...................…… 
1 
2 
3 
4 
5 
6 
 
 
 
126.  Is your toilet is ‘shared by other 
households? 
Yes 
No 
1 
2 
 
127.  What do you use as your main Gas 1  
  188 
source of fuel for cooking in this 
household? 
(Multiple answers) 
Electricity 
Charcoal 
Wood 
Other  
Specify……………….......………………… 
2 
3 
4 
5 
 
128.  How many people currently live in 
your household? Include 
permanent residents and temporary 
visitors. 
 
Number of people in household 
 
 Not sure     98  
  
 
 
 
 
 
 
Thank you very much for your time 
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Annex 10. Papers Published  
Three papers were considered for publication corresponding to the three chapter results.  
The paper corresponding to Chapter 4 (assessment of the curative component) was published in the 
Malaria Journal:   Ferrer BE, Webster J, Bruce J, Narh- Bana S, Narh C, Allotey N, et al. Integrated 
community case management and community-based health planning and services: a cross sectional 
study on the effectiveness of the national implementation for the treatment of malaria, diarrhoea and 
pneumonia. Malaria Journal. 2016;15(340). 
The paper corresponding to Chapter 5 (assessment of the preventive component) has been accepted 
for publication in the BMC Public Health. 
The third paper corresponds to Chapter 6 (cost analysis of HBC) was published in the Malaria 
Journal:  Escribano Ferrer B, Hansen K, Gyapong M, Bruce J, Narh Bana S, Narh C, et al. Cost-
effectiveness analysis of the national implementation of Integrated Community Case Management 
and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea 
and pneumonia. Malaria Journal. 2017;16(277). 
In addition, the OPA was also publised in the BMC Health Services Research: Escribano- Ferrer B, 
Webster J, Gyapong M. Assessing the impact of health research on health policies: a study of the 
Dodowa Health Research Centre, Ghana. BMC Health Services Research. 2017;17(435). 
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